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Zusammenfassung 
In den vergangenen  Jahren sind Lipide, Membranen und deren Organisationsformen mehr 
und mehr in den Fokus der biologischen Forschung gerückt. Es wurde vorgeschlagen, dass in 
zellulären Membranen selbstassemblierende, submikroskopische Aggregate aus 
Sphingolipiden, Cholesterol und bestimmten Proteinen existieren und man vermutet, dass 
insbesondere Viren diese “Lipid Rafts” für ihren Zusammenbau nutzen und auf diese Art ihre 
Proliferationseffizienz erhöhen. Gleichwohl sind die genaue biologische Funktion und auch 
die molekulare Basis der Assoziation bestimmter Protein mit Lipid Rafts auch weiterhin 
unbekannt. In der vorliegenden Arbeit wurde Fluoreszenz-Lebenszeit-Mikroskopie genutzt, 
um die Lipid-Raft-Anreicherung des HIV-1 Glycoproteins gp41 zu untersuchen. Förster-
Resonanz-Energietransfer zwischen fluoreszenzmarkierten viralen und Raft-Marker-Proteinen 
wurde gemessen, um deren gemeinsame, lokale Aufkonzentrierung in Lipid Rafts 
nachzuweisen. Durch Verwendung verschiedener Deletions- und Mutationsvarianten des 
Proteins konnte nicht nur seine Lipid-Raft-Präferenz demonstriert, sondern auch das 
Cholesterol-Bindemotiv (CRAC) als entscheidender Faktor der lateralen Sortierung 
identifiziert werden. Wir haben in diesem Kontext auch eine systematische Zell-zu-Zell-
Variabilität in unseren Daten bemerkt, die einen zugrundeliegenden zellbiologischen 
Mechanismus der Membranorganisation nahelegt. Mithilfe von Fluoreszenz-Polarisations-
Mikroskopie konnte zudem eine klare CRAC-Abhängigkeit der gp41-Oligomerisierung 
aufgezeigt werden. Um darüber hinaus noch eine wichtige biologische Funktion des HIV 
Envelope-Komplexes, die Membranfusion, zu untersuchen, wurde einer der Nebeneffekte 
dieser Funktion, die membranlytische Wirkung verschiedener Teile von gp41verfolgt. Diese 
Eigenschaft der externen Elemente von gp41 wurde mithilfe einer durchflusszytometrischen 
Methode nachgewiesen, wobei sich abermals eine signifikante CRAC-Abhängigkeit 
feststellen liess. Die von uns gewonnenen Daten erlauben einen tieferen Einblick in die 
molekulare Basis und die biologischen Folgen der cholesterol-abhängigen lateralen 
Proteinorganisation für Virusassemblierungsprozesse an biologischen Membranen.  
Schlagwörter:  Human Immundefizienz-Virus 
       Gp41 
      Lipid Rafts 
  Fluoreszenz-Lebenszeit-Mikroskopie 
Abstract 
In recent years, there has been a considerable interest in the molecular organization of 
biological membranes. It has been hypothesized that self-assembling, freely diffusing, 
submicroscopic domains consisting of sphingolipids, cholesterol and certain proteins exist 
and the prevailing view is that those lipid rafts serve as platforms for specific molecular 
interactions by the preferential exclusion and inclusion of proteins. It was presumed, that in 
particular viruses make use of plasma membrane lipid rafts to augment the infection process 
and spread efficiently. However, the exact biological function and physical basis of protein 
partitioning into microdomains remains an outstanding question in virus biology. In the 
present study, fluorescence lifetime imaging microscopy was used to study lipid raft 
partitioning of the HIV-1 glycoprotein gp41 by detecting Foerster Resonance Energy Transfer 
between fluorescently labeled viral and raft marker proteins in living cells. Plasma membrane 
microdomain association of gp41 was demonstrated and by introducing systematic mutations 
and truncations in different gp41 motifs, the cholesterol recognition amino acid consensus 
(CRAC) was identified as the crucial determinant of the lateral sorting. Interestingly, we 
observed a systematic cell-to-cell variability in our raft related data that suggests underlying 
cell-biological mechanisms of membrane organization. Moreover, fluorescence polarization 
microscopy revealed a distinct CRAC requirement for gp41 oligomerization whereas other 
properties, such as intracellular distribution and expression efficiency were clearly 
demonstrated to be CRAC independent. Based on those findings a biological function of 
gp41, namely the membrane perturbation exerted by the protein’s membrane proximal 
external region was investigated using flow cytometry. Again, a significant CRAC 
dependence of that property was found underlining the importance of a functional cholesterol 
binding motif. Our data provide further insight into the molecular basis and biological 
implications of the cholesterol dependent lateral protein sorting for virus assembly processes 
at cellular plasma membranes.  
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aa Amino acid 
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DSM Detergent soluble membrane 
Env Envelope protein 
ER Endoplasmic reticulum 
FACS Fluorescence activated cell sorting 
FAIM Fluorescence anisotropy imaging microscopy 
FLIM Fluorescence lifetime imaging microscopy 
FP Fusion peptide 
FRET Foerster resonance energy transfer 
GalCer Galactosyl ceramide 
Gp120 Glycoprotein 120 
Gp41 Glycoprotein 41 
GPI Glycoslylphosphatidylinositol 
GPMV Giant plasma membrane vesicles 
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HIV Human immunodeficiency virus 
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IN  Integrase 
Ld Liquid disordered 
LLP Lentivirus lytic peptide 
Lo Liquid ordered 
MA Matrix protein 
MPER Membrane proximal external region 
mRNA Messenger RNA 
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NC  Nucleocapsid protein 
Nef Negative regulatory factor 
PAGE Polyacrylamide gel electrophoresis 
PALM Photoactivated localization microscopy 
PBS Phosphate buffered saline 
PC Phosphatidylcholine  
PM Plasma membrane 
PMS Plasma membrane spheres 
PR Protease 
RER Rough endoplasmic reticulum 
Rev 
RNA 
Regulator of expression 
Ribonucleic acid 
RT Room temperature 
RTr  Reverse transcriptase 
SD Standard deviation 
SDS-PAGE SDS polyacrylamide gel electrophoresis 
SEM Standard error of the mean 
SIV Simian immunodeficiency virus 
SU  Surface subunit 
Tat Transactivator of transcription 
TCR T-cell receptor 
TCSPC Time-correlated single photon counting 
TM  Transmembrane subunit 
TMD Transmembrane domain 
Trp Tryptophan 
Vif Viral infectivity factor 
Vpr Viral protein r 
Vpu Viral protein u 
vRNA Viral RNA 
WT Wild type 
YFP, mYFP Yellow fluorescent protein, monomeric yellow fluorescent protein 
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1. Introduction 
1.1 AIDS and the HI virus 
The acquired immune deficiency syndrome (AIDS) with its causative agent the human 
immunodeficiency virus (HIV) ranks amongst the most devastating pandemics ever observed. 
Since the discovery of HIV in the early eighties of the last century1–4 around sixty-million 
people have been infected and nearly half of them have died5–7. In recent years, billions of 
dollars have been spent on HIV research and innumerable studies were published dealing with 
HIV and AIDS (PubMed hits for HIV: 250000) making HIV the most intensively investigated 
and best characterized pathogen in human history. As a result of that effort disease, virus 
lifecycle and viral components have been described accurately and different therapeutic 
strategies were developed. For instance, the application of protease inhibitors that prevent 
virus maturation and thus lower the infectivity of newly synthesized particles, AIDS death 
rates could be lowered by more than two-thirds within the first two years of their licensing in 
the US8. However, the pandemic still spreads uncontrolled in wide parts of the world and the 
number of new infections rose unconfined from below 0,002 ‰ of the global population in 
1960 up to around 0,5 % in 20106,9.         
1.1.1 History 
AIDS resulting from HIV infection, was first described in 1981 when a common pattern of 
symptoms was observed among a small number of homosexual men in the US1. The most 
prevalent causative pathogen, HIV type 1 (HIV-1) was discovered in 1983 in the group of Luc 
Montagnier and in the following years, several related members of the lentivirus genus were 
identified. The Simian immunodeficiency virus (SIV) was discovered in 1985 and HIV type 2 
(HIV-2) shortly afterwards in 198610. In spite of decades of research, to date, the AIDS 
pandemic still continues to spread globally with more than 34 million individuals currently 
infected with HIV6.  
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1.1.4 Origin and evolution of HIV 
These days, it is largely accepted that HIV is a descendant of a simian immunodeficiency 
virus. Phylogenetically, HIV-1 clusters with chimpanzee SIV15 whereas HIV-2 descends from 
a sooty mangabey ancestor virus15. Interestingly, it was found that at least seven independent 
transmissions occurred from sooty mangabey resulting in the 7 known HIV-2 subtypes10 and 
it was hypothesized, that all HIV-1 groups represent separate crossover events from chimps to 
humans. The first zoonotic transmission from chimpanzees was dated back to, most likely 
1908 whereas HIV-2 crossed the species barrier in the 30ies of the last century9.   
1.1.5 HIV transmission 
Typical ways of HIV infection are sexual intercourse without condoms, the use of unsterilized 
syringes by drug users, blood transfusion and mother-to-child transmissions6. Most infections 
occur by sexual exposure, where HIV is transmitted from one individual to another by body 
fluids like for instance blood, sperm or vaginal secretion. It enters the human body via open 
wounds or vulnerable and thin areas of the skin and through mucous membranes and usually, 
multiple sexual exposures are needed for infection to occur. Interestingly, it has been shown, 
most of the mucosally transmitted HIV-1 infections are initiated by a single virus particle16.   
1.1.6 Pathogenesis  
Acute primary infection5,6. After entering the body and if necessary crossing mucosal 
barriers, viruses first infect a large number of CD4 positive cells (Figure 1-4). It replicates 
rapidly and spreads throughout the whole body, in particular infecting the lymphoid organs 
thymus, spleen and the lymph nodes. In this phase up to 70 % of the infected people suffer 
flu-like symptoms. The virus can integrate in the host’s genome and might lie dormant, 
shielded from the immune system, for an extended period of time up to many years.   
Clinically asymptomatic stage5,6. In this phase, lasting for an average of ten years, the 
immune system fights the infection with killer T-cells (CD8 positive T-cells) and B-cell 
produced antibodies. As a result of that, this phase is free of symptoms and the virus load in 
the peripheral blood is very low (Figure 1-4). Still, the patient remains infective and 
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indications were found that HIV is not dormant on a systemic level in this phase of infection 
but rather is very active in the lymph nodes. 
Symptomatic HIV infection5,6. Over time, the immune system is severely damaged by the 
infection. The lymph nodes loose activity as a result of years of continues challenging, the 
virus evolves and becomes more pathogenic and less immunogenic allowing eluding and 
hampering the immune system (see also 1.1.8) and moreover, the organism fails to replace 
destroyed T-helper cells. Opportunistic infections emerge and often multi-system disease and 
infections occur in all parts of the body.  
Progression to AIDS5,6. As the immune system becomes more and more damaged, the 
organism faces progressively severe opportunistic infections and cancer. The HIV viral load in 
the blood dramatically increases while the number of CD4 positive cells drops to dangerously 
low levels. AIDS is diagnosed when the patient has one or more opportunistic infections and 
less than 200 CD4 positive cells per ml (1000 cells/ml for a healthy person)6.  
 
Figure 1-4: Typical course of HIV infections. The relationship between virus load and the number of T-
cells in the context of disease progression in case of untreated HIV infection is plotted. Adapted from 17. 
1.1.7 Immune response  
During the first months of infection, an effective immune response to the virus is established. 
CD8 T-cells act against HIV by directly killing HIV-infected cells and by secreting anti-viral 
chemokines16,18. Whereas CD4 positive cells are quickly depleted after infection, the number 
of CD8 positive cells increases up to 20-fold18. Moreover, a humoral response is developed 
after 4 to 8 weeks with antibodies mainly targeting cell-free virions and to a lower extend 
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infected cells18.  A detailed description of the immune response to acute infections of HIV-1 
can be obtained from the literature19. 
1.1.8 Tropism 
All HIV isolates are able to infect CD4 positive primary T-cells10. However, differences were 
found in the relative tropism for macrophages and human T-cell lines. Therefore, isolates 
were historically divided into three groups with respect to their replication rate and 
syncytium-induction in vitro. The first group are the R5 tropic viruses that infect macrophage 
cell lines in vitro and use CCR5 as a coreceptor10. The second group are the CXCR4 or X4 
tropic viruses that use CXCR4 as a coreceptor and viruses from this group replicate to high 
titers in CD4 positive cell lines10. The third group uses both coreceptors and thus are 
designated dual-tropic or R5/X4 viruses10. It has been reported, that R5 viruses are 
predominantly transmitted and thus macrophages and CD4 positive memory cells are the first 
target of a HIV-1 infection. R5/X4 viruses precede the evolution to X4 tropism and a broader 
T-cell targeting20. Presumably, this evolution from R5 to X4 tropism in an infected individual 
is related to the individual disease progression and development10,20,21 from the milder and 
specific proliferation in macrophages and memory T-cells in the early phase of infection to an 
aggressive and invasive replication with an expanded T-cell tropism in the late phase22. 
1.1.9 HIV structure and components 
A typical HI virus particle is composed of two strands of RNA, 15 different viral and some 
host cell proteins, all surrounded by a lipid bilayer membrane (Figure 1-5). The genetic 
organization of HIV is complex. HIV-1 codes for 9 genes, the canonical genes Gag, Pol and 
Env but also several regulatory and accessory genes, designated Tat, Vif, Vpu, Vpr and Nef. 
The Pol gene encodes three crucial enzymes: the reverse transcriptase (RTr), which converts 
the viral RNA genome into DNA; the integrase (IN), which mediates the insertion of that 
DNA into the genome of the host cell and finally the protease, which is essential for the 
maturation of virions into their infective form. Whereas the genes Tat and Rev are important 
for virus replication, Vif, Vpr, Vpu and Nef modulate immune functions in vivo. Env and Gag 
code for the surface receptor and major structural components, respectively. The envelope 
protein is cleaved into the surface subunit gp120 and the transmembrane subunit gp41 upon 
maturation in the host cell. 
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1.1.9.2 Structural proteins 
 
MA: The matrix protein forms a coat on the inner leaflet of the viral 
membrane. It plays a central role during budding of nascent viruses 
from the surface of infected cells by mediating the Gag interaction 
with the plasma membrane (PM).  (5000 copies/virion)24,25. 
 
CA: The capsid protein forms a cone-shaped coat around the viral 
RNA26. Stable hexamers of this protein assemble to geodesic capsids 
that deliver the viral genome in the host cell. (5000 copies/virion)24,25. 
 
SU and TM: The envelope proteins gp120 (SU) and gp41 (TM) bind 
to receptors on the surface of the target cell and penetrate the plasma 
membrane to finally induce fusion. Only low numbers of those 
trimeric, gp120/gp41 heterodimers were found in viral particles and 
the spikes formed by these proteins were demonstrated to be highly 
decorated with carbohydrates. (4 to 35 trimers/virion)24,25. 
 
NC: The nucleocapsid protein (orange) forms a stable complex with 
the viral RNA (yellow). It works as a primer for the reverse 
transcription and mediates packaging and folding of genomic RNA.  
Moreover, it was reported to assist during virion assembly. (5000 
copies/virion)24,25. 
1.1.9.3 Accessory proteins 
 
Nef: The negative regulatory factor inhibits the expression of cellular 
defensive proteins. It blocks apoptosis, enhances viral replication and 
infectivity and connects cellular proteins to sorting pathways thus 
regulating trafficking, degradation and immune recognition. (extent of 
incorporation unknown)24,25. 
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Rev: The regulator of expression of virion proteins (orange) binds 
hairpins of the viral RNA (yellow) and regulates its splicing and 
transport from the nucleus to the cytoplasm. (not incorporated into the 
virion)24,25. 
 
Tat: The transactivator of transcription (orange) binds to viral RNA 
(yellow) and greatly enhances transcription elongation. (not 
incorporated into the virion)24,25. 
no high resolution    
available yet 
P6: This protein promotes virion budding by recruiting the cellular 
endosomal sorting complex required for transport (ESCRT) 
machinery and is involved in the incorporation of vpr in the nascent 
virus. (5000 copies/virion)24,25. 
 
Vpr: The viral protein r targets the viral genome to the nucleus after 
infection. Moreover, it arrests the host cell in the G2/M cell cycle 
phase. (700 copies/virion)24,25. 
 
Vif: The viral infectivity factor efficiently suppresses the host cell 
infection inhibition by APOBEC3G/APOBEC3F. Vif recruits cellular 
ubiquitin ligases to subject both proteins to degradation. (1 to 150 
copies/virion)24,25. 
 
Vpu: The viral protein u forms an ion channel in the viral membrane 
and causes degradation of CD4. Moreover, by binding cellular 
tetherin and causing internalization, it prevents tethering of nascent 
viral particles at the host cell surface and thus inhibition of virus 
release. (not incorporated into the virion)24,25. 
1.1.10 HIV replication 
The HIV replications cycle is very complex and requires a highly regulated interplay of the 
viral components and interactions with cellular proteins. For a better understanding it is 
schematically displayed in Figure 1-6. The first step of HIV infection is the attachment of the 
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Then, the ends of the double stranded viral DNA are joined non-covalently and the resulting 
circular DNA is moved into the nucleus for further insertion in the host cell chromosome by 
the viral integrase enzyme30. The integrated viral DNA, called proviral DNA can remain 
dormant or, upon activation by cellular transcription factors, RNA may be synthesized 
yielding messenger RNA and viral genomic RNA. For protein synthesis, the integrated 
provirus is first transcribed into mRNA which in turn is spliced and exported to the cytosol30. 
Translation to the regulatory proteins tat and rev occurs and rev begins to accumulate in the 
nucleus, where it eventually binds viral mRNA and mediates the nucleus-exit of unspliced 
transcripts. As a result of that, the structural proteins Gag and Env are translated from the full-
length mRNA which also represents the actual virus genome. As many viral proteins the 
envelope protein gp160 requires cleavage by cellular proteases to process the long polyprotein 
precursors to functional proteins. The viral components assemble at the host cell plasma 
membrane and finally the virion is released by budding. Maturation of the virus particles 
occurs either in the forming bud or in the immature virion after release from the cell. To this 
purpose, the Gag polyprotein has to be cleaved into individual functional proteins by the work 
of the viral protease so that finally the virion rearranges to yield a mature, infective particle31. 
1.1.11 Structure and function of the HIV envelope complex 
As described before, the HIV replication cycle is initiated by adhesion of extracellular virions 
to the target cells and fusion of the virus envelope with cellular membranes, a process that is 
mediated by the viral envelope glycoprotein complex. The prevailing model describes a three 
step mechanism of conformational changes in the envelope complex that cause virus binding 
and membrane fusion (Figure 1-7). At first, the envelope complex exists in the native state 
with the hydrophobic gp41 ectodomain efficiently shielded from the environment32. Upon 
binding of envelope surface subunit gp120 to the receptor protein CD4, the variable regions 
V1, V2, V3 of gp120 are rearranged and the so called bridging sheet which is comprised of 
two double-stranded beta-sheets is formed33. Both, bridging sheet and variable region V3 are 
required for the subsequent gp120 coreceptor binding. Besides rare exceptions, binding of 
primary receptor and coreceptor, usually the chemokine receptors CXCR4 or CCR5, is 
necessary to allow a further progression of the fusion reaction. But, it has been proposed that 
also other cellular proteins like the protein disulfide isomerase (PDI)34, dendritic cell-specific 
intercellular adhesion molecule-3-grabbing non-integrin (DC-SIGN)33, a4b7 integrins33 or 
syndecans35 might be involved in the gp120 rearrangement or in the formation of the 
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involved in the opposing direction, the transport from trans-Golgi-network to the plasma 
membrane. It has been reported, that this latter trafficking route requires a conserved c-
terminal dileucine motif of gp4194 and it is not yet clear, whether YXXL also participates in 
the AP-1 interaction94,96 since contradicting experimental observations were published. 
However, it is known that the C-terminal dileucine also assists the Y712 motif in restricting 
the cell surface localization of env94. Finally, another tyrosine-based motif, Y802W803 was 
demonstrated to specifically bind TIP4746 (tail-interacting protein of 47kDa), a protein that is 
necessary for the retrograde transport from late endosomes to the TGN95. This interaction was 
reported to moderate the formation of a ternary complex between env, Gag and TIP47 and 
therefore influence Gag-Env colocalization, virion infectivity and Env incorporation. From 
the previous, partly contradictory observations it seems that several gp41 motifs are involved 
in host protein interactions and regulation of its intracellular transport and that the interactions 
with cellular trafficking proteins are interdependent, presumably at least partly redundant, and 
perhaps cooperatively.       
1.2.2.3.3 Protein palmitoylations 
The cytoplasmic tail of the HIV-1 Env protein carries 
palmitoylated cysteine residues (Figure 1-18). This protein 
modification was reported to promote association with 
ordered domains in giant unilamellar vesicles (GUVs), giant 
plasma membrane vesicles (GPMVs)97,98 and lipid rafts in 
cellular membranes. Depending on the virus isolate, two, one 
(the N-terminal, left) or even no palmitoylation (Figure 1-22) 
were found indicating a minor importance of that protein 
modification for an efficient virus progression. However, 
experimental results regarding the function of gp41 
palmitoylation are very contradictory. Some publications 
report a palmitoylation-dependence of gp41 raft 
partitioning99,100 and virus incorporation100 whereas others demonstrated that microdomain 
sorting and virus incorporation are completely independent of palmitoylation101 and rather 
require different, yet to be identified factors in the C-terminal part of the gp41 cytoplasmic 
tail90.   
Figure 1-18: Schematic 
representation of HXB2 
gp41 palmitoylations.  
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cross the membrane and upon trimerization of monomers to the oligomeric complex this 
organization might allow the formation of a pore with the hydrophilic residues of the 
amphipathic LLPs exposed to the lumen of that pore.  
1.2.4 Gp41 intracellular trafficking and transport 
The HIV-1 envelope complex is synthesized as a polyprotein precursor from a spliced 
bicistronic vpu/Env mRNA. The unprocessed precursor gp160 contains an N-terminal 
endoplasmic reticulum signal sequence which targets the protein to the membrane of the 
rough endoplasmic reticulum and is post-translationally removed by cellular signal 
peptidases103 (Figure 1-20). A hydrophobic stop-transfer signal in the transmembrane domain 
retains the protein in the ER membrane, leaving the intracellular domain in the cytoplasm and 
later in the interior of the virion27. Concomitant with its translation, gp160 is glycosylated and 
assembles into oligomers as a prerequisite of its trafficking to the Golgi apparatus27. Here, 
gp160 is proteolytically cleaved by cellular furin or furin-like proteases at a conserved motif 
to generate the mature receptor protein gp120 and the transmembrane subunit gp4127. Both 
proteins remain associated by non-covalent interactions, resulting in heterotrimeric complexes 
composed of three individual gp41 and gp120 molecules each27. This process is followed by 
complex high-mannose oligosaccharide-modifications in the trans-Golgi network27.  
Further transport to the plasma membrane in the cell is very complex and highly regulated. 
Although many cellular interaction partners of the envelope proteins have been described, the 
exact progression and significance of different cellular transport routes is under debate. At 
least three different motifs were identified in the gp41 cytoplasmic tail (see Figure 1-17) and 
each of those sequences is able to interact with several adaptor complexes in different cellular 
environments27. It is known that the majority of Env molecules is transported to the plasma 
membrane and rapidly reinternalized via AP-2 driven clathrin-mediated endocytosis27. 
However, the function of this constrained surface localization and also the fate of internalized 
glycoproteins is unknown, but most likely it contributes to the relatively low cell- and virion-
surface levels of Env (~10-30 spikes/virion). Furthermore, it might help the virus to evade the 
host immune response and decrease virus-induced cytopathicity27.  
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be required to bridge both proteins46. However, still several models of Env incorporation in 
virus particles exist (Figure 1-21) and further experiments are required to enlighten the 
interplay of viral proteins in the assembly process. Interestingly, interactions between the 
gp41 CT and Gag also seem to influence virus maturation and rigidity after budding and 
release and, as a result of that, also the infectivity of virus particles95 (see also 1.2.2.3.2).          
1.2.6 Diversity of the envelope complex 
HIV is a dynamic and highly divers virus. A distinction is made between two types of the 
virus with completely different phylogenetic origins. As described before (see 1.1.4), type 1, 
which causes most of the infections worldwide, most likely descents form chimpanzee SIV, 
whereas HIV-2 was supposed to be a zoonosis from the sooty mangabey. Since HIV-2 is 
regionally very restricted it only causes a significant minority of all occurring HIV 
infections10. Therefore, most of the present knowledge has been derived from type 1 virus 
isolates.   
Since the envelope complex is the only virus protein that is exposed to the cell surface, a high 
variability in this protein is mandatory for the pathogen to escape host immune reactions. 
Thus, changes in the gp120 variable region do not only promote the escape of HIV-1 from the 
humoral immune response but also control the coreceptor specificity27. Interestingly, it has 
been suggested that the envelope complex regularly evolves during disease progression in a 
single organism regarding receptor usage and host cell target (from R5 to X4 tropism). The 
switch from the during infection easy-accessible macrophages and memory T-cells (R5) to 
basically all T-cells (X4) was proposed to allow more efficient virus production in later 
phases of the etiopathology22 (see also 1.1.8). A consequence of this variability and mutability 
is a high genetic diversity of the HIV-1 pandemia. Most of the HIV-1 cases can be classified 
into the two main groups, M and O. Group M comprises the majority of HIV-1 isolates and 
can be subdivided into at least nine sequence subtypes or clades, designated A to K. The 
sequence diversity between different isolates is high (see also 1.1.2). The Env amino acid 
sequence varies up to 47 % between the groups and the variation ranges from 25 to 35 % 
between different M group members88. But even within one subtype the variation ranges from 
3 to 23 %88. Most lab-adapted virus isolates used for non-clinical studies in recent years 
belong to the subtype B. The glycoprotein gp41 of the prevalent isolates HXB2 and JRFL 
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share around 86 % of the amino acids (uniprot alignment) but nevertheless show some 
significant differences (Figure 1-22). 
             
Figure 1-22: Partial gp41 sequence alignment of the common HIV-1 virus isolates JRFL (Uniprot-
entry: Q75760), JRSCF (P20871) and HXB2 (P04578). The conserved CRAC domain highlighted in 
dark grey and transmembrane domain in light grey are highly conserved, whereas for instance the 
palmitoylated cysteines C764 and C837 (numeration from HXB2) labeled in black are variable. 
The isolate JRSCF, another important lab strain, although isolated from the same patient as 
JRFL was demonstrated to have a deviating phenotype and also differences in the amino acid 
sequence. One particular difference between the three isolates is the cytoplasmic cysteines 
that are targets of palmitoylation. Whereas HXB2 harbors two palmitoylation sites, JRFL 
comprises only one and JRSCF completely lacks targets of post-translational lipidation 
(Figure 1-22). It should be pointed out here, that usually the HIV-1 literature refers to the 
HXB2 isolate regarding residue numbering, amino acid sequences and structures.   
1.3 Lateral membrane organization 
Cellular membranes are formed by hundreds of different lipid species108, interacting with a 
tremendous amount of membrane proteins in various conformational states. As a result of that 
complexity, eukaryotic bilayers are believed to exist not only in various ordering states with 
respect to their environmental context and lipid composition109 but also to be laterally 
heterogeneous110 (schematically displayed in Figure 1-23A). It is therefore widely accepted 
that biological membranes and in particular plasma membranes have a subcompartmentation 
due to self-organizing properties of the molecules they are consisting of. Ordered domains 
with a higher lipid packaging than the surrounding membrane have been reported to 
spontaneously form in artificial membrane systems of a suited composition111,112 
JRFL NEQELLELDKWASLWNWFDITKWLWYIKIFIMIVGGLVGLRLVFTVLSIVNRVRQGYSPL 706 
JRSCF NEQELLELDKWASLWNWFGITKWLWYIKIFIMIVGGLIGLRIVFSVLSIVNRVRQGYSPL 707 
HXB2 NEQELLELDKWASLWNWFNITNWLWYIKLFIMIVGGLVGLRIVFAVLSIVNRVRQGYSPL 715 
 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -  
JRFL SFQTLLPAPRGPDRPEGIEEEGGERDRDRSGRLVNGFLALIWVDLRSLCLFSYHRLRDLL 766 
JRSCF SFQTLLPATRGPDRPEGIEEEGGERDRDRSGQLVNGFLALIWVDLRSLFLFSYHRLRDLL 767 
HXB2 SFQTHLPTPRGPDRPEGIEEEGGERDRDRSIRLVNGSLALIWDDLRSLCLFSYHRLRDLL 775 
 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -  
JRFL LTVTRIVELLGRRGWEVLKYWWNLLQYWSQELKNSAVSLLNATAIAVAEGTDRIIEALQR 826 
JRSCF LTVTRIVELLGRRGWEILKYWWNLLQYWSQELKNSAVSLLNATAIAVAEGTDRIIEVVQR 827 
HXB2 LIVTRIVELLGRRGWEALKYWWNLLQYWSQELKNSAVSLLNATAIAVAEGTDRVIEVVQG 835 
 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -  
JRFL TYRAILHIPTRIRQGLERALL 847 
JRSCF VYRAILHIPTRIRQGLERALL 848 
HXB2 ACRAIRHIPRRIRQGLERILL 856 
 

28  INTRODUCTION   
many doubts remain regarding the lateral subcompartmentation model in general but more 
importantly regarding the hitherto experimental approaches119,120 (also addressed in 1.3.2).     
1.3.1 Lipid rafts in the virus context  
Proteins supposed to be associated with membrane microdomains cover the whole spectrum 
of life. Rafts and raft associated proteins were found in viruses98, bacteria121,122 and all kinds 
of eukaryotic cells118,123. Nevertheless, a reasonable focus of research in the field lies on 
viruses and phages since especially virus assembly and budding dictates a high spatial and 
temporal control of molecular interactions. Correspondingly, virus proteins were found in raft 
preparations of infected cells90,98,123–126 pointing to an important function of lipid 
microdomains in virus lifecycles. Furthermore, for several viruses the role of microdomains 
and cholesterol in both infection and assembly was demonstrated by observing the severe 
effects of raft disrupting agents like methyl-beta-cyclodextrin125,127,128 or nystatin127 on 
different virus functions.  
1.3.1.1 The relevance of rafts in the HIV-1 lifecycle 
Depletion of cholesterol from HIV-1 virions, was shown by Campbell and coworkers128, to 
cause a significant reduction of infectivity and this effect was abrogated after restoring 
cholesterol. Moreover, HIV-1 particles produced from cholesterol-depleted cells were proven 
to be less infectious and virus entry could be inhibited by cholesterol-binding compounds129. 
Furthermore, it is known that both HIV-1 receptors on a T-cell surface, CD4 and CCR5, are 
associated with lipid rafts and CD4 mutants defective in raft partitioning are unable to support 
HIV-1 infections130 pointing to an important role of lipid rafts in the first infection steps. Vpu, 
another HIV-1 protein, counteracts the function of cellular tetherin, which fixes assembled 
virions at the plasma membrane and prevents virus spread131. Both proteins, tetherin and vpu 
were found to be raft associated and it is reasonable that their interaction depends on the 
common clustering in lipid microdomains132,133. Finally, it is well documented that the 
assembly of Gag oligomers occurs in lipid rafts at the plasma membrane and a mechanism 
based on the myristoylation of the p17 subunit could be proposed, explaining the molecular 
background of the polyprotein’s lateral sorting into ordered microdomains105.  
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1.3.1.2 Function of a potential gp41 raft partitioning 
The general relevance and in particular the function and of a protein’s raft partitioning is still 
under debate. For virus proteins the most obvious guess would be a role in virus assembly and 
budding. Although it could be shown that cholesterol depletion of HIV-1 infected cells is 
significantly impairing virus production and virus infectivity115 the question whether gp41 raft 
partitioning is influencing its incorporation in virus particles, or virus infectivity has yet not 
been elucidated definitely. Publications regarding that question are not always consistent and 
sometimes contradictory90,100,101. Further studies are necessary to deepen our understanding of 
the biological background of protein enrichment in membrane microdomains and specific 
lipid binding motifs.   
1.3.2 Methods used to study membrane microdomains 
In recent years, different techniques have been applied to study cellular lipid rafts. Often 
detergent resistant membranes (DRM) were investigated assuming that those preparations are 
representative for plasma membrane microdomains90,106,119,134. In those experiments a 
remarkable compositional discrepancy was found between DRM and the membranes they are 
derived off regarding both purified lipids and proteins135. This finding points to a lateral 
subcompartmentation of the plasma membrane, a hypothesis that was further supported by 
cholesterol depletion assays. For those experiments cells were treated with cholesterol 
depleting agents like cyclodextrins or statins since cholesterol is supposed to be a major 
component of plasma membrane microdomains and it was demonstrated that raft related 
properties are significantly influenced by the cholesterol depletion135. But, both methods are 
controversial and obtained results should be judged carefully136. Although  DRM preparations 
are generally supposed to selectively purify lipids and proteins comprising plasma membrane 
microdomains, often contradictory results were obtained in different attempts and findings 
were found to be prone to slight changes in the experimental setups117. Cholesterol depletion 
assays on the other hand generate reproducible and reliable results, but since cholesterol is a 
crucial factor of cellular metabolism, side-effects of a depleting treatment are hard to survey 
and might influence observed properties in an unpredictable manner117.  
Recently, several new techniques were applied to circumvent those drawbacks and observe 
lipid rafts within the native environment of an undisturbed cell. FRET approaches, 
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fluorescence polarization anisotropy and FCS (fluorescence correlation spectroscopy) as well 
as super resolution microscopic methods like STED (stimulated emission depletion), STORM 
(stochastical optical reconstruction), PALM (photoactivated localization microscopy) or SIM 
(structured illumination) confirmed cholesterol-dependent clustering of proteins in nanoscale 
microdomains with diameters of 100 nm and less in living cells117,137,138.    
1.3.3 Protein factors of lateral membrane sorting 
In recent years, several determinants for a targeting of proteins to lipid rafts have been 
proposed or even identified. GPI anchors98,113,139–143 and protein acylation97,98,100,144 were 
found to cause a lipid phase preference. Acylation is conducted with myristic acid on the N-
terminal amino group or with palmitic acid on cysteine residues145 and in their final form, GPI 
anchored proteins are linked with a stearoyl group146. Considering that, in general saturated 
acyl chains of phospholipids and cholesterol moieties induce partition into the highly ordered 
lipid rafts due to their smooth surface, all the aforementioned modifications are usually 
believed to support a lateral sorting of the protein they are bound to.  Another indirect 
mechanism depends on other bilayer components that are themselves part of a particular 
domain. Proteins to be targeted to lipid rafts might bind those scaffolding molecules like 
caveolin or raft enriched lipids like cholesterol to associate with lipid rafts. Finally, the 
influence of membrane thickness and the smoothness of transmembrane domains are physical 
factors the might also contribute to protein sorting and preferential lateral sorting. In theory, 
the thick and ordered lipid rafts should facilitate incorporation of unruffled and longer 
membrane spanning domains due to energetic reasons and to avoid hydrophobic mismatch147.       
1.3.4 Molecular background of a potential gp41 raft partitioning 
Since several viral proteins were shown to be directly associated with DRM and HIV-1 in 
general turned out to be highly influenced by cholesterol114,115,129,130,148  it is very likely that 
the envelope glycoprotein complex is associated with plasma membrane lipid rafts. It is the 
only HIV-1 transmembrane protein and as described before it contains several determinants 
supposed or known to drive proteins into ordered lipid microdomains.  
Interestingly, over the years all of the aforementioned raft partitioning mechanisms have been 
proposed to play a role in the lateral sorting of env. The gp41 cholesterol recognition amino 
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acid consensus, for instance, was reported to specifically bind cholesterol, suggesting an 
important function of this sequence for microdomain sorting. Contradictory results were 
obtained regarding gp41 palmitoylation sites. In 2000, Rousso et al. reported that gp41 DRM 
partitioning and virus infectivity depends on palmitoylated cysteins100, whereas Chan et al. 
demonstrated a wild type like behavior, including unaffected raft partitioning, of gp41 
palmitoylation mutants101. The fact that isolated virus clones were found to contain one, two 
or even completely lack palmitoylated cysteines also points against an important function of 
this modification for the induction of raft partitioning. Taking a more holistic point of view 
Yang showed in 2010 that α-helical and amphipathic motifs within the cytosolic domain of 
gp41, the so called lentivirus lytic peptides, affect gp41 localization in lipid rafts90. Insertion 
of proline in the hydrophobic face of those helices turned out to significantly reduce gp41 
association with lipid rafts without influencing intracellular localization, cell surface 
expression, virion incorporation or viral replication capacity. An extrinsic factor of gp41 raft 
partitioning might be the interaction with other viral components. Indications were found for 
example, that the microdomain sorting of the envelope complex is a result of its interaction 
with the Gag polyprotein, which is itself widely accepted to be a raft protein106. 
In summary, gp41 was repeatedly shown to be enriched in DRM by several groups in the last 
ten years. However, evidence based on more reliable methods than DRM preparation are still 
missing and moreover, the molecular background of the preference for ordered domains 
remains insufficiently elucidated.  
1.4 The toolbox: fluorescence spectroscopy and microscopy 
Fluorescence-based methods are indispensable tools of modern biological research. They 
offer a high versatility, specificity and sensitivity and allow visualization and analysis of 
complex and dynamic events in a wide range of systems from completely artificial structures 
like for instance GUVs to the physiological context of a living animal149. Processes can be 
studied over several orders of magnitude in time (from picoseconds to days)150 and space 
(from nm to cm)137,149. Although many assays just assess fluorescence intensities and 
wavelength, a wide spectrum of methods has emerged utilizing different aspects of the 
fluorescence process to collect as many information as possible. 
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Usually, emission spectra are independent of the excitation wavelength because of this rapid 
relaxation process. External conversion, which is an energy transfer to the solvent or a solute, 
depletes the excited state by molecular collision. This kind of quenching depends on contact 
between analyte and quencher and therefore is a function of temperature, solution viscosity 
and quencher concentration. Intersystem crossing is another energy dissipation pathway. The 
excited electron has to change its spin multiplicity from singlet to triplet state and since this 
process is essentially quantum-mechanically forbidden, it is very unlikely and thus occurs in a 
time range of ms to minutes. The most prominent process, fluorescence is the returning of the 
electron to the lower energy level it originated from that is accompanied by an emission of 
light. Since internal conversion causes a significant energy loss, the wavelength of the emitted 
photons is reduced compared to the excitation light, resulting in red-shift or Stokes shift of the 
emission.      
1.4.1 Foerster resonance energy transfer 
Among the huge variety of applied fluorescence-based methodologies, Foerster resonance 
energy transfer (FRET) assays remained unique for decades as the only techniques that allow 
investigation of processes with a nanometer resolution. FRET is a process in which the energy 
of the excited state of a fluorophores (donor) is non-radiatively transferred to another 
fluorophore (acceptor) via a dipole-dipole coupling mechanism. The rate constant of FRET 
depends on the distance and relative orientation of the participating fluorophores, the overlap 
between the donor emission and acceptor excitation spectra, the quantum yield and the 
fluorescence lifetime of the donor151. Since FRET is proportional to the sixth power of the 
distance between the two contributing fluorophores, FRET typically spans distances of 2 to 10 
nm and therefore is often used as a reporter of direct molecular interactions or a specific 
clustering. The following formula describes the rate of energy transfer  
𝒌𝑻(𝒓) =
𝟏
𝝉 
(
𝑹 
𝒓
)
𝟔
   (2) 
Where τD is the decay time of the donor in absence of the acceptor, R0 is the specific Forester 
distance and r is the donor-acceptor distance150.  
Hitherto, FRET was already often used to study subresolution protein-protein 
interactions98,124,151 but concomitant with recent improvements in the detector technology an 
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experimental precision could be achieved that enables investigations even in the Ångström 
range with resolutions advancing in the atomistic regime152. Those approaches can help to 
complement static high resolution methods like nuclear magnetic resonance (NMR) and 
electron microscopy (EM) with dynamic data and for the first time allow to follow molecular 
processes instead of just observing static conformations152,153.     
Several experimental approaches are available to measure FRET based on different properties 
of the energy transfer. As described before, for FRET to occur the donor fluorophore has to be 
in the excited state. Instead of relaxing upon emission of fluorescence, excited states 
undergoing FRET transfer the excitation energy radiationless to another fluorophore. This 
causes a decrease of the number of emitting donor fluorophores and thus a reduced 
fluorescence intensity. In parallel, acceptor emission emerges without a specific excitation. 
Both values, emission intensity of the donor and emission intensity of the acceptor can be 
used to estimate steady-state FRET. Another property of fluorophores that can be used to 
study energy transfer is the lifetime of the excited state. The likelihood of an energy transfer is 
the higher the longer an electron is in the excited state and as a result of that, long-living 
excited states undergo energy migration with a higher probability. As a consequence, the 
overall lifetime of the excited state is significantly reduced.      
1.4.2 Fluorescence lifetime imaging microscopy and FLIM-FRET 
Several techniques can be applied to assess fluorescence lifetime data using a microscopic 
setup. Fluorescence lifetime imaging microscopy (FLIM) is a method that maps the spatial 
distribution of fluorescence lifetimes within microscopic images. In general, the lifetime of an 
excited state is the average time individual molecules spend in the excited state prior to 
relaxation to the ground state150. Since fluorescence emission is a random process, molecules 
will not emit their photons at a distinct timepoint. Therefore, in the ensemble description the 
emission of a certain fluorophore will decay according to: 
𝑰(𝒕) = 𝑰 𝐞𝐱𝐩 (
−𝒕
𝝉
)   (3) 
In this mathematical description, the fluorescence lifetime τ is the characteristic time needed 
for the fluorescence intensity I to decrease to 1/e of its initial value Io
150.  
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Technically, a distinction is made between lifetime measurements in the frequency and in the 
time domain. In time domain fluorometry, the sample is excited with a pulse of light and the 
emission photons are detected with high temporal resolution. The decay time is then 
calculated from the slope of a histogram of the individual photon arrival times. Alternatively, 
in frequency domain measurements the excitation intensity is modulated, forcing the emission 
to respond at the same modulation frequency. The lifetime of the fluorophore causes a shift of 
the emission in time and this phase shift can be used to calculate the decay time. Different 
microscopic setups are available such as the time-correlated single photon counting (TCSPC) 
with confocal microscopes or fast gated intensifier CCD cameras in wide field microscopy. 
TCSPC has a very good signal-to-noise ratio and a high temporal resolution in terms of single 
photon events but suffer of long acquisition times and thus a low temporal resolution in terms 
of the imaging process. For fast processes, wide-field detection is preferable150.       
FLIM-FRET experiments are based on the fluorescence lifetime of the FRET donor. Since 
FRET offers an additional possibility for the FRET donor to relax to the ground state, upon 
energy transfer the probability of relaxation is significantly increased. As a result of that, the 
fluorescence lifetime of a FRET donor decreases in presence of a suitable FRET acceptor. 
Taking this phenomenon into account, the FRET efficiency can be calculated according to:  
𝑬𝑭𝑹𝑬𝑻 = 𝟏 − (
𝝉  
𝝉 
)   (4) 
Where τDA and τD are the fluorescence lifetimes of the donor in presence and absence of the 
acceptor, respectively and EFRET is the FRET efficiency
150.  
1.4.2.1 TCSPC 
For time correlated single photon counting (TCSPC) measurements, the sample is excited 
with pulsed laser light. It is crucial that laser intensity and pulse frequency are precisely 
adjusted in a way that at maximum one photon is detected per repetition cycle. This setting 
allows assigning every emission photon to its respective excitation pulse. The time delay 
between every individual excitation pulse and the arrival of the emission photon is then 
determined and ‘stored’ in a histogram (Figure 1-25). Upon detection of sufficient single 
events the histogram is representative of the lifetime decay and can be analyzed to obtain the 
average lifetime of the fluorophore’s excited state150. 
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𝒓(𝒕) =
𝑰 (𝒕)−𝑮×𝑰 (𝒕)
𝑰 (𝒕)−𝟐×𝑮×𝑰 (𝒕)
    (5) 
Since, monochromators, dichroic mirrors and even detectors can have different sensitivities 
for vertically and horizontally polarized light the measured intensities do not directly reflect 
polarization parameters of the sample but are rather influenced by those factors as well. To 
take this into account, the G-factor has to be estimated as an instrumentation specific 
correction factor:  
𝑮 =
𝑰 
𝑰 
       (6) 
with I  being the intensity of the parallel and I  the intensity of the perpendicular channel.    
1.4.4 Total internal reflection fluorescence microscopy  
In fluorescence microscopy, the physical limits of optics define the maximal achievable 
resolution. Recently, new super resolution methods like STED, STORM, PALM or SIM 
pushed light microscopy below the limits of Abbe’s criterion (recently reviewed in 156,157). 
However, even some of those superresolution microscopes suffer of a very low optical 
resolution in the z-direction. Total internal reflection fluorescence microscopy (TIRFM) 
makes use of an evanescent illumination to exclusively excite fluorophores in a restricted 
region adjacent to the glass-water interface158 thus achieving a high z-resolution. To this aim, 
in TIRF microscopy the angle of the incident laser beam is tilted with respect to the normal of 
the glass surface of a coverslip or a glass-bottom dish for instance. When the light strikes the 
surface at a sufficient high angle, it is entirely reflected. Nevertheless, the reflected light 
generates a highly restricted electromagnetic field that decays exponentially with distance. As 
a result of that, the field extents at the utmost around 100 nm or less into the specimen in the 
z-direction158. This approach significantly improves signal-to-noise and allows single-
molecule detection in areas close to the glass surface of the object slide158. Thus, TIRF 
microscopy is often used to observe and study plasma membrane fluorophores and processes 
at the cell surface although the penetration depth of this technique does not allow 
distinguishing between fluorophores at or in the plasma membrane and molecules that are 
only adjacent.     
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1.4.5 Fluorescence activated cell sorting (FACS) 
Flow cytometry is a technology that simultaneously measures multiple physical parameters of 
single particles in a fluid stream as it passes through a beam of light159. Obtainable data 
include the relative size, granularity or rather internal complexity of the observed particles 
and the fluorescence intensity of as many fluorophore species one is able to distinguish in 
parallel. Any object from 0.2 to 150 µm in size is suitable for analysis and all available data 
will be collected for every individual particle in the fluid stream. Fluorescence activated cells 
sorting is a specialized type of flow cytometry. It provides a method for sorting the analyzed 
particles based on their specific light scattering and fluorescence properties. For fluorescence 
activated cell sorting (FACS), the stream of particles is dissected into individual droplets by a 
vibrating mechanism159. The system and the particle solution are adjusted to have a high 
probability of just on cell per droplet so that upon selective collecting of single droplets, 
specific cells can be sorted. To this aim, every individual droplet has to be provided with an 
electric charge and an electrostatic deflection system diverts single particles into containers 
based upon their charge159.  
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2. Aim of the study 
Assembly and the subsequent budding of enveloped viruses are complex and highly regulated 
processes. At the site of assembly, all necessary components have to be enriched and arranged 
with an outstanding local and temporal precision. Most likely, this accurate orchestration is 
achieved not only by specific molecular interactions between the participating molecules but 
also by a systematic use of the subcompartmentation that is provided by cellular lipid rafts. 
Both structural HIV proteins, gp41 and Gag have been found in detergent resistant membrane 
fractions100,115,160–162 and the viral envelope was found to resemble DRMs in composition and 
physical properties163,164. However, since DRMs were lately considered as a poor model of 
plasma membrane lipid rafts and the experimental procedure is supposed to harbor a high risk 
of inducing artifacts136, other methods have to be preferentially applied to study the lateral 
sorting of membrane proteins. Correspondingly, Gag and Env were shown to cluster with 
cellular raft components123,161,165 in microscopy experiments and cholesterol depletion was 
demonstrated to impair HIV-1 particle production115,132,161,166,167. Nevertheless, live cell 
experiments are lacking in that context and studies regarding the lateral sorting mechanism 
and the protein domains responsible for the association of the HIV-1 Env glycoprotein 
complex with lipid rafts are controversial or even contradictory. In general, observing the 
lateral organization of proteins in the plasma membrane is hindered by the fact, that lipid 
domains in biological membranes are very small, in the submicroscopic region, and highly 
dynamic168,169.  
In the present study, a FRET-based assay was applied to elucidate the raft partitioning of the 
HIV-1 glycoprotein gp41 in plasma membranes of mammalian cells98,144. Fluorescence 
lifetime imaging microscopy was used to detect the energy transfer between a 
glycoslylphosphatidylinositol (GPI) anchored cyan fluorescent protein (CFP) and the protein 
under study tagged with a yellow fluorescent protein. Since GPI anchors are generally 
believed to drive proteins into plasma membrane microdomains, GPI-CFP was employed as a 
putative raft marker protein. Assuming average microdomain diameters below 100 nm, two 
labeled proteins associated with lipid rafts should encounter each other with a high probability 
resulting in an efficient FRET (Figure 2-1).  
Different variants of the fluorescently labeled gp41 were generated by truncation and site-
directed mutagenesis to pinpoint the molecular background of the potential raft partitioning of 
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3. Material and Methods 
3.1 Materials 
3.1.1 Chemicals  
Chemicals that are not included in the following list were purchased either from Sigma-
Aldrich (Taufkirchen, Germany) or Carl Roth (Karlsruhe, Germany) in analytical standard 
quality. Phospholipids and fluorescent phospholipid analogues were obtained from Avanti 
Polar Lipids (Alabaster, AL, USA). 
Table 1: Chemicals used for molecular biology, biochemical and biophysical assays.   
Compound Manufacturer 
3,3′-Diaminobenzidine tetrahydrochloride 
(DAB)  
Sigma-Aldrich, Taufkirchen, Germany 
3-Amino-1,2,4-triazole (Aminotriazole)  Sigma-Aldrich, Taufkirchen, Germany 
Acetic acid, 100 %  Carl Roth, Karlsruhe, Germany 
Acrylamide/bisacrylamide (37.5:1), 30 %,  Carl Roth, Karlsruhe, Germany 
“Rotiphorese® Gel 30” Carl Roth, Karlsruhe, Germany 
Ammonium persulfate (APS) Sigma-Aldrich, Taufkirchen, Germany 
BactoTMagar                                                                                                     BD Biosciences, Heidelberg, Germany 
BactoTMtryptone       BD Biosciences, Heidelberg, Germany 
BactoTM yeast extract BD Biosciences, Heidelberg, Germany 
Chloroform Uvasol® for spectroscopy  Merck, Darmstadt, Germany 
Cholesterol  Sigma-Aldrich, Taufkirchen, Germany 
Coomassie Brilliant Blue R-250  Carl Roth, Karlsruhe, Germany 
4',6-diamidino-2-phenylindole (DAPI)  Invitrogen, Karlsruhe, Germany 
Dithiothreitol (DTT) Sigma-Aldrich, Taufkirchen, Germany 
ER-Tracker™  Invitrogen, Karlsruhe, Germany 
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Ethanol for spectroscopy, >99.5 % Ph. Eur.  Carl Roth, Karlsruhe, Germany 
Ethylenediaminetetraacetic acid (EDTA)  SERVA, Heidelberg, Germany 
Formaldehyde 37 % (w/v) Fluka/Sigma-Aldrich, Taufkirchen, Germany 
Formalin solution, 10 %, neutral buffered  Sigma-Aldrich, Taufkirchen, Germany 
Glycine  Sigma-Aldrich, Taufkirchen, Germany 
Methanol Uvasol® for spectroscopy  Merck, Darmstadt, Germany 
N,N,N’,N’-Tetramethyl-ethane-1,2-diamine 
(TEMED)  
Sigma-Aldrich, Taufkirchen, Germany 
N-Ethylmaleimid (NEM) Sigma-Aldrich, Taufkirchen, Germany 
Octyl β-D-glucopyranoside  Sigma-Aldrich, Taufkirchen, Germany 
Potassium cyanide (KCN) Sigma-Aldrich, Taufkirchen, Germany 
Sodium dodecyl sulfate (SDS)  Carl Roth, Karlsruhe, Germany 
Sucrose  AppliChem, Darmstadt, Germany 
3.1.2 Equipment and instruments 
Basic laboratory equipment is not included in this list. 
Table 2: Equipment and instruments used in this work. The list comprises centrifuges, microscopes 
and thermocyclers. 
Compound Manufacturer 
Biophotometer plus  Eppendorf, Hamburg, Germany 
Centrifuge Avanti J-20XP (Rotor JLA10.500)  Beckman Coulter, Krefeld, Germany 
Centrifuge Heraeus Biofuge Stratos  Thermo Scientific, Langenselbold, Germany 
Confocal laser scanning microscope 
FluoViewTM  FV1000  
Olympus, Hamburg, Germany 
Electrophoresis equipment (agarose gel 
electrophoresis)  
Bio-Rad, München, Germany 
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Electrophoresis equipment (SDS-PAGE) Mini-
PROTEAN 3 electrophoresis system with 
accessories 
Bio-Rad, München, Germany 
Gel documentation system DESAGA Digital 
CabUVIS with CCD camera HV-C20A (Hitachi)  
Sarstedt, Nümbrecht, Germany 
Incubators Heraeus  Thermo Scientific, Langenselbold, Germany 
Infrared imaging system Odyssey®  LI-COR Bioscience, Bad Homburg, Germany 
Inverted epifluorescence microscope IX-81  Olympus, Hamburg, Germany 
Laminar flow hood Heraeus  Thermo Scientific, Langenselbold, Germany 
Nucleofection system Lonza 4D  Lonza, Basel, Switzerland 
Phase contrast inverted microscope (cell 
culture) Telaval 31  
Zeiss, Göttingen, Germany 
Phosphorimager: Fluorescent image 
analyzer FLA-3000  
Fujifilm, Düsseldorf, Germany 
Power supply for electrophoresis and 
Western blotting: PowerPac 1000 and 
Amersham EPS 601  
                                                                          
Bio-Rad, München, Germany                                 
GE Healthcare, Freiburg, Germany 
Rotary evaporator: Rotavapor R-200  Büchi Labortechnik, Essen, Germany 
Shaker: Mini-rocker MR-1 and                          
rocking shaker  
Bioscan, Paris, France                                           
GFL, Burgwedel, Germany 
Spectrofluorometer AMINCO-BowmanTM 
Series 2 
Thermo Electron Corporation, Germany 
Thermal Cycler MyCyclerTM  Bio-Rad, München, Germany 
Thermomixer comfort  Eppendorf, Hamburg, Germany 
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Trans-Blot® SD semi-dry electrophoretic 
transfer cell  
Bio-Rad, München, Germany 
Ultra-pure water purification system Milli-Q  Millipore, Schwalbach, Germany 
Ultracentrifuge Optima L-100K                     
Rotors: 45Ti, 70.1Ti, SW40Ti, SW60Ti 
Beckmann Coulter, Krefeld, Germany 
Ultracentrifuge TL-100, tabletop, rotor TLA 
100.3 
Beckman Coulter, Krefeld, Germany 
Ultracentrifuge XL-70 and Optima L-100K  Beckman Coulter, Krefeld, Germany 
UV transilluminator  Vilber Lourmat, Eberhardzell, Germany 
UV-Vis spectrophotometer UV1  Thermo Electron Corporation, Germany 
3.1.3 Consumables 
Basic laboratory consumables are not included in this list. 
Table 3: Consumables used in this work. List includes cell culture vessels and other laboratory 
plasticware. 
Device Manufacturer 
Microfuge Tube Beckman, 1.5 ml, 
polyallomer   
Beckman Coulter, Krefeld, Germany 
blot paper, extra thick Bio-Rad, München, Germany 
Cell culture flasks T25, T75, T175  Nunc, Langenselbold, Germany 
Cell culture plates 6-well and 12-well  Nunc, Langenselbold, Germany 
Cuvettes, acrylic, and semi-micro cuvettes, 
polystyrene  
Sarstedt, Nümbrecht, Germany 
Glass bottom culture dishes for microscopy, 
35 mm, uncoated  
MatTek, Ashland, U.S.A, # P35G-1,5-14C 
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Glass cover slips for microscopy                        
24×60 mm                                                           
24x32 mm 
Carl Roth, Karlsruhe, Germany 
Nitrocellulose membrane: Amersham 
Hybond ECL 
GE Healthcare, Freiburg, Germany 
3.1.4 Cell culture media and reagents 
Table 4: Reagents used in this work. Including cell culture media, antibiotics and transfection reagents.  
Reagent Manufacturer 
BSA (Bovine serum albumin, 35 % in DPBS) Sigma-Aldrich, Taufkirchen, Germany 
DMSO (Dimethylsulfoxid) for cell culture  Sigma-Aldrich, Taufkirchen, Germany 
DMEM (Dulbeccos Medium Essential 
Medium) without phenol red, high glucose  
PAA Laboratories GmbH, Pasching, Austria 
PBS (+/+) (Phosphate Buffered Saline with 
Ca2+ and Mg2+) 
PAA Laboratories GmbH, Pasching, Austria 
PBS (-/-) (Phosphate Buffered Saline without 
Ca2+ and Mg2+) 
PAA Laboratories GmbH, Pasching, Austria 
FBS (Fetal bovine serum) PAA Laboratories GmbH, Pasching, Austria 
L-Glutamine (200 mM)  PAA Laboratories GmbH, Pasching, Austria 
LipofectamineTM 2000 Transfection Reagent  Invitrogen, Karlsruhe, Germany 
Geneticin solution (50 mg/ml), sterile 
filtered  
Sigma-Aldrich, Taufkirchen, Germany 
Penicillin/Streptomycin                                   
(100×: 10,000 U/ml, 10 mg/ml) 
PAA Laboratories GmbH, Pasching, Austria 
Trypsin/EDTA  PAA Laboratories GmbH, Pasching, Austria 
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TurboFectTM Transfection Reagent  Fermentas, St. Leon-Rot, Germany 
3.1.5 Enzymes, molecular biology reagents  
Table 5: Enzymes and substances for molecular biology. Including Cloning enzymes and reagetns and 
buffers for agarose gel electrophoresis.    
Substance Manufacturer 
Agarose Biozym Scientific, Hessisch Oldendorf, 
Germany 
DNA Loading Dye (6×) Fermentas, St. Leon-Rot, Germany 
dNTP-Mix, 10 mM each Fermentas, St. Leon-Rot, Germany 
DNA Ladder, GeneRulerTM 1kb  Fermentas, St. Leon-Rot, Germany 
T4 DNA Ligase  New England Biolabs, Frankfurt/Main, 
Germany 
CIP (Calf Intestinal Alkaline Phosphatase) New England Biolabs, Frankfurt/Main, 
Germany 
Polymerases                                                  
Phusion™ High-Fidelity DNA Polymerase                         
Taq DNA Polymerase 
                                                                           
Finnzymes, Espoo, Finland                                                                                                                                                                                                                                                                                                     
peqlab, Erlangen, Germany                                                                                        
Restriction enzymes                                            
AgeI, BamHI, BsaI HF, BsrGI, SacII, XhoI  
New England Biolabs, Frankfurt/Main, 
Germany 
TBE buffer, Rotiphorese® 10×, running buffer 
for agarose gel electrophoresis 
Carl Roth, Karlsruhe Germany 
DNA Gel Stain SYBR® Safe (1000×) Invitrogen, Karlsruhe, Germany 
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3.1.6 Kits for DNA preparation 
Table 6: Kits used for molecular biology.  
Kit Manufacturer 
QIAquick Gel Extraction Kit Qiagen, Hilden, Germany 
QIAprep Spin Miniprep Kit Qiagen, Hilden, Germany 
QIAGEN Plasmid Maxi Kit Qiagen, Hilden, Germany 
3.1.7 Antibodies 
3.1.7.1 Primary antibodies 
Table 7: Primary antibodies. Used for immunofluorescence and Western Blot. 
Antibody Provider 
anti-GFP antibody, monoclonal (mouse IgG) 
#11[814460 001] 
Roche, Mannheim, Germany 
3.1.7.2 Secondary antibodies 
Table 8: Secondary antibodies. Used for immunofluorescence and Western Blot. 
Antibody Provider 
AlexaFluor 568 anti-mouse (goat IgG), 
#11004 
Invitrogen, Karlsruhe, Germany 
IRDye-680 anti-mouse (goat IgG), #926-
32220  
LI-COR Bioscience, Bad Homburg, Germany,   
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3.1.7.3 Labeled antibodies 
Table 9: Labeled antibodies. Used for immunofluorescence. 
Antibody Provider 
AlexaFluor555 anti–GFP, #A31851 Invitrogen, Carlsbad, CA 
3.1.8 Plasmids 
Table 10: Plasmids. Used for cloning. 
Antibody Provider 
pECFP-N1 Invitrogen, Karlsruhe, Germany 
pEYFP-N1 Invitrogen, Karlsruhe, Germany 
pCAGGS JR-FL gp160WT Scolari, Humboldt University, Berlin, 
Germany 
pfastFT-N1 Verkusha170, New York, USA 
3.1.9 Buffers and solutions  
Table 11: Cell culture media and solutions. Used for biochemistry, cell staining and molecular biology.  
Cell culture media 
Complete medium DMEM with 10 % (v/v) FBS, 2 mM L-
Glutamine and  Penicillin/Streptomycin (100 
U/ml, 100 µg/ml) 
Freezing medium 
 
70 % (v/v) DMEM, 20 % (v/v) FBS, 10 % (v/v) 
DMSO 
Coomassie staining solutions 
Coomassie staining solution 45 %  (v/v) ethanol, 10 % (v/v) acetic acid, 
2.5 g/l Coomassie Brilliant Blue R-250 
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Coomassie destaining solution 40 % (v/v) ethanol, 7.5 % (v/v) acetic acid 
Immunofluorescence solutions 
Fixative 4 % formalin in DPBS with Ca2+ and Mg2+ 
(made from a 10 % formalin stock solution) 
Blocking buffer 3 % (w/v) BSA in DPBS (for cell culture) 
Permeabilization buffer 0.5 % (v/v) Triton X-100 in DPBS 
PBST 3.2 mM Na2HPO4, 0.5 mM KH2PO4, 1.3 mM 
KCl, 135 mM NaCl, 0.05 % Tween 20, pH 7.4 
Fluorescent cell labeling dyes 
DiO (lipiphilic carbocyanine)  Invitrogen, Karlsruhe, Germany 
R18 (Octacedyl rhodamine B) Invitrogen, Karlsruhe, Germany 
LysoTracker Red Invitrogen, Karlsruhe, Germany 
ER-Tracker Red Invitrogen, Karlsruhe, Germany 
Propidium iodide Invitrogen, Karlsruhe, Germany 
DAPI (4',6-diamidino-2-phenylindole) Invitrogen, Karlsruhe, Germany 
C6-NBD-PC (1-palmitoyl-2-{6-[(7-nitro-2-1,3-
benzoxadiazol-4-yl)amino]hexanoyl}-sn-
glycero-3-phosphocholine) 
Avanti Polar Lipids, Alabaster, USA 
Isolation of Virus Like Particles 
TNE buffer 
 
10 mM Tris-HCl, 100 mM NaCl, 1 mM EDTA, 
pH 7.4 
TNE sucrose gradient linear gradient formed from 20 % and 60 % 
(w/v) sucrose in TNE buffer 
Isolation of GPMVs 
GPMV buffer 2 mM CaCl2, 10 mM Hepes, 0.15 M NaCl 
Protein palmitoylation assay 
lysis buffer  25 mM HEPES, 25 mM NaCl, 1 mM EDTA, 
Proteinase Inhibitor Cocktail, pH7.5) 
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blocking buffer  100mM HEPES, 1mM EDTA, 2.5 % SDS, 
0.1 % MMTS, pH7.5 
binding buffer  100mM HEPES, 1mM EDTA, 1 % SDS, pH 7.5 
Media for propagation of E.coli 
LB medium 10 g/l BactoTM tryptone, 5 g/l BactoTM yeast 
extract, 5 g/l NaCl with 50 µg/ml kanamycin 
or 100 µg/ml ampicillin 
LB agar LB medium with 15 g/l agar, 50 µg/ml 
kanamycin or 100 µg/ml ampicillin 
Antibiotic stocks 50 mg/ml ampicillin; 100 mg/ml kanamycin 
(in ddH2O, sterile filtered)   
PBS 
 
137 mM NaCl, 2.7 mM KCl, 8.1 mM 
Na2HPO4, 1.5 mM KH2PO4, pH 7.2 
SDS-PAGE buffers 
Stacking gel (5 %) 
 
5 % (w/v) acrylamide/bisacrylamide (37.5:1; 
30 % stock solution “Rotiphorese® Gel 30”, 
Carl Roth, Karlsruhe, Germany), 125 mM 
Tris-HCl pH 6.8, 0.1 % (w/v) SDS, 0.1 % (w/v) 
APS, 0.1 % (v/v) TEMED 
Resolving gel (10% or 12%) 10 % or 12 % (w/v) 
acrylamide/bisacrylamide, 375 mM Tris-HCl 
pH 8.8, 0.1 % (w/v) SDS, 0.1 % (w/v) APS, 
0.04 % (v/v) TEMED 
SDS sample buffer, non-reducing (4×) 5 % (w/v) SDS, 0.5 g/l bromophenol blue, 
25 % (v/v) glycerol, 500 mM Tris-HCl pH 6.8 
SDS sample buffer, reducing (4×) 5 % (w/v) SDS, 0.5 g/l bromophenol blue, 
25 % (v/v) β-mercaptoethanol, 25 % (v/v) 
glycerol, 500 mM Tris-HCl pH 6.8 
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Protein standards Precision Plus Protein All Blue Standards 
[Bio-Rad, München, Germany]; PageRuler™ 
Prestained Protein Ladder [Fermentas, St. 
Leon-Rot, Germany] 
Running buffer 3 g/l Tris-HCl, 1 g/l SDS, 14.4 g/l glycine; pH 
8.3 
Western blotting solutions 
Transfer buffer 40 % (v/v) running buffer, 20 % (v/v) 
methanol, 0.06 % (w/v) SDS 
Blocking buffer (for IR-dye coupled secondary 
antibodies and fluorescence detection) 
Odyssey® Blocking Buffer 1:2 in PBS  
Washing buffer  PBS with 0.1 % (v/v) Tween®-20 (PBST) 
3.1.10 Biological material 
3.1.10.1 Eukaryotic cells lines  
Table 12: Cell lines used in this work. The cell type is indicated in brackets.  
Cell line Cat. no.  
CHO-K1 Chinese hamster ovary cells (epithelial-like) ATCC CCL-61 
HeLa Human cervical cells (epithelial) ATCC CCL-2 
MDCK II  Madin-Darby canine kidney cells (epithelial) ATCC CCL-34 
HEK293T  Human embryonic kidney cells (epithelial) ATCC CCL-1573 
RBL Rat basophil leukemia (epithelial)    ATCC CRL-1378 
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3.1.10.2 Prokaryotic cells 
Table 13: Bacteria used in this work. Cells were used for transformation.  
Cell line Description 
E.coli DH5α genotype: F– endA1 recA1 hsdR17(rk– mk+) supE44 λ– thi-1                                    
gyrA(Na1) relA1 Φ80 lacZΔM15Δ (lacZY A-argF), chemically 
competent, provided by Christine Klaus (Humboldt-University) 
3.1.11 Software 
Table 14: Software applied in this work. Provider or source and the specific application of the programs 
or plugins are stated in the list.  
Software Provider Application 
A plasmid Editor 
(ApE) 
M. Wayne Davis, Utah, USA cloning simulation; DNA sequence 
viewing, alignment, editing and ORF 
analysis 
FV 10-ASW 
FluoView1000 
Olympus, Hamburg, Germany device control, image viewing and 
data analysis software for confocal 
microscope FV1000 
ImageJ         
Version 1.46e 
Wayne Rasband, National 
Institute of Health, Bethesda, MD, 
USA (http://imagej.nih.gov/ij/) 
signal quantification, particle 
tracking, image processing 
MtrackJ         
ImageJ plugin  
Erik Meijering, Biomedical 
Imaging Group, Erasmus MC, 
Rotterdam, Netherlands  
particle tracking 
Spot Tracker 
ImageJ plugin  
Daniel Sage, Biomedical Imaging 
Group, Ecole Polytechnique Féd. 
de Lausanne , Switzerland  
particle recognition 
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Symphotime, 
Version 3.2.4  
PicoQuant, Berlin, Germany analysis of FLIM and polarization 
microscopy   
MetaMorph  
 
Olympus, Hamburg, Germany device control, image viewing and 
data analysis software for IX-81 
epifluorescence microscope 
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3.2 Methods 
3.2.1 Molecular biology 
To reveal the localization or function of a certain protein it is often necessary to specifically 
change its amino acid sequence. For this purpose the sequence of the encoding DNA has to be 
controlled and adapted. The easiest way to study a protein in a cellular context is to clone the 
respective DNA sequence into an expression vector and deliver it into target cells by a suited 
method. Expression is than purchased by the cellular machinery and the designed protein can 
then be investigated in the physiological environment of the selected cellular system.  
For mammalian expression, purified DNA under the control of a suited promotor is required. 
Thus, a prerequisite of an experimental examination is often a cloning of the DNA sequence 
under study. Subsequently, the obtained plasmid is transformed and amplified in bacteria 
followed by purification and transfer into the mammalian cells. A typical strategy consists of 
the following steps:  
1. Generation of the gene of interest with flanking restriction sites using PCR 
2. Enzymatic digestion to target the gene insertion to a specific vector position 
3. Enzymatic ligation of vector and insert 
4. Transformation into competent bacteria and antibiotic selection  
5. Amplification of positive bacterial clones 
6. Plasmid DNA purification 
7. Transfection via lipofection 
3.2.1.1 Molecular biology methods 
3.2.1.1.1 Polymerase chain reaction (PCR) 
Since the first description of the polymerase chain reaction in 1985171 this method was 
improved and extended so that it nowadays is an indispensable tool of molecular biology. The 
fundamental principle of a PCR is simple. Basically it combines all sufficient and necessary 
components of native DNA replication under the controlled conditions of an in vitro-assay.    
PCRs are carried out in a thermocycler machine that allows the fast temperature change which 
is needed to control the progression of that cyclic reaction. Firstly, the template, containing 
the DNA sequence to be amplified is denaturated at 94°C. Subsequently, upon lowering of the 
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temperature to 45-70°C, the primers, available in high excess, hybridize with the template 
open strands. Finally, the temperature is raised to the optimum of the thermophile DNA 
polymerase to allow extension of the primer and thus formation of template complementary 
DNA strands. In every cycle the number of DNA fragments is doubled and as a result of that, 
upon many repetitions amplified exponentially. A typical PCR protocol used to amplify DNA 
of HIV-1 envelope fragments is reported in the table below (Table 15). 
Table 15: Standard PCR. PCR scheme used for the amplification of gp41 DNA fragments. 
PCR mix PCR scheme 
50 ng DNA template Cycle step T (°C) Time (min) 
0.5 mM dNTPs Initial denaturation 94 5 
1 µM Forward primer  
30x 
Denaturation 94 1 
1 µM Reverse primer Annealing 50 1 
10x PCR Buffer Extension 72 1 
5 U Taq-polymerase Final extension 72 10 
final V=50µl ddH2O Cooling 12 ∞ 
3.2.1.1.2 Colony PCR 
Colony PCR was performed to verify successful insertion of DNA into a plasmid. For this 
PCR the same protocol as described above was used with the only exception that the initial 
denaturation time was extended to 10 min. Instead of template DNA parts of an E.coli colony 
were picked with a pipette tip and resuspended in the reaction mixture. Although colony PCR 
primers do not have to contain restriction sites and can be chosen freely to amplify any 
arbitrary fragment of the target gene, in this study usually the original cloning primers were 
used for the colony PCRs.  
3.2.1.1.3 AB-PCR 
To introduce small mutations in the range of one or just a few amino acids, a special form of 
site-directed mutagenesis can be used, the AB-PCR or overlap-extension PCR172. Hereby, 
primers are designed to bind in the region of the desired mutation. DNA amplification is 
performed in two steps (Figure 3-1).  
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Figure 3-1: AB-PCR principle. This site directed mutagenesis procedure allows the introduction of 
small mutations in two independent PCR steps. Required are the two conventional flanking primers a2 
and b2 (black) with restriction sites for the subsequent cloning of the PCR product, two overlapping 
primers (black) a1 and b1 that carry the mutation (red) in the middle, and the wild type template (dark 
grey). In the first step, two PCRs are run in parallel, one using the primer pair a1/a2 and another one 
using pair b1/b2. Those PCRs yield two overlapping fragments of the final gene, both including the 
restriction sites on one end and the mutation adjacent to the other end. In a second PCR steps the 
fragments serve as templates and, in combination with the flanking primers, as second set of primers for 
the amplification of the complete gene, containing the desired mutation.  
First, two fragments of the gene are amplified independently, ranging from either sides of the 
gene to the mutation site. Here, primers are binding that contain the nucleic base changes 
surrounded by bases being complementary to the original DNA sequence. The first two PCRs 
yield two fragments of the native gene with overlapping sequences and the selected mutation. 
In the second part of the assay, both PCR-products are mixed to serve as templates and 
primers for the synthesis of the complete, mutated gene. Additional primers binding on both 
sides of the gene are added to increase the yield of the amplification. A typical PCR protocol 
used to introduce the CRAC mutation in HIV-1 envelope fragments is reported in the table 
below (Table 16). 
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Table 16: AB-PCR. PCR scheme and reagents used for site-directed mutagenesis using AB-PCRs. 
PCR mix PCR scheme 
 A-PCR B-PCR Cycle step T (°C) Time (min) 
50 ng DNA template DNA template Initial denaturation 94 3 
0.5 mM dNTPs dNTPs  
30x 
Denaturation 94 30 
1 µM Fw-Primer (a2) Fw-Primer (b2) Annealing 50 30 
1 µM Rv-Primer (a1) Rv-Primer (b1) Extension 68 1 
10x PCR Buffer PCR Buffer Final Extension 68 10 
5 U Taq-polymerase Taq-polymerase Cooling 4 ∞ 
V=50µl ddH2O ddH2O 
AB-PCR Cycle step T (°C) Time (min) 
50 ng A-PCR product Initial denaturation 94 3 
50 ng B-PCR product  
30x 
Denaturation 94 30 
0.5 mM dNTPs Annealing 50 30 
1 µM Fw-Primer (a2) Extension 68 1 
1 µM Rv-Primer (b2) Final Extension 68 10 
10x PCR Buffer Cooling 4 ∞ 
5 U Taq-polymerase 
V=50µl ddH2O 
3.2.1.1.4      Agarose gel electrophoresis 
In order to verify size and to purify the obtained DNA, PCR products were examined using 
agarose gels produced with 1 % (w/v) agarose in TBE buffer supplemented with the DNA 
stain SYBR Safe. Electrophoresis was run at 90-120 V to separate negatively charged DNA 
fragments according to their size. For further applications, DNA bands were cut from the gel 
and the DNA was extracted using the QIAquick Gel Extraction Kit according to the 
manufacturer’s protocol. This procedure is necessary to eliminate reagents and enzymes from 
previous steps. Especially digestion enzymes need to be removed by gel electrophoresis since 
they might stick to the restriction sites and hamper the following ligation due to sterical 
prevention of sticky end hybridization and the ligase binding.  
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3.2.1.1.5 Enzymatic cleavage and dephosphorylation 
Both, PCR products and target vector were subjected to enzymatic cleavage. Restriction 
endonucleases cut the DNA within enzyme specific sequences yielding two or more double-
stranded DNA fragments with, depending on the enzyme used, sticky (single stranded 
overhangs) or blunt (both backbones cutted at the same base pair) ends. In general, cloning 
strategies are chosen with insert and vector being digested with the same two enzymes that 
produce sticky ends to achieve a directional control of the insert incorporation in the cleaved 
vector. A typical protocol for a double digestion of a PCR product or purified vector DNA is 
reported in the following (Table 17).  
Table 17: Digestion protocol. Reagents mix for a typical enzymatic cleavage of vector and insert. 
Digestion Mix 
1 µg DNA  
10 – 20 U 1st Enzyme  
10 – 20 U 2nd Enzyme 
10x Cleavage Buffer 
1-2 hours of cleavage at 37° C are followed by dephosphorylation of the vector to avoid self-
ligation. To this aim, the reaction mixture of the plasmid-digestion was supplemented with 
calf intestinal alkaline phosphatase (1 µl) which removes the reactive 5′ phosphate. The 
reaction products were further analyzed and purified by agarose gel electrophoresis 
(3.2.1.1.4), and DNA fragments were extracted using the QIAquick Gel Extraction kit for 
subsequent ligation.  
3.2.1.1.6 Ligation  
As a result of the enzymatic digestion insert and plasmid possess complementary sticky ends. 
Thus, the DNA fragments spontaneously associate with each other. The enzyme T4 DNA 
ligase catalyzes the formation of phosphodiester bonds between the juxtapositioned 3′ 
hydroxyl and 5’ phosphate groups of the different DNA strands. It joints blunt or cohesive 
ends, leading to DNA molecules with the desired insert incorporated in the target vector. The 
linearized plasmid was incubated with an excess of DNA insert (molar ratio around 1:3-1:5) 
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and the T4 DNA ligase in the corresponding ligase buffer at 16°C for at least 1 h or better 
overnight (Table 18). 
Table 18: Ligation protocol.  Reagents mix for a typical ligation reaction of vector and insert. 
Ligation Mix 
0.2 µg vector DNA  
0.8 µg insert DNA  
400 cohesive end U T4 DNA-Ligase  
10x T4-Ligation Buffer 
3.2.1.1.7 Transformation of E.coli 
Amplification of plasmids was performed by transformation into chemically competent E.coli 
DH5α. 100 µl aliquots of bacteria were carefully thawed on ice and mixed with a few 
nanograms to 1µg plasmid DNA. The solution was incubated on ice for 10 min, treated by 
heat shock at 42°C for 45 s and placed back on ice for 5 min. The transformation proceeded 
by addition of 500 µl LB medium and an incubation of 1 hour at 37°C before plating the mix 
on agar plates containing the appropriate antibiotic (usually 50 µg/ml) for selection of bacteria 
carrying the plasmid. The plates were incubated overnight at 37° C and single colonies were 
picked for colony PCR or plasmid purification. Clones were stored in 30 % glycerol in LB 
medium at –80° C. 
3.2.1.1.8 Plasmid purification 
For plasmid purification, single colonies were picked from agar plates for inoculation in 2-
300 ml LB-medium with appropriate antibiotics (50 µg/ml) for selection. After propagation at 
37° C for 16 h in a shaking incubator, bacteria were pelleted, and plasmids were isolated using 
the QIAprep Spin Miniprep Kit (for below 10 ml culture) or QIAGEN Plasmid Maxi Kit (for 
300 ml culture) according to the manufacturer’s manual. DNA concentrations were 
determined photometrically by measuring the absorbance at 260 nm (Biophotometer plus), 
and the plasmids were used for sequencing, transfection of eukaryotic cells or molecular 
biology. 
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3.2.1.2 Cloning strategy for viral fusion protein variants 
In this section, the general cloning strategy that was followed to obtain the fusion proteins 
described in the thesis at hand is briefly described.  
The cloning vectors pECFP-N1, pEYFP-N1 were used to generate plasmids for 
overexpression of fluorescent fusion proteins. They all encode a fluorescent protein under 
control of a constitutive cytomegalovirus (CMV) immediate early promoter for expression in 
mammalian cells and possess a multiple cloning site upstream of the fluorescent protein ORF 
for insertion of the sequence of interest. As all cloning plasmids, both harbor a bacterial origin 
of replication and a gene encoding an antibiotic resistance for prokaryotic selection. 
Moreover, eukaryotic selection is permitted by a neomycin resistance gen. GFP-derived 
fusion proteins possess dimerizing properties144. To prevent unwanted self-aggregation of 
fluorescently tagged proteins, monomeric variants were used provided by Silvia Scolari173 
(HU Berlin, Germany). The corresponding single amino acid exchange was generated using 
AB-PCR and was described in detail in the thesis of Silvia Scolari173. All fluorescent proteins 
utilized in this work, if not otherwise mentioned, are the monomeric forms of the original 
enhanced fluorescent proteins.  
The vector containing the HIV-1 envelope sequence (Uniprot ID: Q75760) originating from 
the JRFL isolate of HIV-1 was kindly provided by Silvia Scolari (HU Berlin, Germany). 
Fluorescent virus protein chimeras were generated based on the plasmids described above. 
Relevant sections of the complete gp160 precursor protein plasmid, JRFL gp160wt were 
amplified by polymerase chain reaction using the following primer (Table 19).  
Table 19: Cloning primers. Forward and reverse primers of clonings for the protein variants gp41-YFP, 
Δ1 and Δ2. The restrictions sites for NotI and BsrgI digestions in forward and reverse primers, 
respectively are underlined. 
Primer Sequence 
Forward gp41-YFP&Δ1 CGAGC TGTACA AGGAAATTGACAATTACACAAG 
Forward Δ2 GAGC TGTACA AGCTGTGGTATATAAAAATATT 
Reverse gp41-YFP AGAGCT GCGGCCGC TTATAGCAAAGCCCTTTCCA 
Reverse Δ1&Δ2 AGTC GCGGCCGC TTAGTATCCCTGCCTAACTCTAT 
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All forward primer contain the restriction site BsrGI whereas reverse primer comprise NotI. 
Cloning vectors and PCR products were digested using both enzymes, subsequently gel 
purified and ligated with a 1:5-1:10 molar excess of the insert. Successful clonings yielded 
virus protein variants directly linked to the C-terminus of the fluorescent protein.  
The rabbit lactase phlorizin hydrolase (LPH) signal peptide (SP) DNA sequence derived from 
the GPI-XFP vector provided by Mark Keller was cut from the plasmid and ligated to the n-
terminus of the fluorescent protein to ensure physiological targeting of the virus protein 
chimeras. In eukaryotes, signal sequences are n-terminal extensions of nascent polypeptide 
chains. They direct the insertion of the protein into the membrane of the endoplasmic 
reticulum and are usually cleaved off by signal peptidases. Since sometimes, cleaved signal 
peptides are supposed to fulfill yet-to-define post-targeting functions174, this GPI-SP strategy 
was chosen to express the same signal peptide in both donor-only and cells expressing donor 
and acceptor protein to avoid any SP-induced side effects.     
Presumptively successful cloned vectors were verified by colony PCR and sequencing 
(Invitek, Berlin, Germany) using the following primers (Table 20).  
Table 20: Sequencing primers. Sequencing primer binding either in the fluorophore directing towards 
the protein or within the vector directing towards the fluorophore. 
Primer Sequence 
Forward XFP CTG CTG CCC GAC AAC CAC TAC CTG A 
Forward pre Protein CGT GTA CGG TGG GAG GTC TAT ATA AG 
Mutations were introduced in the cholesterol recognition amino acid consensus by site-
directed mutagenesis as described later. The following primers were used for the 
corresponding AB-PCRs (Table 21). 
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Table 21: AB-PCR primer. Site-directed mutagenesis using the two primers reported here was applied to 
introduce single amino acid changes from leucine to isoleucine (underlined) in the CRAC motif.   
Primer Sequence 
Forward mCRAC ACA AAA TGG ATT TGG TAT ATA AAA ATA TTC ATA 
Reverse mCRAC         TAT GAA TAT TTT TAT ATA CCA AAT CCA TTT TGT 
3.2.2 Cell biology 
3.2.2.1 Cell culture and propagation 
CHO-K1, Cos7, HEK293T, HeLa and MDCKII cells were grown in complete DMEM 
(DMEM with 10 % FBS, 5 % L-Glutamine, 5 % Penicillin against gram-positive and 5 % 
Streptomycin against gram-negative bacteria), RBL-2H3 cells in RBL medium (MEM 
medium with 30 % RPMI 1640, 10 % FBS, 5 % L-Glutamine, 5 % Penicillin and 5 % 
Streptomycin) under mammalian cell culture conditions in a humified atmosphere at 37°C 
with 5 % CO2. All working steps were performed in the sterile environment of a laminar flow 
hood. If not otherwise mentioned, the cells were grown in 75 cm2 (T75) culture flasks 
supplied with in 10-12 ml medium. All cells were splitted 1:10 or 1:12 when ~90 % 
confluence was reached (2-3 times per week). For this purpose, adherent cells were washed 
with 10 ml PBS without Ca2+ and Mg2+ and incubated with 2 ml Trypsin/EDTA for three up to 
several minutes depending on the cell type at 37°C. After detachment of the cells, the trypsin 
reaction is blocked with 10 ml complete DMEM and 1 ml of the cell suspension is transferred 
to a new flask supplied with 9-11 ml of fresh complete medium.    
3.2.2.2 Cell storage and thawing 
For longtime storage mammalian cells had to be detached using Trypsin/EDTA as described 
above. Subsequently, floating cells were centrifuged with <300 g for 10 min at RT. After 
resuspension of the cell pellet in freezing medium (3.5 ml complete DMEM, 1 ml FBS, 0.5 ml 
DMSO) suited aliquots, containing high densities of cells (1x106-5x106 cells per ml) were 
distributed in cryotubes and frozen slowly (-1° C per minute) in a -80°C refrigerator using an 
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isopropanol freezing container. Finally the tubes were transferred into a liquid nitrogen tank 
for virtually unlimited storage.  
To reactivate stored cells, complete DMEM was prewarmed to 37° C. Cell suspensions from 
the nitrogen tank were unfrozen in water bath and mixed with the warm medium. After 
centrifugation (<300 g, 10 min at RT) the cell pellet was resuspended in warm medium and 
transferred to a culture flask for further propagation. Freshly thawn cells were only grown 
until 70 % density and should not be directly used for experiments since passage 0 is 
supposed to contain freezing/thawing artifacts.    
3.2.2.3 Transient and stable transfection 
Typically, transfection of plasmid DNA into eukaryotic cells was conducted using the cationic 
lipid-based Lipofectamine 2000 or the Turbofect reagent according to the manufacturer’s 
instructions. Usually, transfections were performed in a 35 mm glass-bottom dish or single 
wells of a 6 well for microscopy or FACS experiments, respectively.  
Lipofectamin 2000 transfection. A total of 4 µg DNA and 10 µl Lipofectamine 2000 were 
used for transfection of cells grown to 90 % confluency in 35 mm dishes. Both, DNA and 
transfection reagent were mixed independently with pure DMEM to final volumes of 250 µl. 
The solutions were incubated for 5 min at RT, combined, thoroughly mixed and incubated for 
another 20 min at RT. In the meanwhile, the cells were washed with prewarmed PBS with 
Ca2+ and Mg2+ and covered with 1.5ml of warm DMEM without additives. Then, the 
transfection mixture was added dropwise to the cells and the dishes were gently swirled. The 
transfection medium was replaced by DMEM with additives after 4 h of incubation at 37°C to 
avoid cytotoxic effects of the transfection reagent. 
Turbofect transfection. 4 µg DNA are required to transfect a 35 mm dishes of mammalian 
cells grown to 90 % confluency. 6 µl of pre-vortexed turbofect were mixed with the DNA in 
200 ml of complete DMEM and after another vortexing, incubated for 20 min. Meanwhile, 
the cells were washed with pre-warmed PBS with Ca2+ and Mg2+ and covered with 1.8 ml of 
warm, DMEM without additives. Then, the transfection mixture was added to the cells; the 
dishes were gently swirled and incubated at 37°C. The transfection medium could be replaced 
by complete DMEM after 4 h but the cytotoxicity of turbofect is so low that even incubations 
overnight are possible. 
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Nucleofection. This specialized type of electroporation-based DNA delivery was conducted 
with an Amaxa Nucleofector 4D device. Since for this procedure, suspended cells are 
required, cells were firstly trypsinized and resuspended in PBS without Ca2+ and Mg2. 
Subsequently, the cell concentration was assessed using a hemocytometer, 1x106 cells were 
resuspended in a mix of 82 µl transfection reagent and 18 µl supplement with 2 µg of DNA 
and finally filled in the nucleofection cuvette. Then, a suited electroporation program was 
used according to the manufacturer’s protocol to deliver the DNA (for instance T03 for CHO-
K1). Finally, cells were allowed to relax for 10 minutes at room temperature in the cuvettes 
and added to glass bottom dishes or 6 wells with 2 ml prewarmed DMEM with additives.  
Stable transfection. Different protocols are available to achieve a permanent expression of 
genetically modified genes. Stable transfections are extensions of transient transfections. 
Thus, to produce stable transfected cells, firstly a lipofection as described before was 
performed. Both aforementioned reagents, but also other transfection methods such as CaCl2 
based DNA delivery or electroporation are suited for the initial step.  
Cells with a confluency of 40-70 % were usually transfected as described before in 35 mm 
dishes or 6 wells. After transfection and protein expression for 1 to 2 days in complete 
DMEM, the medium was exchanged against selection medium (DMEM supplemented with 
500 µg/ml Geneticin). This concentration of the Geneticin (or shortly G418) was pretested to 
kill non-transfected cells completely within two weeks of exposure. Thus, the cells were 
propagated in the selective medium for at least one week. In that period, confluent cultures 
were splitted 1:5 to avoid losing transfected cells by hard splitting. After one to three weeks of 
selection, cells expressing fluorescent proteins were further enriched by FACS. To this 
purpose, cultures were detached using 0.5 ml of a mild reagent, 2 mM EDTA in PBS without 
Ca2+ and Mg2+. 2 ml PBS without Ca2+ and Mg2+ was then added to the suspended cells prior 
to centrifugation (<300g, 10 min at RT). The cell pellet was resuspended in PBS without Ca2+ 
and Mg2+ and subjected to FACS. Cells were analyzed and 2 to 3 populations were selected 
for sorting: a high fluorescent population, a medium plus the high fluorescent population and 
all fluorescent cells. 100-5000 events of every population were sorted in 4 different wells of a 
12 well, prepared with 1 ml of complete, prewarmed selection medium. Subsequently, the 
cells were quickly transferred to an incubator and propagated further for some days. From the 
12 well, populations were chosen for further cell culture, freezing or experiments depending 
on the transfection efficiency, protein expression level, population homogeneity and cell 
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condition. If the transfection efficiency was still too low for stable transfected cells, further 
selection using G418-supplemented medium or another round of the FACS assay was 
performed. Propagation of sufficiently selected cells required utilization of complete DMEM 
containing 250 µg/ml G418 to maintain the selective pressure and avoid a spontaneous loss of 
the protein expression. We observed that the feasibility of a stable expression does not only 
depend on cell type, selection conditions and transfection efficiency but also to a great extent 
on the protein which is overexpressed. Whereas some proteins were stably expressed very 
easily just by the use of selection medium, other proteins could not be obtained in a stable 
expression system even upon application of different selection condition, FACS sorting or 
manual selection of single cell colonies.   
3.2.2.4 Giant plasma membrane vesicles formation 
Two different preparation methods were used to produce GPMVs, also called blebs. Cells 
form GPMVs spontaneously upon treatment with buffer containing N-Ethylmaleimid or a 
mixture of paraformaldehyde and DTT as previously described 97,175 (Figure 3-2). 
 
Figure 3-2: GPMV assay workflow. Cells were transfected with the GFP or YFP labeled proteins and 
prior to the experiment, labeled with a marker possessing a preference of disordered domains. Then, cells 
were treated with the blebbing mixture to induce the formation of GPMVs. After collection of the cell 
supernatant, sedimented bleb solutions were investigated using epifluorescence microscopy utilizing a 
temperature controlled setup that will be described later (Figure 3-3). Obtained images were analyzed 
regarding intensity in the ordered and in the disordered domain of the phase separated GPMVs by 
applying the plot profile function of ImageJ to finally calculate the raft partitioning parameter Kp,raft.  
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Briefly, confluent cells seeded in 6 wells or 35 mm dishes are washed twice with PBS with 
Ca2+ and Mg2+. Subsequently, cellular plasma membrane were prestained using 20 µM 
solutions of DiO or octadecylrhodamine (R18) in PBS (+/+) for 10 min at 4° C. After removal 
of the labeling solution and another two washing steps with GPMV-buffer, the blebbing 
solutions were added to the cells either containing 2 mM NEM or 2 mM DTT and 25 mM 
paraformaldehyde in GPMV buffer. The cells were incubated for one to two hours at 37° C 
and the supernatant was collected in a conical glass or eppendorf tube where the vesicles were 
allowed to sediment for about 30 min at 4° C. GPMVs are stable for at least some hours up to 
several days. To study phase separation, bleb solutions needed to be cooled down to 
temperatures below 4° C. Conventional cooling devices and glass slides were not sufficient to 
provide those conditions. Thus, a special setup of cooling device and a user-assembled glass-
slide-chamber had to be prepared for every sample (Figure 3-3). 
 
Figure 3-3: Sample chamber and cooling device setup for GPMV microscopy. Firstly, a silicon grease 
square was drawn on a glass slide. Then, a small drop of the sample was pipetted in the middle of that 
square which was subsequently covered with a cover slip. Using again silicon grease, the whole chamber 
was directly attached to the bottom of the peltier element on the object holder.  
To this aim, a squared chamber of at about 1.5x1.5 cm was prepared, by drawing thin lines of 
silicon grease on a conventional, rectangular glass slide (24x60 mm). A drop of 10-30 µl of 
the GPMV solution, taken from the bottom (to get the sedimented GPMVs), but not the 
ground of the tube (to avoid cell debris), was placed in the middle of that square. Then, a 
cover slip (24x32 mm) was pushed softly on the silicon grease to flatten the GPMV-solution 
drop and seal the chamber. This arrangement was then, with the bigger glass slide facing 
towards the cooling device, attached to the bottom of a precooled peltier-element, again using 
a small film of silicon grease. To avoid fogging of the cooled cover slip with condensed water, 
compressed air was blown at the sample. The whole setup was then ready for fluorescence 
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microscopy. Images of the equatorial plane of the blebs were taken at different temperatures 
using an epifluorescence microscope (Olmypus IX81). The images were analyzed using the 
plot profile function of ImageJ and the raft partitioning parameter Kp,raft was calculated 
according to:    
𝑲𝒑,𝒓𝒂𝒇𝒕 =
𝑰𝒓𝒂𝒇𝒕
𝑰   𝒓𝒂𝒇𝒕
     (7) 
3.2.2.5 Fluorescence labeling of fixed and living cells 
For different fluorescence microscopy approaches cells were labeled with fluorescent 
antibodies, compartment specific fluorescent probes or fluorescent lipid analogs. To this aim, 
cells were grown in 35 mm glass-bottom dishes and labeled prior to the microscopic 
experiments. 
3.2.2.5.1 Immunofluorescence (IF) 
Antibody staining experiments were conducted to prove the identity of specific cellular 
regions or label viral proteins. Briefly, the different primary and the secondary antibodies 
(typically Alexa568 anti-mouse antibodies from Invitrogen, Carlsbad, CA) were diluted to 
1 mg/ml in 1 % BSA/PBST. Mammalian cells were washed twice with PBS (+/+) and fixed 
with 4 % paraformaldehyde for 10 min at room temperature. Then, the cells were 
permeabilized and blocked with 0.3 % Triton X-100, 0.2 % Tween 20, 3 % BSA in PBS (+/+) 
for 30 min at RT. The cells were stained with the primary antibody solution for 1 h at room 
temperature, washed three times, labeled with the secondary antibody for another 1 h at RT 
and washed again three times. Without further mounting, the samples were imaged within 
some hours or latest at the next day.  
Antibody staining experiments were also performed to quantify the amount of surface-
exposed GFP-labeled proteins. Here, fusion proteins were transfected utilizing turbofect and 
expressed for at least 24 h as described before. Afterwards, cells were washed twice with PBS 
(+/+) incubated with the AlexaFluor555 anti–GFP for 60 min at 4° C and then washed 
thoroughly again. To ensure a complete saturation of accessible YFP molecules with 
antibodies, different antibody concentrations were pretested. A concentration of 1 µg/ml 
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turned out to be sufficient to achieve complete labeling of external fluorescent proteins, since 
higher antibody concentrations did not cause a further increase of the antibody fluorescence. 
3.2.2.5.2 Labeling of subcellular structures 
Viral fusion proteins were co-expressed with different fluorescently labeled, cellular proteins 
or specific commercially available compartment marker dyes to study their intracellular 
distribution and localization. Viral fusion chimeras labeled with cherry were co-transfected 
with rab5-GFP, rab7-GFP, rab11-YFP and Tau-YFP for 24 h using turbofect according to the 
manufacturer protocol. Moreover, live cell staining experiments were conducted using ER-
Tracker blue (Invitrogen, Carlsbad, CA) or lysotracker (Invitrogen, Carlsbad, CA) according 
to the manufacturer’s protocol 24 h post-transfection with YFP-labeled viral fusion proteins.  
For visualization of DNA or cellular actin filaments, fixed and permeabilized cells were 
stained with DAPI, propidium iodide (PI) or rhodamine phalloidin respectively. This was 
generally done following immunostaining.  
Staining of the cell nuclei was performed by incubation of the cells with 100 nM DAPI in 
PBS (+/+) at RT for three minutes, by labeling with 500 nM PI in PBS (+/+) for five minutes 
or with 100nM rhodamine phalloidin in PBS (+/+) for 30 minutes. Staining procedures were 
followed by three washing steps with PBS (+/+) prior to imaging. 
3.2.2.5.3 Labeling of cellular membranes with C6-NBD-PC  
NBD-PC was used as a reporter of the rigidity and order of cellular membranes. To this aim, 
CHO-K1 cells were seeded in different concentrations one day prior to the experiment. At the 
day of microscopy, an aliquot of 5 nmol dried C6-NBD-PC was redissolved in 10 µl ethanol 
which were subsequently filled up to 100 µl with PBS (+/+). To obtain the final labeling 
solution, 20 µl of this mixture were vortexted with 1 ml of PBS (+/+) yielding a final 
concentration of 1 µM. Then, the cells were washed twice with PBS (+/+) and incubated with 
the final labeling solution for 10 min at 4° C. After two final washing steps with PBS (+/+) 
and the addition of medium without additives and phenolred, the cells were used for 
microscopy at 37° C.   
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3.2.2.6 Production of virus-like particles 
To produce HI virus-like particles, expression of the Gag polyprotein is necessary and 
sufficient. A fluorescently labeled variant of this protein was used, which was obtained 
through the NIH AIDS Research and Reference Reagent Program, Division of AIDS, NIAID, 
NIH: pGag-EGFP (Cat#11468) originally generated by Dr. Marilyn Resh. To study 
incorporation of fusion proteins, HEK293T cells were transfected with pGag-EGFP and the 
protein under study. All transfections were performed in 9 cm dishes using turbofect 
according to the manufacturer’s protocol. 48 h post-transfection cell supernatants were 
collected and filtered through a 0.2 µm pore-size filter. The VLPs were then separated from 
remaining cell debris by centrifugation for 1.5 h at 160000 g in an SW40 rotor. Subsequently, 
the pellet was resuspended in 100 µl TNE buffer and further purified by another 
centrifugation through a 20 % sucrose cushion for 2 h at 160000 g. Finally, the pellet was 
resuspended in 50 µl TNE buffer and analyzed using SDS-PAGE and Western Blot. Here, 
both virus-derived fusion proteins were detected utilizing GFP-antibodies. 
3.2.3 Microscopy  
3.2.3.1 Confocal fluorescence microscopy (CLSM) 
An inverted FluoView 1000 microscope was modified for FLIM measurements with a time-
resolved LSM Upgrade kit (PicoQuant, Berlin, Germany). Differential Interference Contrast 
(DIC), fluorescence intensity and FLIM images were obtained with a 60x UplanSApo oil 
immersion objective (numerical aperture 1.35) at 25° C with a frame size of 512x512 pixels 
and a pixel dwell time of 4 µs per pixel. For different combinations of fluorophores, different 
excitations sources, filter sets and dichroic mirrors were used. If not otherwise state the 
following microscope settings were applied (Table 22). As excitation source, the microscope 
was equipped with a multi-line argon laser, providing 458 nm, 488 nm and 515 nm 
wavelength, and two laser diodes providing 405 nm and 561 nm. Emission was detected with 
two independent confocal photon multiplier tubes. Signals of double labeled cells were 
recorded sequentially and, if necessary, obtained intensities were analyzed with the ImageJ 
analysis program.  
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Figure 3-4: Raft partitioning assay workflow. This experimental approach can be roughly divided in 
three practical and three analytical steps. Firstly, (A) cells were transfected with GPI-CFP and the YFP 
labeled protein under study or, for the calculation of the FRET efficiency, with GPI-CFP alone. (B) 
Expressing cells were imaged using conventional confocal microscopy for subsequent intensity analysis 
and afterwards (C) investigated with the FLIM setup. For the calculation of a relevant average 
fluorophore lifetime and FRET efficiency suited areas of interest (D), usually plasma membranes or Golgi 
apparatus were selected. (E) Histograms of the detected photons in the selected area were generated by 
using the Symphotime software (red columns) and a decay curve was calculated (blue dashed line). (F) 
The fitting yielded individual fluorescent lifetimes and the respective amplitudes according to the fitting 
model selected. For CFP, usually a biexponential decay was assumed and the amplitude-weighted average 
lifetime τav in absence and presence of acceptor fluorophores was used to calculate the FRET efficiency 
(see FLIM analysis).  
Briefly, images were accumulated for 98 s with an average photon count rate of 40000-60000 
counts per second. Regions of interest (usually plasma membrane or Golgi apparatus) were 
selected from FLIM images and the corresponding photon counts were summed up into a 
lifetime histogram, according to their arrival time by the SymPhoTime software.     
3.2.3.2.1 FLIM analysis 
The intensity distribution decay that is represented by the lifetime histogram was further 
analyzed by fitting, using a nonlinear least squares iterative procedure which is included in the 
SymPhoTime software. As other fluorescent protein variants, CFP adopts  different 
conformational states176,177 with different fluorescence properties that have to be considered in 
fluorescence lifetime fits. Therefore, a decay that is a sum of 2 exponential terms was 
assumed. For every single cell the amplitude-weighted average lifetime was calculated 
according to     
𝝉 𝒗 =
∑ 𝜶 𝝉  
∑ 𝜶  
     (8) 
Where τav is the amplitude-weighted average lifetime, α is the amplitude of a lifetime 
component and τ is the corresponding lifetime. FLIM images were generated by the 
Symphotime software by displaying pixelwise average lifetimes in pseudocolors.  
The calculated decays were judged by the χ2 values and the residuals of the fit. Cells 
expressing donor protein alone or coexpressing FRET-donor and acceptor protein were 
measured and the FRET efficiency was calculated as follows.  
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𝑬(%) = (𝟏 −
𝝉  
𝝉 
) × 𝟏     (9) 
Here, E(%) represents the FRET efficiency in percent, τDA the average weighted lifetime of 
donor in presence and τD in absence of the acceptor.  
3.2.3.2.2 FRET clustering analysis  
To elucidate whether obtained FRET values are a result of co-clustering or respectively direct 
protein interactions, or otherwise just reflect concentration dependent random collisions, the 
relation between acceptor concentration and FRET efficiency was examined. Confocal images 
were analyzed using ImageJ to obtain the fluorescence intensity of YFP at the plasma 
membrane assuming a direct proportion between acceptor concentration and fluorescence 
signal. Normalized and background corrected YFP fluorescence values of specific regions of 
single cells were plotted against the corresponding FRET efficiency and fitted to a binding 
kinetic model according to the following equation144.  
𝑬(%) =
𝑬 𝒂 (%)×𝑭 𝑭 
𝑭 𝑭 +𝑲 
   (10) 
Clustering in lipid rafts was assumed if obtained Kd values were significantly lower than the 
average acceptor fluorescence values FYFP within the experiments. Readers should refer to 
previous publications in this context 98,144 for more details. 
3.2.3.3 Fluorescence anisotropy imaging microscopy 
The workflow of a typical FAIM assay to study protein oligomerization is depicted in Figure 
3-5. The experimental setup for time resolved single photon detection was described 
previously (see 1.4.2). An expanded setup, explicitly described on the manufacturer’s 
website178 was used for fluorescence anisotropy imaging. After removal of DIC depolarization 
filters, images were obtained using a 60x water objective (numerical aperture 1.2) with a 
frame size of 512x512 pixel. A pulsed 470 nm laser diode with a repetition frequency of 20 
MHz was applied to excite YFP. The polarized emission light was separated with a 
polarization beam splitter and detected using a 540/40 emission filter for the perpendicular 
polarized light and a 540/30 emission filter for the parallel polarized light prior to a τ-SPAD 
and Perkin/Elmer SPAD respectively. The polarization characteristics of the different 
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Where r is the anisotropy, Iǁ and I  are the intensities of the parallel and perpendicular light 
and G is the instrument specific G-factor. To quantify the extent of the measured 
depolarization, maximum values of Gauss-distributed anisotropy histograms of different 
proteins were compared. Typically, if the distribution did not commensurate to the 
requirements of a simple Gaussian distribution, other regions of interest were selected in the 
FAIM images to spatially separate different species which then can be used to obtain 
individual anisotropy maxima.  
3.2.3.4 Single particle tracking (SPT) 
Single particle tracking of cells expressing fluorescently labeled viral proteins were conducted 
with the confocal setup described previously (3.2.3.1). Equatorial sections of the cells were 
imaged with a resolution of 256x256 pixel and a pixel dwell time of 4 µs resulting in an 
image acquisition time of at about 1 sec per image. Obtained t-stacks were analyzed following 
a protocol developed by Chris-Tina Höfer (Humboldt University, Berlin). Briefly, particles 
were identified using the SpotTracker ImageJ plugin and tracked with the plugin MtrackJ. 
With the known image acquisition parameter, the trajectories or more precisely the particle 
displacement can be utilized to estimate physical meaningful data such as particle velocity or 
covered distance.     
3.2.3.5 Epifluorescence microscopy  
Epifluorescence microscopy was used to study phase separation in GPMVs. Although, 
equatorial sections were obtained for the analysis of domain partitioning and phase separation, 
epifluorescence microscopy was preferred to confocal microscopy because it allows easier 
identification of phase separating vesicles in inhomogeneous solutions and in general, permits 
faster image acquisition, which is a huge advantage for the observation of the freely diffusing 
blebs. Epifluorescence microscopy was conducted utilizing an inverted Olympus IX-81 
microscope equipped with a cooled monochrome CCD-camera. Images were obtained with a 
40x UPlanFL air objective (numerical aperture 0.75) using U-MWNiba filters (BP470-495, 
BA520IF, DM510-550) for green fluorescence such as GFP, YFP or FITC and a U-MWG2 
filter set (BP510-550, BA590, DM570) for red fluorescence, like DiO or R18. Depending on 
the individual protein concentration and labeling efficiency, images were obtained with 
  MATERIAL AND METHODS  77 
exposure times from 0.5 s to several seconds for the green channel and below 0.5 s for the red 
channel.     
3.2.3.6 Total internal reflection fluorescence microscopy (TIRFM) 
TIRFM was used to study the plasma membrane localization of expressed virus protein-
derived fluorescent chimeras. An inverted FluoView 1000MPE microscope (Olympus, Tokyo, 
Japan) was modified with a beam expander to allow illumination of the whole field of view 
using laser excitation sources and a highly sensitive, cooled Hamamatsu Orca ER CCD-
camera for epifluorescence observation. The tilting of the angle of the incidenting light beam 
was achieved by a displacement of the beam, away from the center of the observation 
objective179 (60x UplanSApo oil objective with a numerical aperture 1.45 ). In a typical 
TIRFM experiment, the glass attached parts of the cells under study were focused and imaged 
in the epifluorescence mode applying beam expander and CCD-camera. Then, the TIRFM 
angle was tilted until the out-of-focus light from intracellular structures disappeared and 
plasma membrane structures dominated the image. As a rule of thumb, if the angle is right, 
changes of the focus should not change the structures displayed but only the sharpness of the 
plasma membrane components. Since only an evanescent field of the excitation light was used 
to illuminate the fluorophores, high laser intensities of around 50 % and image acquisition 
times of at about 1 sec were used.        
3.2.4 Flow cytometry 
Flow cytometric experiments were performed with a BD FACS Aria II. Initially, adherent 
cells were detached using either trypsin, 2mM EDTA in PBS (-/-) or a cell scraper. Afterwards 
the cells were pelleted with a tabletop centrifuge (<300g, 10 min at RT) and resuspended in 
PBS (-/-). Typical cell cytometry experiments were conducted with a 100 µm nozzle and a 
ND2 laser attenuation filter. The drop formation was induced with an amplitude of 12 and a 
frequency of 30. The exact arrangement of the optical elements and the exact filter 
configuration can be obtained from the BD website or the manufacturers manual (page 37). 
As excitation sources served a 405 nm, a 488 nm and a 633 nm laser that allowed, in 
combination with the provided filter setup, simultaneous observation of blue (DAPI), green 
(GFP) and red (Propidium Iodide, Alexa 568) fluorescence.    
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3.2.5 Biochemical methods 
3.2.5.1 Protein palmitoylation assay (acyl-biotinyl exchange) 
Acyl-biotinyl exchange was performed as described by Wan et al. 180to prove qualitatively 
gp41 palmitoylation. For this purpose, 90 % confluent cells were transfected in 35 mm dishes. 
After one to two days of expression, the medium was changed and the cells were incubated 
for another hour. After two washing steps with cold PBS (+/+), 200 µl lysis buffer were 
applied, the cells were scraped from the bottom of the culture dish and subjected to 20 strokes 
of homogenization on ice utilizing a dounce homogenizer. Afterwards, nuclei were removed 
by centrifugation for five minutes at 800 g. The supernatant was mixed with four volumes of 
ice cold acetone to precipitate proteins and incubated for at least 30 min at 4° C. After a first 
centrifugation at 13000 g for 10 min the pellet was washed with ice cold acetone and 
centrifuged again. The obtained pellet was then dissolved in 50 µl blocking buffer to saturate 
accessible cysteines in the protein solution and incubated for at least ten minutes at 40° C 
while vigorously shaking. Subsequently, the proteins were acetone precipitated, acetone 
washed twice and redissolved in 50 µl binding buffer. Thiopropylsepharose beads were 
washed three times with binding buffer and redissolved in binding buffer to a final 
concentration of two to 3 mg of dry powder per 15µl. This volume was then added to the 
protein solution followed by 10 µl of freshly prepared 2 M hydroxylamine hydrochloride 
solution with a pH adjusted to 7-8 using NaOH and HCl and incubated for at least two hours 
at RT to allow binding of the beads with the depalmitoylated cysteines. The supernatant of 
this binding represents non-palmitoylated proteins. Bead-bound proteins were pelleted by 
applying 1000 g for one min and washed five times with binding buffer. The final pellet was 
redissolved in 50 µl binding buffer supplemented with 50 mM DTT and incubated at RT for 
20 min. After a final centrifugation with 1000 g for one min the supernatant, containing 
originally palmitoylated protein, and the supernatant of the bead-binding step were subjected 
to SDS-PAGE and Western blot to estimate the fraction and identity of palmitoylated and non-
palmitoylated proteins in the cell lysate.              
3.2.5.2 SDS polyacrylamide gel electrophoresis  
Proteins were separated according to their molecular weight by SDS-PAGE. For this purpose, 
gels were prepared by casting resolving gels of 10 or 12 % acrylamide/bisacrylamide at pH 
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8.8 and overlaying them with a 5 % collecting gel at pH 6.8. Then, the samples were 
incubated with a reducing SDS sample buffer at 95° C for 5 min and loaded onto the gel. For 
the weight determination of isolated proteins, a molecular weight marker was loaded as well 
and afterwards, electrophoresis was run at constant voltage of 100 V for at about 5 minutes to 
allow a homogenous alignment of the samples in the collection gel and then raised to 180 V in 
the resolving gel. For detection of the proteins after electrophoresis, the gel was processed by 
Coomassie blue staining or Western blotting.  
3.2.5.3 Coomassie blue staining 
For the detection of total protein in a SDS polyacrylamide gel, the gel was incubated for 1-2 h 
in Coomassie staining solution. Subsequently, the gel was washed twice with ddH2O and 
destained for at least two hours or better overnight. The amount of proteins was detected 
(detection limit is about 0.1 µg of protein) at 700 nm with the Odyssey Infrared Imaging 
System (LI-COR). 
3.2.5.4 Western blotting 
Western blotting was performed after electrophoretic separation of proteins to identify 
specific protein bands by antibody recognition. A prerequisite of that detection is a transfer of 
the proteins under study from the gel onto a nitrocellulose membrane (‘blotting’). To this aim, 
the membrane and two pieces of thick blotting paper (Whatman paper) were soaked in 
transfer buffer. Then, a stack consisting of blocking paper, membrane, gel and another piece 
of blocking paper was placed in a Trans-Blot Semi-Dry Transfer Cell (Bio-Rad). An electric 
field was applied perpendicular to the stack with 20 V for 30-60 min. The efficiency of the 
transfer was estimated by the molecular weight marker. Since the membrane binds all proteins 
unspecifically, it needed to be blocked after the transfer to prevent unspecific binding of 
antibodies in the following steps by incubation for 1 h at RT with blocking buffer (LI-COR 
Odyssey Blocking buffer 1:1 diluted with PBST). The membrane was gently agitated during 
all incubation steps. Primary antibodies, which are specific for the protein of interest, were 
typically used in a 1:3,000 and secondary antibodies in a 1:10,000 dilution in blocking buffer. 
The membrane was incubated with the primary antibody for at least 1 h or better overnight at 
4°C, followed by three times washing for 10 min with PBST and incubation with the 
secondary antibody for another one to two hours at RT. Finally, the membrane was washed as 
  MATERIAL AND METHODS  81 
before and stored in PBS. Secondary antibodies labeled with an IRDye were detected with the 
LI-COR Odyssey scanner by excitation at 700 nm.  
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4. Results 
4.1 Generating tools to study gp41 lipid raft partitioning  
The main objective of this work was to characterize the lateral segregation of the HIV-1 
glycoprotein gp41 in the plasma membrane of mammalian cells. To this aim, virus protein 
chimeras were produced by tagging fragments of gp41 with a yellow fluorescent protein. 
Upon cotransfection with a GPI-anchored CFP as a raft marker emerging FRET reports raft 
association of the protein under study. 
4.1.1 Construction of the raft marker 
In order to have a genetically encoded, fluorescent raft marker, a GPI-anchored cyan 
fluorescent protein (CFP) was produced. The original cDNAs of GPI-CFP and GPI-YFP was 
provided by Patrick Keller 181 and modified by Silvia Scolari173. Briefly, a GPI-anchor signal 
was C-terminally linked with CFP and N-terminally with a plasma membrane targeting signal. 
Due to the properties of the membrane anchor, the resulting protein is not only efficiently 
transported to the plasma membrane but also preferentially incorporated in cholesterol 
enriched microdomains98,144.  
Native GFP and GFP-derived proteins have the propensity to spontaneously form 
homodimers. The aim of our approach was to study FRET between CFP- and YFP-linked 
proteins as a result of their putative enrichment in plasma membrane lipid rafts. Hence, a 
direct interaction between CFP and YFP had to be prevented. For this reason, the single amino 
acid mutation A206K, reported to completely abolish the oligomerization potential of GFP144 
and its derivatives, has been introduced in both fluorophores by AB-PCR.  
4.1.2 Construction of the chimeric gp41 fusion protein gp41-YFP 
When designing fluorescently tagged fusion proteins, several requirements have to be taken 
into account. Since behavior, structure and function of the chimeric proteins should resemble 
their native equivalent as much as possible, the position of the fluorophore has to be chosen 
carefully. In the present study, the focus lies on the assembly related processes. Therefore, 
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from the full envelope complex we removed the full external subunit gp120 and most of the 
gp41 external domain based on the assumption that those parts are too distal from 
transmembrane domain and bilayer to influence membrane-related properties. An initial 
construct was designed with an N-terminal signal peptide and a yellow fluorescent protein 
linked to the external domain of gp41 (Figure 4-1). The glycoprotein’s membrane proximal 
external region and the complete cytoplasmic domain was included to preserve the external 
cholesterol binding motif and several internal motifs known to mediate intracellular, host 
protein or membrane interactions. In order to allow various fluorophore combinations in co-
expression and staining experiments, different gp41 fusion proteins were produced by 
replacing YFP with CFP, GFP or Cherry.   
 
Figure 4-1: Schematic illustration of the gp41 chimeric protein. From the wild type glycoprotein 
precursor complex gp160, irrelevant parts of gp41 and the surface subunit gp120 were replaced by a 
fluorescent protein yielding the fusion protein gp41-YFP. In this variant, CRAC domain, YXXL 
endocytosis motif, palmitoylation site, YW tyrosine based sorting signal and C-terminal dileucine motif 
(highlighted in red) are maintained to ensure a physiological membrane interaction. A cartoon 
representation of a predicted gp41 structure is displayed in the lower panel. 
4.2 Characterizing the chimeric gp41 
Several experiments were performed to elucidate whether the fluorescent tagging of gp41 
affected properties of the protein in the context of post-translational trafficking, assembly and 
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budding. To this end, we scrutinized intracellular localization, palmitoylation and 
incorporation in virus-like particles.  
4.2.1 Intracellular distribution and trafficking 
Upon expression in different mammalian cell lines, gp41-YFP was always found to be 
similarly distributed. In all tested cell lines, namely Cos7, HeLa, CHO-K1 and HEK293T, 
expression and localization showed significant deviations within the cell population. 
Nevertheless, all expressing cells displayed an inhomogeneous distribution of the protein over 
the complete cell body and a strong accumulation in the perinuclear region (Figure 4-2, 
white arrows).  
 
Figure 4-2: Gp41-YFP localization in different mammalian cell lines. Projections of z-stacks assessed 
by confocal microscopy of Cos7, HeLa, CHO-K1 and HEK293T-cells, expressing chimeric gp41-YFP 
are displayed. The white arrows indicate the gp41 accumulation in the perinuclear region. Scale bar, 
10µm. 
This accumulation in the perinuclear region is highly cell type dependent and in particular in 
HeLa and HEK293T cells it was found to be very pronounced. Since this local enrichment 
comes with a decrease of the plasma membrane localization, lipid raft partitioning 
experiments are rendered difficult in those cell types. Thus, CHO-K1 cells were used for 
further experiments. Antibody staining, nucleus staining and coexpression with different 
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fluorescent proteins were performed to identify the intracellular compartments and organelles 
and characterize the vesicles the protein was incorporated in.  
Gp41-YFP is highly enriched in the Golgi apparatus. First of all, gp41-YFP expressing 
cells were stained with a commercially available fluorescent ER marker. Colocalization was 
found only in the perinuclear region but not, or only to a minor extend in other parts of the 
cell (Figure 4-3). Considering that ER-Tracker is labeling both, Golgi apparatus and 
endoplasmic reticulum (personal communication with Invitrogen application specialists) this 
finding suggests an only insignificant detention of gp41-YFP proteins in the ER and thus a 
physiological folding. However, to undoubtedly identify the perinuclear region gp41-YFP was 
found to be accumulated in, two independent antibody stainings were performed. 
  
Figure 4-3: Intracellular localization of gp41 in CHO-K1 cells. Gp41-YFP or gp41-Cherry (displayed 
in green) expressing cells were labeled with ER-tracker, antibodies specific for the Golgi-apparatus 
proteins giantin182 (cis/media) and 58K183 (trans/late) or co-transfected with Tau-YFP as a specific 
microtubule marker (displayed in violet). Scale bar, 10µm. 
Both cellular Golgi proteins, Giantin and 58K were found to colocalize with the intracellular 
accumulation site of gp41-YFP (Figure 4-3). Whereas giantin mainly resides in cis and medial 
parts of the Golgi apparatus182, 58K should be concentrated in the later compartments and 
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Trans-Golgi network183. Gp41-YFP was found to colocalize with both, reporting a 
homogenous distribution of the protein in all subcompartments of this organelle. This results 
is in agreement with previous studies that already reported high concentrations of the HIV-1 
envelope complex in the Golgi apparatus184 and moreover, indicate a native folding of the 
fusion proteins in the ER since only correctly folded proteins are able to reach the Golgi 
apparatus whereas missfolded proteins accumulate in the ER and are subjected to degradation. 
Finally, a fluorescently tagged tau protein (Tau-YFP) was co-expressed with gp41-Cherry. Tau 
is a cytoskeleton binding protein185 and thus, Tau-YFP can be used to visualize cellular 
microtubules in live cell experiments. Upon co-expression, the accumulation of gp41 was 
traced in the central crossing point of the microtubular network, presumably representing the 
microtubule organization center (MTOC) which is known to be associated with the Golgi 
apparatus186 (Figure 4-3).  
Gp41-YFP intracellular progression is associated with cellular transport vesicles and the 
chimeric protein is efficiently endocytosed. In order to elucidate gp41-YFP trafficking 
pathways, colocalization with fluorescently labeled rab proteins or a specific lysosomal 
marker was studied using confocal microscopy. Rab-GTPases are proteins that regulate 
trafficking between cellular organelles187 (Figure 4-4). Since different rab proteins are 
associated with specific intracellular routes, labeled rab proteins can be used to identify 
cellular vesicles in live cell experiments.  
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Figure 4-4: Intracellular localization of rab proteins. Whereas most of the known rab protein are 
ubiquitous in all mammalian cells and bind many cellular membrane compartments from clathrin coated 
pits and vesicles (CCV) over early, late and recycling endosomes to lysosomes and ER-Golgi 
intermediate compartments (IC), Golgi apparatus, trans-Golgi network (TGN) and plasma membrane, 
some rab protein are cell or tissue specific (M=Melanosomes, SG=secretory granules, T=T-cell granules). 
Adapted from 187.   
Four different rab proteins were coexpressed with gp41-YFP to study transport and in 
particular endocytosis of the viral chimeric proteins. In addition, cells expressing gp41-YFP 
were stained with a lysosome-specific dye to cover a wide spectrum of cellular membranous 
compartments. Again, a correct folding and only minor degradation of gp41-YFP were 
pointed out by the finding of a negligible localization in lysosomal vesicles (Figure 4-5). 
Clear colocalization on the other hand was found with the endocytosis- and recycling-
associated rab proteins rab5, rab7, rab11 (Figure 4-5). This is indicative of the efficient 
reinternalization of gp41-YFP that is caused by interactions between specific motifs within 
the protein’s cytoplasmic domain and cellular trafficking proteins, namely the adaptor 
proteins AP-1 and AP-227.  
 
Figure 4-5:  Intracellular transport of viral fusion proteins. Colocalization study of gp41-YFP with a 
lysosomal marker and different rab proteins indicative of early endosomes and clathrin-coated vesicles 
(rab5), late endosomes and lysosomes (rab7) and early and recycling endosomes (rab11). White areas 
indicate co-localization in the overlay images. Scale bar, 10µm. 
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4.2.2 Incorporation of the construct in virus-like particles 
Fluorescent gp41-YFP is incorporated into virus-like particles (VLPs). During the 
assembly process enveloped viruses not only have to target their components to the site of 
assembly but they also have to efficiently bend cellular membranes and induce curvature to 
finally form infective particles. In case of HIV the Gag polyprotein alone is necessary and 
sufficient to bend bilayers and even cause virion release. In absence of other viral 
components, Gag expression causes formation of virus-like particles that resemble their 
pathogenic equivalents in size and shape. Since in released virus particles Gag forms a 
polymeric layer of proteins, it is the only viral component able to interact with the HIV 
envelope complex. Therefore, gp41 incorporation in VLPs strongly resembles the 
physiological equivalent in the infection context.   
The protocol for this method was established and improved before with HEK293T cells 
(personal communication, Andrea Gramatica, Humboldt University). The cells were 
transfected with gp41-YFP and Gag-GFP separately or co-transfected with both proteins and 
after 48 h emerged VLPs in the supernatant were scrutinized using SDS-PAGE and Western 
blot. As expected, solely expression of Gag-GFP yielded high amounts of VLPs indicated by a 
strong band of the protein whereas gp41 transfected alone could not be detected in the 
respective supernatants (Figure 4-6). On the other hand, clear bands of both virus-derived 
proteins, were found in the supernatant of co-transfected cells (Figure 4-6). This result proves 
incorporation of gp41-YFP in nascent virus-like particles and points to a wild type like 
behavior in the assembly and budding context.  
 
Figure 4-6: Characterization of virus-like particles. HEK293T cells were transfected with the 
indicated proteins labeled with YFP (gp41-YFP) or GFP (Gag-GFP). 48 h post-transfection the cell 
supernatant was harvested and a sucrose cushion purification was conducted. Obtained virus-like particle 
preparations were subjected to electrophoresis separation in a 10 % SDS-polyacrylamide gel and detected 
on Western blots using anti-GFP antibodies.  
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4.3 Investigating plasma membrane raft partitioning of gp41 
In the preceding sections gp41-YFP could be demonstrated to mimic and resemble the 
behavior of the wild type envelope complex regarding intracellular trafficking and 
interactions with other viral proteins. For the remainder of the study the partitioning in plasma 
membrane lipid rafts should be in the focus. To this end, gp41-YFP was co-expressed with the 
raft marker GPI-CFP in CHO-K1 cells and examined with the confocal FLIM-FRET setup as 
described above (3.2.3.2). The results of one typical experiment are displayed in Figure 4-7. 
As previously shown 98,139, the raft marker clearly localized at the plasma membrane 
(Figure 4-7A) and amplitude-weighted CFP  fluorescence lifetimes of around 2.5 ns were 
obtained (Figure 4-7C). To prove the reliability of the method, different positive controls were 
performed. Firstly, GPI-CFP was co-transfected with GPI-YFP as a raft clustering positive 
control. Both proteins were colocalized (Figure 4-7A), mainly at the plasma membrane and to 
a lower extent also in the Golgi apparatus. A reduced average CFP lifetime was measured, 
corresponding to a FRET efficiency of around 8 % (Figure 4-7B). For comparison, a GPI-
anchored construct double-labeled with a linked CFP and YFP tag was investigated. This 
protein produced lifetimes below 2 ns, reporting a FRET efficiency of around 20 % 
(Figure 4-7B). The intracellular distribution of the chimeric gp41-YFP strikingly differed 
from that of GPI-anchored fluorescent proteins (Figure 4-7A). As described before, the 
glycoprotein was enriched in Golgi apparatus and intracellular vesicles while only a smaller 
fraction was found at the plasma membrane (Figure 4-7A, compare also 4.5.2). Nevertheless, 
upon co-expression with gp41-YFP the lifetime of GPI-CFP was significantly reduced, 
corresponding to a FRET efficiency of around 5-6 % (Figure 4-7B). To exclude that this 
decrease of the CFP lifetime results from cellular changes induced by the overexpression of 
the viral protein, GPI-CFP co-transfected with gp41-cherry instead of gp41-YFP was 
investigated. Since the spectral overlap of cherry with CFP is rather small compared with that 
of YFP and CFP, the reduction of donor lifetime in presence of this acceptor protein should be 
less pronounced. Indeed, essentially no decrease in the CFP fluorescence lifetime 
(Figure 4-7B) was found, confirming that the drop in presence of YFP labeled fusion proteins 
is a result of occurring FRET. 
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Figure 4-7: FLIM-FRET analysis of fluorescently labeled gp41 and GPI-constructs from one 
experiment. (A) Confocal and FLIM images o f CHO-K1 cells expressing the FRET donor GPI-CFP and 
different proteins labeled with YFP or Cherry as FRET acceptors. FLIM images are shown in pseudocolors 
displaying long lifetimes in red and yellow (i.e. first column) and shorter lifetimes in green and blue (i.e. 
second column). Scale bar, 20µm. (B) CFP fluorescence lifetime histograms of plasma membranes from cells 
containing GPI-CFP and YFP-labeled fusion proteins. A magnification of the decays is depicted in the inset 
(C) Examples of amplitude-weighted average CFP lifetimes at the plasma membranes of 10-15 cells per 
sample analyzed from one individual experiment. The corresponding FRET efficiency is indicated in the 
columns. The asterisks denote *** p<0.001, * p<0.05 by Student’s test for unpaired data.  
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4.4 Perspectives - gp41 trafficking 
In the “Perspectives” sections, experiments are described that were conducted to target some 
of the comprehensive questions that emerged from the observations circumstantiated so far. 
The results have been exerted from just a few, not sufficiently verified trials and should be 
contemplated with caution. However, although continuative and repeated experiments are 
necessary to proof the observations they allow glimpses on possible upcoming findings.      
The trafficking of gp41 is a typical example for a biological process that has significant 
consequences for many, not directly connected experimental questions. For example, studying 
raft partitioning of a protein, independent of the method applied, requires an, at least to a 
certain extent, stable localization at the plasma membrane. As described before (1.2.4) the 
HIV-1 glycoprotein is known to contain several motifs mediating interactions with cellular 
components and causing an efficient reinternalization from the cell surface. This has to be 
taken into account when designing raft partitioning experiments and interpreting obtained 
results. There is a huge variety of methods available to elucidate the role of host cell proteins 
in infection progression and virus assembly. Direct interactions between the molecular 
components can be studied biochemically using crosslinking and co-immunoprecipitation 
assays, yeast two hybrid systems or by techniques like surface plasmon resonance and FRET 
approaches. Nevertheless, much additional information can be gathered by more indirect 
approaches. Particle tracking for instance can generate data allowing to specifically identify 
cellular routes utilized by a protein under study. Time correlated localization studies, usually 
via pulse chase assays, do report on the exact lifecycle and fate of newly synthesized proteins 
in expressing cells. Both kind of approaches were exerted to study gp41 constructs in a 
cellular context.  
4.4.1 Particle tracking of fluorescently labeled fusion proteins 
In recent years many cellular factors of the envelope complex’ intracellular trafficking have 
been discovered. Nevertheless, the exact progression of the protein transport and the 
significance of many of the pathogen-host interactions are not completely understood.  
The gp41-YFP fusion protein seems to be transported in kinesin associated vesicles. To 
shed further light on precise progression of gp41 trafficking in expressing cells, particle 
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tracking experiments were conducted. Cells transfected with gp41-YFP were observed using 
confocal microscopy with a high temporal resolution. Obtained t-stacks were then semi-
automatically analyzed to generate single particle trajectories and thus motility data. Peak 
velocities of 200-800 nm/s were obtained and the trajectories (Figure 4-8) indicated 
movement in many different directions (towards the nucleus, directing to the periphery of the 
cell). The velocities point to a basically kinesin driven transport188. Considering that gp41 has 
been reported t o interact with the adaptor proteins AP-1 and AP-2, which are known to link 
cargo with kinesin proteins189 this finding is in agreement with literature-based expectations.  
 
4.4.2 Timing of gp41 intracellular distribution 
An open question regarding the gp41 live cycle is how exactly the protein’s progression is in 
infected cells. Although it is well understood what cellular trafficking proteins it interacts with 
and thus what routes it follows, the order and context of different transport steps need to be 
further elucidated.  
By replacing the YFP fluorescent tag with a newly developed fluorescent timer protein, we 
addressed this question in live cell experiments. Fluorescent timer (FT) proteins were 
designed to change their excitation and emission upon aging170. The molecular basis of that 
transformation is the protein’s maturation process. In its final conformational state, a FT 
protein shows a red fluorescence, but shortly after synthesis its nascent conformation causes a 
Figure 4-8: Particle tracking of gp41-YFP containing vesicles in CHO-K1 cells. (A) Confocal image 
of a cell expressing gp41-YFP with different independent trajectories displayed as colored lines. 
(B) Particle velocities of single vesicles calculated from time stacks of 180 seconds in length. Scale bar, 
10µm. 
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transient emission of blue light (Figure 4-9B). As a result of that, individual proteins linked 
with a timer fluorophore can be classified with respect to their specific age just by assessing 
their fluorescence properties. Three different variants of the timer fluorophore were developed 
with deviating maturation kinetics, fastFT, mediumFT, and slowFT. For the dynamics 
investigated in this study, only the fast variant covers the relevant time scales and was thus 
used for the experiments described below. 
 
The gp41-FT proteins remains intracellularly localized after reinternalization. Upon 
expression of gp41-fastFT in CHO-K1 cells, both protein forms (blue and red) were found 
distributed over most of the cell body. But, significant differences were found in the cell 
periphery and perinuclear region (Figure 4-9A). Whereas red fluorescence was found to be 
concentrated in the perinuclear region, the blue form of the protein was easily visible in the 
plasma membrane and Golgi apparatus. Interestingly, this observation indicates that only 
younger proteins are localized at the plasma membrane. If gp41 would be reinternalized and 
then recycled to the plasma membrane, older proteins (red fluorescence) should be detectable 
at the surface as well. It appears promising to conduct further experiments to characterize the 
gp41 succession in the cell in more details. A fluorescent timer pulse chase approach using 
inducible promotors as described in Subach et al. for LAMP-2A170 most likely will allow a 
precise elucidation of the trafficking steps of the protein.      
Figure 4-9: Confocal images of timer fluorophore-labeled gp41. (A) The quickly maturating timer 
fluorophore fastFT was used to replace YFP from gp41-YFP. Gp41-fastFT was expressed in CHO-K1 
cells and imaged using confocal microscopy. (B) Spectrometric characterization of the fastFT emission in 
dependence of the maturation time (from Subach et al.170). Scale bar, 10µm. 
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4.5 Chasing the molecular basis of gp41 raft partitioning 
In the preceding part the FLIM-FRET based raft partitioning assay was established and 
verified by conducting different negative and positive controls. Moreover, the chimeric 
protein gp41-YFP was demonstrated to still exhibit many important features of its 
physiological counterpart, the native gp160 protein. Intracellular distribution and trafficking, 
but also incorporation in virus-like particles were indicated to be undisturbed by the 
fluorescent labeling. Next, to elucidate the intrinsic domains, motifs or amino acids 
responsible for the properties of the protein, truncation and mutation variants had to be 
generated.    
4.5.1 Construction of gp41-truncation and mutation variants 
Numerous variants of the original, membranotropic wild type gp41-YFP were produced. 
Substantial protein section or complete domains were removed to unravel the role and 
significance of gp41 motifs for raft partitioning, trafficking and other assembly related 
properties (Figure 4-10). 
 
Figure 4-10: Gp41 fusion protein variants. Schematic representation of different fluorescently labeled 
gp41 variants. Important sequences, such as CRAC, YSPL internalization signal, palmitoylated cysteine 
and the C-terminal dileucine motif are highlighted in red whereas the mutated CRAC is displayed in blue. 
The α-helical sections of the protein are shown in green and yellow. SP=Signal peptide.       
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Two truncation variants are of particular importance in the following investigations. The 
protein Δ1 was generated by removing most of the cytoplasmic domain (truncation at amino 
acid 703) of the wild type-like gp41-YFP. An additional removal of the external MPER 
(amino acid 670), but retaining the CRAC domain was performed to generate the Δ2 variant. 
Moreover, a leucine to isoleucin exchange in the gp41 CRAC domain, yielding gp41mCRAC 
and Δ1mCRAC, was conducted. Since cholesterol is highly enriched in lipid rafts, the 
functionality of this cholesterol binding motif should have a significant impact on the 
protein’s raft partitioning.  
4.5.2 Characterization of gp41 fusion proteins 
The cytosolic region of gp41 contains three known amino acid sequences mediating 
interaction with different cellular adaptor proteins that are involved in directed vesicle 
transport (see 1.2.2.3). To study the influence of those motifs and other parts of the 
cytoplasmic domain in that context, the truncations and mutations were investigated to 
characterize their role for gp41 localization and trafficking. 
The variant Δ1 shows physiological intracellular trafficking. Colocalization studies as 
described before (4.2.1) were performed to reveal the role of the gp41 cytoplasmic tail in the 
context of endocytosis. The CT truncation variant Δ1 was co-transfected with rab5, rab7 and 
rab11 or stained with ER-tracker and lysotracker after transfection. Negligibly colocalization 
was found again with ER and lysosomal marker indicating a physiologic synthesis and 
folding (Figure 4-11). Compared to the wild type-like gp41-YFP (Figure 4-5), slightly less 
spatial correlation was found with rab5, rab7 and rab11 reflecting a significantly reduced 
endocytosis of that truncated variant lacking all 3 known internal, endocytosis-related 
interaction motifs (Figure 4-11).     
The gp41 cytosolic domain restricts gp41 surface exposure. Total internal reflection 
fluorescence microscopy can be used to exclusively image fluorescent molecules close to the 
surface of the microscopic slide. Therefore, it is an ideal tool to study fluorescent proteins at 
or adjacent to the surface of an expressing cell. Gp41-YFP was detected using conventional 
epifluorescence microscopy yielding the already described distribution of fluorescence with a 
bright spot in the Golgi apparatus and no clearly visible staining of the plasma membrane. 
Upon TIRFM illumination, the fluorescence signal from perinuclear compartments was 
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considerably reduced and the fine structure of the plasma membrane emerged. This finding is 
indicative of a surface exposure of the protein under study and supports the assumption that 
the fluorescently tagged gp41-YFP construct is expressed physiologically. Nevertheless, the 
protein variant Δ1 showed significantly more plasma membrane exposure due to the removal 
of the cytoplasmic internalization motifs.  
 
Figure 4-11: Intracellular distribution of the Δ1 variant. Colocalization study of Δ1 with lysosomal 
and ER-specific markers and different fluorescently labeled rab proteins as reporter of early endosomes 
and clathrin-coated vesicles (rab5), late-endosomes and lysosomes (rab7) and early and recycling 
endosomes (rab11). Scale bar, 10µm. 
The localization of different gp41 variants was furthermore investigated utilizing confocal 
microscopy. Obtained fluorescent images from equatorial slices of transfected cells were 
analyzed regarding plasma membrane fluorescence. Cells were co-transfected with GPI-CFP 
and gp41 variants since the CFP fluorescence allows an easy identification of the plasma 
membrane on confocal images. After selecting the plasma membrane in CFP images, the YFP 
fluorescence in the same region of interest was assumed to report plasma membrane 
expression of the YFP-labeled protein under study. As expected, gp41-YFP was significantly 
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depleted at the plasma membrane compared to the cytoplasmic truncation variant Δ1 
(Figure 4-12B). Nevertheless, for both variants (gp41-YFP and Δ1) the surface exposure was 
found to be unaffected by the introduction of a CRAC-mutation, demonstrating that 
differences in the raft related FRET between mutant and respective wild type (gp41mCRAC 
and gp41-YFP, Δ1mCRAC and Δ1) are not a side effect of a changes in the plasma membrane 
expression (Figure 4-12). Surprisingly, the Δ2 variant showed a decrease in the surface 
exposure compared to the Δ1 variant. It is unlikely that this is a result of a recovery of the 
gp41-internalization since Δ2, as Δ1 lacks all intrinsic endocytosis motifs. Probably, it is 
rather consequence of an in general lower expression level of the Δ2 construct.  
 
Figure 4-12: Plasma membrane exposure of gp41 fusion proteins. (A) Epifluorescence and TIRFM 
images of CHO-K1 cells expressing gp41-YFP or Δ1. Scale bar, 10µm. (B) The average YFP intensity at 
the plasma membrane of transfected CHO-K1 cells was obtained by analyzing background corrected 
confocal images. Each bar represents 20-50 cells from at least 2 independent experiments.  (C) The anti-
GFP fluorescence signal was detected as a measure of YFP plasma membrane expression in flow 
cytometer experiments. Individual bars represent at least two independent experiments. Individual bars 
represent two independent experiments. In all graphs the error bars display SEM. *** p<0.001, ** 
p=0.001-0.01, ns p>0.05.  
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Both aforementioned methods have their intrinsic limitations. Since in the image analysis 
assay only equatorial slices of the cells were analyzed, it can be argued that the results might 
only report the protein distribution in a distinct, potentially not representative region of the 
cells. TIRFM on the other hand gives only an impression of the surface exposure whereas 
quantification is difficult. Moreover, both described assays do not allow distinguishing 
between surface expression and intracellular fluorophores close to the plasma membrane. 
Even TIRFM, although it offers a minimal penetration depth of around 50-100 nm achieved 
with our instruments, still illuminates not only the plasma membrane but also adjacent 
cytoplasmic compartments. Therefore, flow cytometric, live cell immunofluorescence 
experiments were conducted. Anti-GFP fluorescent antibodies were used to specifically label 
those fusion proteins that are localized at plasma membrane, since only this population 
exposes its YFP to the extracellular environment. Then, the fluorescence emission of both 
reporters, YFP and the fluorescent moiety of the antibody was assessed in the flow cytometer 
experiments. Expressing cells were selected with respect to their YFP signals and the 
fluorescence intensity of the antibody was quantified as a measure of the fusion protein 
surface exposure. The results strongly resemble the observations described before 
(Figure 4-12). Both mutants displayed no significant differences to their respective wild type 
forms and again the Δ1 plasma membrane exposure was increased compared to the gp41-YFP 
construct and Δ2. The findings demonstrate that the microscopic assays described above, 
although only considering equatorial slices and based on image analysis of conventional 
confocal images, can be used to obtain quantitative data about plasma membrane localization. 
For comparison, GPI-YFP was analyzed with both approaches as well and the raft marker 
protein was found to be in three to five fold higher concentrations at the plasma membrane 
than the virus protein variants.   
The gp41 cytoplasmic tail exclusively controls reinternalization. We hypothesized that the 
finding of a relatively low plasma membrane signal of Δ2 compared to Δ1 is a result of an in 
general lower expression level than the other fusion protein variants. This observation 
illustrates that the overall expression of the different labeled proteins cannot be expected to be 
identical and the cellular distribution has to be studied in more detail to obtain meaningful 
data regarding trafficking and reinternalization. To this aim, the flow cytometric live cell 
assay described before was expanded (Figure 4-12). Again, cells transfected with 
fluorescently labeled proteins were stained with anti-GFP fluorescent antibodies to quantify 
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the amount of surface exposed proteins. In addition, the ratio of antibody to YFP signal was 
assessed as a measure of plasma membrane to overall expression (Figure 4-13).  
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Figure 4-13: Plasma membrane versus overall expression ratio of gp41 fusion proteins. The anti-
GFP fluorescence signal was detected as a measure of fusion protein plasma membrane expression in 
flow cytometer experiments. The ratio of antibody fluorescence versus overall YFP fluorescence is 
displayed to qualitatively investigate the proportion of protein expression in general to plasma membrane 
expression. Individual bars represent at least two independent experiments. In all graphs the error bars 
display SEM. *** p<0.001 and * p=0.01-0.05, ns p>0.05. 
In this assay, all variants with a truncated cytoplasmic tail, namely Δ1, Δ1mCRAC and Δ2 
displayed similar ratios whereas a significantly lower ratio was found for gp41-YFP and 
gp41mCRAC (Figure 4-13). Since the truncation variants (Δ1, Δ1mCRAC and Δ2) are all 
deficient in the interactions with cellular adaptor proteins this observations underline the 
relevance of the cytoplasmic tail for gp41 re-internalization. Moreover, it is indicated that the 
cellular distribution and in particular the gp41 reinternalization, is mainly controlled by the 
cytoplasmic tail whereas the external region that was removed from the variant Δ1 to obtain 
Δ2, did not contribute to this property. In agreement with the microscopic assay, both CRAC 
mutants displayed an intracellular distribution that resembles their respective wild type forms 
(Figure 4-13). 
4.5.3 Plasma membrane raft partitioning of gp41 variants 
The extracellular CRAC motif is the major factor of the gp41 plasma membrane raft 
association. In confocal microscopy, all gp41 variants proteins showed accumulations in the 
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perinuclear region but their plasma membrane exposure significantly differed. Gp41-YFP and 
gp41mCRAC were always found to be very weakly expressed at the surface, whereas 
significantly higher concentrations were usually found for all variants lacking the cytoplasmic 
domain (Figure 4-10). As rationalized before (4.5.3), the truncation variants were found to be 
enriched at the plasma membrane compared to the wild type gp41-YFP due to the removal of 
the protein’s cytosolic domain that comprises all protein inherent endocytosis motifs46,94 
(compare also the section 4.5.2). Nevertheless, co-transfection of wild type protein gp41-YFP 
or the truncation variants Δ1 and Δ2 with the raft marker GPI-CFP caused comparable 
decreases of donor lifetimes, reproducibly yielding average FRET efficiencies of around 5 
percent (Figure 4-14, Table 23).  
 
Figure 4-14: Confocal images and obtained FRET efficiencies of fluorescent gp41 variants. 
(A) Typical confocal images of GPI-YFP and various YFP-tagged gp41 variants expressed in CHO-K1 
cells. Scale bar, 15µm. (B) Average FRET efficiencies with SEM calculated from measuring the lifetimes 
in the plasma membrane of at least 3 independent experiments each with 10-20 cells analyzed for each 
protein under study. The asterisks denote *** p<0.001, ** p<0.01, * p<0.05, ns p>0.05 by Student’s test 
for unpaired data.  
To investigate the role of cholesterol in the gp41 lateral organization, CRAC mutants of the 
wild type and the variant Δ1 were scrutinized. Upon co-transfection with GPI-CFP lower 
FRET efficiencies were found for both, gp41mCRAC and Δ1mCRAC (Figure 4-14, Table 23) 
reproducibly. Since intracellular distribution and expression levels were comparable to their 
respective wild type proteins (compare 4.5.2) this finding substantiates a specific function of 
the CRAC motif in lateral plasma membrane sorting to microdomains that contain GPI-
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anchored proteins. For the sake of completeness, the different aforementioned positive and 
negative controls (4.3) were repeated several times to obtain significant data from 
independent experiments for all proteins investigated. All obtained fluorescence lifetimes are 
stated in Table 23. It is of note that the absolute lifetime values from the individual 
experiment reported in Figure 4-7 strikingly differ from the average values reported here. This 
is indicative of the high variability of CFP-lifetimes between different experiments. Low 
standard deviations could be achieved only by several repetitions of the measurements.     
Table 23: Fluorescence lifetimes of GPI-CFP in presence and absence of different FRET-acceptor 
proteins. Average CFP lifetimes with SEM of at least 3 independent experiments each with 10-20 cells 
analyzed for each protein under study. 
sample GPI-CFP 
GPI-CFP    
& GPI-
YFP 
GPI-CFP-
YFP 
GPI-CFP 
& gp41-
YFP 
GPI-CFP 
& gp41 
mCRAC 
GPI-CFP 
& gp41 
Cherry 
GPI-CFP 
& Δ1 
GPI-CFP  
& Δ1 
mCRAC 
GPI-CFP 
& Δ2 
τav [ns] 
2.53 
±0.01 
2.38 
±0.01 
1.94 
±0.01 
2.42 
±0.01 
2.52 
±0.01 
2.52 
±0.01 
2.40 
±0.02 
2.46 
±0.01 
2.4 
0±0.02 
4.6 Verifying plasma membrane raft clustering  
To verify the reliability of the FRET-based assay an analysis approach was used which was 
initially introduced by Zacharias et al144. According to that reference, FRET efficiencies are 
independent of acceptor concentrations, if energy transfer does not originate from random 
fluorophore interactions. We applied this model by plotting the acceptor intensity, which is 
proportional to the fluorophore concentration, versus the FRET efficiency for at least 20 cells 
per protein studied (Figure 4-15). The FRET efficiencies of cells expressing the CRAC-
comprising variants gp41-YFP, Δ1 and Δ2 showed saturation at low expression levels, which 
indicates a non-random organization (Figure 4-15, black plots). Importantly, the distribution 
of our experimental values in the three plots suggests an additional complexity of the system 
under study. As every dot represents an individual FRET value of one single cell, the plots 
indicate different populations of cells, at least two, with different, raft-related properties. To 
take this into account, the two populations were divided in groups of cells with FRET 
efficiencies of below and above 10 %. Both populations were then used for additional fits 
yielding significantly better statistics (Figure 4-15, light and dark grey). An interesting result 
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proteins are very similar to their respective wild type forms (see 4.5.3), this observation 
demonstrates a CRAC dependent clustering of the glycoprotein gp41. We surmise that the 
FRET values assessed for the proteins gp41-YFP, Δ1 and Δ2 can be considered as reliable 
reporter of their accumulation in cholesterol enriched microdomains and are not an artifact of 
concentration dependent random interactions within the lipid bilayer or unwanted side effects 
of the fusion protein overexpression. 
4.7 Insertion: Investigating population heterogeneities in membrane organization 
As described before, unexpectedly our FRET data revealed considerable heterogeneities in the 
populations of transfected cells. At least two subpopulations with different microdomain 
properties were indicated. Taking into account that all gp41 constructs containing a functional 
CRAC domain showed virtually identical affinities to lipid domains, they should sense and 
report membrane organization comparably. Indicative of that assumption, we found a similar 
distribution of FRET values for all three constructs in the clustering analysis (Figure 4-15). 
Therefore, to shed further light on cell-to-cell differences in the lipid raft properties, FRET 
data of gp41-YFP, Δ1 and Δ2 joined in a common clustering analyses and histograms 
(Figure 4-16) yielding a more accurate analysis due to the higher number of observations 
considered. For comparison, the same procedure was conducted with the proteins that were 
found to be excluded from lipid rafts, namely gp41mCRAC and Δ1mCRAC. Merging all data 
from cells comprising a functional CRAC domain supports the previously suggested model. 
FRET versus intensity plots (Figure 4-16A) and even more strikingly the FRET histogram 
(Figure 4-16B) point to distinct and distinguishable populations of cells with a significant 
difference in the plasma membrane lipid rafts. Again, the assumption of a high and a low 
FRET population improved the curve fitting significantly, but furthermore, we found a clear 
bimodal distribution in the histogram with peaks at 6 and 18 % FRET efficiency, comprising 
about 80 and 20 %, respectively, of all cells considered. This observation indicates significant 
deviations of the plasma membrane organization between individual cells of a cell line and 
thus is in agreement with previous observations of a heterogeneity in the exposure of the raft 
related sphingolipid GM1 at the surface of monoclonal cells 190. Conceivably, it reports a cell-
to-cell variability in lipid rafts that could originate from differences in the lipid composition 
and physical properties of the domains, from their size and from their total fraction. 
Unexpectedly, a similar observation was made upon combining of all data of non-raft proteins 
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Cell-to-cell variability in membrane organization is an intrinsic property of 
homogeneous cell populations. CHO-K1 cells were seeded in low concentrations to study 
intra-population variations in the context of local density and position of individual cells in a 
colony (at the border or surrounded by other cells). At the next day, the cells were labeled 
with C6-NBD-PC, serving as a reporter of general membrane order. C6-NBD-PC shows 
fluorescence lifetimes that strongly depend on the organization of the membrane it is 
embedded in112,191 and thus, ordered membrane environments are displayed by long lifetimes 
whereas disordered membranes cause a decrease of the stability of the excited state and thus a 
reduction of the fluorescence lifetime (Figure 4-18A).  
 
Again, a combination of all data in a histogram revealed two major populations, comprising 
80 and 20 % of the cells (Figure 4-18B) which is in remarkable agreement with the previous 
experiments (see 4.7). CHO-K1 cells were investigated in different positions of a petri-dish 
and single colonies of variable size were selected to cover a wide spectrum of individuals with 
a differing local context. Although clear differences between single cells were found in this 
experiment, no obvious correlation between membrane order and position in the colony, 
position of the colony in the dish or cell shape were found. Contrary, significant differences 
were occasionally found between cells of a single colony or cells with the same size 
(Figure 4-18A, indicated by arrows). This observation points to another origin of the 
systematic differences obtained. We surmise that the cell cycle might be the underlying 
Figure 4-18: C6-NBD-PC fluorescence lifetime variations upon incorporation in cellular 
membranes. (A) CHO-K1 cells were labeled with C6-NBD-PC as a reporter of the membrane order. 
Amplitude-weighted average fluorescent lifetimes are displayed in pseudocolors in the range between 6.5 
and 8 ns. Significant differences were found between single cells even within the same colonies (white 
arrow) or between cells in a similar local context (grey arrow). (B) Lifetime histogram of around 250 
analyzed cells. Two populations were indicated by the plot, displayed in bright and dark grey, comprising 
around 80 and 20 % respectively. Scale bar, 40µm. 
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Moreover, the observation of similar FRET efficiencies in the Golgi apparatus as at the 
plasma membrane is indicative of the lateral segregation already existing in the Golgi 
apparatus. Statistical relevance of the difference between wildtype and CRAC mutant was 
only found for gp41-YFP but not for Δ1 (Figure 4-20). This is a result of the high variance of 
the values that is typical for this kind of FRET-approach and also a result of the relatively low 
number of analyzed cells due to the small fraction of GPI-CFP expressing individuals with a 
perinuclear accumulation. 
4.9 Detecting palmitoylation of gp41 variants 
The gp41 fusion proteins are palmitoylated in CHO-K1 cells. Since recent experimental 
data from other cellular and viral glycoproteins97,98 suggest a more important role of gp41 
lipidations for the raft partitioning of the protein, a biochemical assay was performed to verify 
palmitoylation of the non-truncated constructs. Both variants comprising cysteine 764, gp41-
YFP and gp41mCRAC but not the truncated construct Δ1 were clearly found to be 
palmitoylated (Figure 4-21). Considering the wild type-like raft partitioning of the Δ1 variant 
(Figure 4-14), this finding is in support of the previous conclusion that gp41 lipidation at 
position 764 play a minor or no role in the protein’s raft partitioning. 
- +
gp41mCRAC
gp41
Δ1
 
Figure 4-21: Acyl-biotinyl exchanged pull-down of gp41 fusion proteins. Isolated, palmitoylated 
proteins (+) and the non-palmitoylated fraction (-) were detected on Western blots using anti-GFP 
antibodies.     
4.10 Analyzing lipid raft partitioning using giant plasma membrane vesicles 
A growing number of methods have been applied in recent years to study membrane 
organization and lipid rafts. Fundamental work in the field focused on artificial membrane 
systems like large unilamellar vesicles (LUVs) and giant unilamellar vesicles which allow 
studying membrane behavior in the context of a distinct bilayer composition and under clearly 
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defined conditions. In particular GUVs offer the advantage to show phase separation and 
domain formation in a micrometer scale and thus allow a microscopic investigation of that 
lateral segregation. However, although they are a valuable model system, GUVs and LUVs 
significantly differ in many characteristics from cellular membranes. They should be rather 
considered as a system to study general thermodynamic and physical properties of membrane 
assemblies than as an actual model of naturally occurring bilayers. Therefore, vesicles derived 
from cellular membranes, the so called giant plasma membrane vesicles195, plasma membrane 
spheres (PMSs)196 or blebs were often utilized to study lipids, proteins and peptides in a 
context that resembles physiological conditions more closely. GPMVs can be used to report a 
potential intrinsic preference for a certain bilayer environment since they are known to 
undergo µm-scale phase separation upon cooling. Thus, compared to living cells, GPMVs 
offer the advantage to allow a microscopic observation of a protein’s or a lipid’s distribution. 
Depending on the cell line, a spontaneous formation of plasma membrane vesicles can be 
induced by different treatments. Whereas some cell lines shed the so called PMS already upon 
incubation in hypotonic medium196, other cells have to be treated with different chemicals to 
induce GPMV formation175. In the present study, two different preparation protocols were 
followed. Blebbing was either triggered by utilizing paraformaldehyde and dithiothreitol 
(PFA/DTT) or N-ethylmaleimide (NEM) since both reagents were reported to generate 
vesicles with significantly different properties. It has been shown, that proteins associated 
with the disordered phase of PFA/DTT blebs localize to the ordered phase in NEM-blebs97.  
The protocols of these methods are based on a published workflow by Levental97 (Figure 3-2). 
Prepared vesicles were cooled down to induce macroscopic phase separation, microscopically 
imaged and subsequently analyzed. Partitioning of the protein under study in ld and lo domain 
is quantified and considered as reporter of its intrinsic membrane domain preference.      
4.10.1 GPMV preparation types 
When the GPMV preparation protocol was published first197, several different preparation 
methods have been described and tested. The most reliable and easy approach bases on a 
mixture of paraformaldehyde and dithioreitherol. However, in recent years it was shown in 
several studies, that this preparation method produces vesicles with significantly different 
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properties compared to the native plasma membrane97,175. Therefore, different protocols were 
utilized to circumvent or at least minimize preparation induced artifacts (Figure 4-22).  
 
Figure 4-22: Comparison of GPMV preparation methods. RBL cells were labeled with R18 and 
subjected to blebbing for one hour. After sedimentation for another 30 minutes, suspensions were 
observed using epifluorescence microscopy. PFA/DTT preparations turned out to produce considerably 
more blebs, less contamination (grey arrows) and more often phase separation (white arrows). Scale bar, 
30µm.     
NEM was often applied as alternative since it could be shown that the lateral segregation of 
plasma membrane proteins in NEM-induced vesicles resembles much better their behavior 
under physiological condition175. Moreover it was found, that GPMVs produced with this 
method require very low temperatures to undergo microscopic phase separation whereas 
PFA/DTT blebs are known to spontaneously form ordered and disordered domains already 
close to room temperature. On one hand this might indicate a physiological and more relevant 
behavior of those particles but on the other hand it also renders the investigation more 
laborious since temperatures below 4°C are hard to achieve on a microscopic stage and 
produce further problems like condense water and freezing of the sample. Another huge 
drawback of the NEM preparation protocol is the low efficiency of that procedure.  
PFA/DTT preparations produce high concentrations of clean GPMVs. To investigate the 
differences between the two aforementioned preparation methods, we tested both with rat 
basophile leukemia cells  (RBL) which are supposed to be a well suited GPMV-preparation 
cell line (see 4.10.2). Compared to the PFA/DTT assay the absolute number and the 
percentage of phase separating GPMVs produced upon NEM-treatment was found to be 
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significantly lower and the samples were often highly contaminated with cell debris and 
irregularly shaped membranous particles (Figure 4-22).  
4.10.2 Cell type dependence of GPMV preparation 
Different cells lines show significant differences in their sensitivity to bleb induction. 
Whereas some of them already start blebbing upon cooling or treatment with hypotonic PBS, 
for most of the standard laboratory culture cells the treatment has to be more invasive. 
Usually, PFA/DTT reliably stimulates the production of GPMVs from many different cell 
lines97,197. Nevertheless, the quality and quantity of the obtained vesicles remarkably differ. In 
many publication RBL cells are used113,175,191,195,198–200 since they seem to yield high amounts 
of vesicles and solutions that are relatively free of cell debris and other impurities.   
GPMV preparations from RBL cells yield the highest amount and quality of plasma 
membrane vesicles. We tested six different standard cell lines regarding their sensitivity to 
the blebbing procedure (Figure 4-23). The dog-derived cell line MDCK (Madin-Darby canine 
kidney), the human cell lines HEK293T (human embryonal kidney) and HeLa (Henrietta 
Lacks, cervical cancer), the rodent cell lines CHO-K1 (chinese hamster ovary) and RBL and 
the african green monkey cell line Cos7 (Cercopethecus aethiops origin-defective SV-40) 
were used to cover a wide spectrum of different species and tissues. GPMVs were produced 
from all cell lines and observed using epifluorescence microscopopy. Obtained images were 
then judged with respect to the number and purity (contamination with cell debris) of GPMV, 
heterogeneity and occurring phase separation.  In our experiments, in particular the cell lines 
MDCK and HeLa produced very low numbers of clean membrane vesicles and thus are not 
suitable for blebbing assays. Cos7 and even more CHO-K1 cells yielded better preparations. 
The absolute number of vesicles was still very low, but they turned out to be pure and 
relatively free of attached cell debris. HEK293T cells are only weakly adherent compared to 
the other cell lines considered. As a result of that, the GPMV supernatants of HEK293T cells 
always contain many floating cells or even huge cell aggregates that entered the solution due 
to the harsh blebbing procedure. Since the protocol includes cell labeling prior to the 
blebbing, high numbers of cells in the samples tend to outshine the small vesicles and 
preclude reasonable microscopic investigations. RBL preparations on the other hand, yielded 
very high amounts of phase separating vesicles that are widely free of other artifacts and 
pollutions.  
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Figure 4-23: Comparison of different cell lines for GPMV preparation. Six cell lines were seeded in 
petri dishes and after overnight culture; blebbing was induced by PFA/DTT treatment. After 
sedimentation for another 30 minutes, suspensions were observed using epifluorescence microscopy. 
Typical images are displayed above. Scale bar, 30µm. 
4.10.3 Domain partitioning of fluorescent proteins in GPMVs 
To study bilayer phase preference of the proteins under study directly, RBL cells were 
transfected with fluorescently labeled fusion proteins and investigated with the GPMV assay 
described before.   
GPI-YFP and Δ1 segregate to different phases in PFA/DTT blebs. GPI-YFP and the gp41 
variant Δ1 were tested first since both proteins were found to possess a high surface 
expression. Although RBL cells are better suited for bleb formation (4.10.2), transfection was 
conducted in CHO-K1 cells since plasmid delivery in RBL cells is not possible with 
conventional lipofection methods and requires expensive nucleofection. Nevertheless, 
following transfection, the proteins were expressed for 24 hours and PFA/DTT blebbing was 
performed for 1h. DiD was used as a marker for the disordered domain and as expected, GPI-
YFP as a known ordered phase protein was found in the DID-negative regions of the vesicles 
(Figure 4-24A).  
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Figure 4-24: Phase partitioning of fusion proteins in GPMVs prepared according to PFA/DTT 
protocol from CHO-K1 cells transfected with GPI-YFP or Δ1. (A) Typical epifluorescence images of 
YFP-labeled fusion proteins (green) and DiD (red) in exemplary GPMVs. Scale bar, 5µm. (B) Intensity 
line plots of fluorescence in the YFP (green), displaying GPI-YFP and Δ1 respectively, and DiD (red) 
channel. Black lines indicate the position of the membrane in the plot and thus the position considered for 
the calculation of the partitioning coefficient. (C) Partitioning coefficient in the ordered domain of phase 
separating GPMVs from 10 different vesicles containing GPI-YFP or Δ1 and DiD. The asterisks denote 
*** p<0.001, ns p>0.05 by Student’s test for unpaired data.    
Line plots of those vesicles showed maxima of YFP and DiD at the respective minimum of 
the other fluorophore demonstrating that GPI-YFP preferentially partitions in the ordered 
domains of blebs from CHO-K1 cells (Figure 4-24B). On the other hand the protein Δ1, that 
has been shown before to colocalize with GPI-anchored proteins in nm-size domains of the 
plasma membrane (Figure 4-14) was found to be highly enriched in the DiD-positive phase. 
Moreover, the protein was not only observed to colocalize with the ld marker but it turned out 
to be excluded from the lo phase. This indicates a strong association of the fusion protein with 
the disordered domain of PFA/DTT blebs. Partitioning coefficients were calculated to further 
quantify this observation. Comparable values were found for DiD and Δ1 and a significantly 
increased raft partitioning was obtained for GPI-YFP. This finding is in agreement with 
previous publications reporting that PFA/DTT causes an unphysiological lateral sorting 
behavior of many raft but not GPI-anchored proteins97.   
The NEM vesicle preparation protocol produces vesicles with negligible protein 
concentrations. To circumvent the issue of an unphysiological phase partitioning behavior of 
raft proteins due to the treatment with PFA/DTT, and alternative, less harsh protocol was 
proposed198. Since the NEM-based vesicle preparation turned out to be less efficient in 
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general (Figure 4-22), the better suited RBL cells were utilized to obtain sufficient amounts of 
GPMVs. Thus, GPI-YFP or the viral proteins Δ1 and gp41-YFP were nucleofected in RBL 
cells and after an expression of 24 h subjected to NEM-vesicle preparation. The supernatant 
of those cells contained only small fractions of pure, sufficiently sized and phase separating 
vesicles due to the low efficiency of the NEM protocol. Although the overexpression was 
verified to cause normal protein concentrations using confocal microscopy (data not shown), 
unexpectedly, all NEM induced GPMVs showed, if any only an extremely dim, virtually 
undetectable fluorescence of the virus derived fusion proteins. GPI-YFP signals on the other 
hand were detectable in many vesicles and even phase segregation occurred occasionally (not 
shown).      
Anti-GFP antibody labeling does not increase the detectable fusion protein fluorescence. 
Conceivably, both aforementioned viral fusion proteins are incorporated in NEM-GPMVs at 
very low concentrations. A labeling with fluorescent antibodies was performed in order to 
amplify the fluorescent signal and to allow detection of low concentrated proteins. Two 
different labeling protocols were tested. Either the antibody staining was conducted on 
adherent cells before the blebbing procedure or preformed blebs were immunofluorescently 
labeled in the collected cell supernatant. Unfortunately, both procedures have some serious 
inherent drawbacks. 
Firstly, we tested an antibody labeling of preformed vesicles. To verify the binding of the 
antibody, an Alexa568 anti-GFP was utilized in combinations with YFP-labeled fusion 
proteins. Indeed, we could obtain GPMVs with both fluorescent signals demonstrating the 
feasibility of the assay. Upon labeling with FITC-labeled antibodies we achieved a slight 
amplification of the overall green fluorescent signal. Unfortunately, this improvement of the 
detectable fluorescence was accompanied by a strong increase of the background fluorescent 
due to unbound antibody in the vesicle environment. Since a washing of the fragile vesicles is 
not possible, this inevitable side-effect lowers the signal-to-noise ratio to an extent that 
completely outweighs the slight signal increase by the treatment (not shown).    
In contrast to that, antibody-labeling of expressing cells clearly increased their fluorescence 
signals without increasing the background. Surprisingly, this amplification effect was not seen 
in the blebs produced by those cells. Whether antibodies are somehow excluded from 
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blebbing plasma membrane fractions or the signal amplification was too weak to be sensed 
cannot be concluded from those experiments (not shown).  
4.11 Inquiring oligomerization of chimeric proteins 
An early and important step of virus maturation is the assembly of newly synthesized protein 
monomers to functional oligomeric complexes. Although initial oligomerization of gp160 is 
known to occur in the Endoplasmic reticulum201–203 posttranslationally, oligomer stability was 
reported to be significantly impaired by the cleavage in the Golgi apparatus203. The 
localization and timing of an enduring and stable gp41 oligomer formation is hard to study 
and might be coupled to protein maturation level and cell type. Possibly, depending on 
circumstances and cellular context an efficient and stable oligomerization demands specific 
plasma membrane components or even the tight packing in the virus envelope.    
4.11.1 FAIM as a tool to study gp41 oligomerization 
Fluorescence anisotropy is a physical property that allows investigating homo-FRET, energy 
migration between chromophores of the same species. Therefore, it is often used to report 
oligomerization of labeled proteins without any previous purification in the context of living 
cells. Moreover, FAIM even enables the localization of this intermolecular assembly event.   
Env derived fusion proteins show low fluorescence anisotropies. First of all, transfections 
were conducted either with the fluorescently labeled Δ1 variant, possessing high plasma 
membrane expression rates or with GPI-YFP as a monomeric negative control and expressing 
cells were investigated with respect to fluorescence polarization. As expected98, a 
homogeneous and localization independent fluorescence anisotropy of about 0.3 was found 
for GPI-YFP (Figure 4-25 and Figure 4-26). These anisotropy values obtained for GPI-YFP 
are in agreement with previous results for GPI-anchored fluorescent protein98,139 and, 
according to Sharma et al.139 indicate GPI-YFP monomers clustered in plasma membrane 
lipid rafts of less than 5nm in diameter. While the Δ1 variant showed a comparable 
fluorescence polarization in intracellular compartments, mainly Golgi apparatus and 
endoplasmic reticulum, a significantly reduced anisotropy of around 0.1 was found at the 
plasma membrane (Figure 4-25 and Figure 4-26).  
  RESULTS  117 
 
Figure 4-25: FAIM in presence and absence of GFP-antibodies. (A) Fluorescence anisotropy of YFP 
labeled proteins. Confocal and fluorescence polarization images of CHO-K1 cells transfected with the raft 
marker GPI-YFP and the Δ1 fusion protein. (B) Fluorescent labeled protein expressing cells were tagged 
with a red fluorescent anti-GFP (αGFP) antibody in order to study the influence of fluorophore motility 
and rotational motion on the fluorescence anisotropy. Scale bar, 15µm. 
Low fluorescence anisotropy reports oligomerization. In this context, either an increased 
rotational mobility or homo-FRET can cause low anisotropy values. Since depending on the 
fluorophores, homo-FRET requires often even shorter distances to occur (<4nm)150 than 
hetero-FRET, this energy migration is usually considered as a reporter of direct interactions or 
in case of one labeled protein species of oligomerization. To exclude that the reduced 
anisotropy at the plasma membrane is a result of a facilitated rotational motility, live cell anti-
GFP fluorescent antibody staining experiments were performed (Figure 4-25). If indeed an 
accelerated motion of the fluorescent protein at the plasma membrane would cause the 
anisotropy decrease observed, it should be significantly increased by the direct binding of a 
bulky antibody. However, the anisotropy of both proteins, GPI-YFP and Δ1 were found to be 
unaffected by the antibody treatment, indicating that low anisotropy values, in fact reflect 
appearing homo-FRET. It might be objected, that this homo-FRET might be another 
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consequence of the clustering of the proteins under study in plasma membrane lipid rafts as 
described before98. But, in disagreement with that hypothesis, the putative, non-oligomeric 
raft marker protein GPI-YFP, although being highly enriched in lipid rafts (Figure 4-14), 
displayed a higher and homogenous anisotropy over the whole cells. 
Gp41-YFP oligomers are stabilized at the plasma membrane. The observation of an  
oligomerization of the Δ1 variant at the plasma membrane suggest that their assembly largely 
occurs here and not already, subsequent to the protein synthesis, in the Endoplasmic 
reticulum. Since an important characteristic of this variant is the absence of the well 
characterized gp41 endocytosis signals, the protein is transported to the plasma membrane and 
if any, only a small subset of the Δ1 population is reinternalized into cytoplasmic 
compartments. The wild type protein gp41-YFP on the other hand, still comprising internal 
domain and hence the interaction sites for the cellular endocytosis machinery is endocytosed 
efficiently. Accordingly, gp41-YFP was not only found to be non-monomeric at the plasma 
membrane but also in intracellular membrane compartments (Figure 4-25 and Figure 4-26A). 
This finding either suggests that gp41-YFP oligomers found in intracellular membranes 
represent already assembled multiprotein complexes reinternalized from the cell surface or it 
reports that the gp41 cytosolic domain contains factors that cause intracellular 
oligomerization. 
Gp41 oligomerization is CRAC dependent. Different protein inherent determinants of the 
HIV-1 envelope glycoprotein oligomerization have been reported in the last decades. Most of 
all, the transmembrane domain84,204 and extracellular region69,205–209 were shown to be 
involved in the assembly of functional trimers. The fusion proteins used in this study lack a 
considerable portion of the external region of gp41 and the complete gp120 interaction 
partner. To elucidate which of the remaining protein domains are relevant for oligomerization, 
several truncation and mutation variants were compared applying the anisotropy approach 
(Figure 4-26). As expected, on average low anisotropy values of around 0.2 were found for 
cells expressing gp41-YFP and Δ1 (Figure 4-26E), reporting that the maintained gp41 
domains comprise all intrinsic factors sufficient to ensure efficient oligomerization of both 
proteins. In contrast, anisotropy values comparable to the putative monomer control GPI-YFP 
were obtained for both CRAC-mutants, gp41mCRAC and Δ1mCRAC and the truncation 
variant Δ2 indicating an important function of CRAC domain and external region for 
oligomer assembly (Figure 4-26). 
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Figure 4-26: Oligomerization analysis using fluorescence a microscopy. (A) Fluorescence anisotropy 
images of CHO-K1 cells transfected with the raft marker GPI-YFP or gp41 fusion proteins. Pseudocolors 
refer to absolute anisotropy values. Scale bar, 15µm. (B and C) Anisotropy histogram plots allow 
appraising the oligomeric diversity of the protein under study. (D and E) Bar charts of average anisotropy 
maxima to compare the overall oligomerization state. Only the protein variant Δ1 and as a reference 
gp41-YFP were analyzed with respect to the localization dependence of occurring oligomerization (B and 
D) since only in Δ1-expressing cells differences were found. 5-10 different cells from at least two 
independent experiments were analyzed for the localization analysis and 5-15 from at least three different 
experiments for the different protein variants. The asterisks denote *** p<0.001, ** p<0.01, * p<0.05, ns 
p>0.05 by Student’s test for unpaired data. Bars display average values with SEM.  
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Considering the truncation variants scrutinized, it is evident that whereas an external region 
including a functional CRAC motif is sufficient (Δ1) to drive gp41 oligomerization in the 
plasma membrane of expressing cells, the transmembrane domain alone is not (Δ2). It is of 
note that in the context of two protein backbones (gp41-YFP and Δ1) the mutation of the 
CRAC motif abolished oligomerization completely, although both proteins still comprise 
TMD, MPER and the majority of the CHR. 
4.12 Analyzing membrane perturbation caused by the MPER of gp41  
4.12.1 Flow cytometric study of gp41 membrane perturbation 
In 2010 Apellaniz et al. reported, that peptides derived from the membrane-proximal external 
region (MPER) of gp41 possess membrane-disturbing properties210. It was shown, that the 
MPER causes membrane perturbation resulting in a pore-formation and leakage of large and 
giant unilamellar vesicles. It is reasonable to assume, that a comparable disturbance of the 
membrane integrity in a living cell is significantly affecting its condition even up to the 
viability. We performed flow cytometer experiments to investigate this hypothesis. As a 
parameter for the plasma membrane integrity we measured the cellular uptake of propidium 
iodide (PI). Precisely, cells expressing different fusion proteins were treated with PI and 
analyzed using a FACS (Figure 4-27).  
The gp41-YFP fusion protein possesses membrane perturbation properties. As a proof of 
principle, three different samples were investigated. Cell transfected with gp41-YFP, Gag-
GFP as membrane lytic negative control and mock-transfected cells were analyzed using the 
PI uptake assay. Untransfected cells revealed a PI-positive population of small particles 
(Figure 4-27, blue arrows) and a PI-negative population of bigger objects, most likely 
representing intact cells (Figure 4-27, red yellow). A very similar distribution was found for 
cells transfected with Gag-GFP. The population of dead cells was slightly elevated, most 
likely due to the overexpression of the viral protein (Figure 4-27, blue arrows). In case of cells 
transfected with gp41-YFP the plots remarkably changed. The population of dead cells 
increased significantly, probably as a result of the membrane lytic influence of gp41. 
Moreover, a new population of cells with the size of an intact cell but with a significantly 
higher PI intensity appeared (Figure 4-27, yellow arrows). These events might represent 
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intracellular endocytosis signals that control PM localization and retention, and the external 
MPER as the actual molecular factor of pore forming and bilayer disturbance. 
 
Figure 4-28: Plasma membrane perturbation of gp41 variants. CHO-K1 cells transfected with different 
fluorescent proteins were treated with PI as a reporter of plasma membrane and cell integrity. (A) Density plots 
of typical flow cytometer experiment. The propidium iodide channel is displayed in the y-axis, fluorescent 
protein signal in x-direction. In order to quantify the impact of the proteins on the cell viability and membrane 
integrity, the upper right quadrant populations, representing dead amongst fluorescent were related to the total 
fluorescent populations in both right quadrants. The obtained ratio was then plotted in bar charts as a reporter of 
membrane integrity. (B) Membrane perturbation results from at least three independent experiments per protein. 
To balance protein independent cell variations between different experiments, all samples of one experiment 
were normalized to the wild type gp41 fusion protein and obtained PI uptake values were then averaged over all 
experiments. The asterisks denote ** p=0.001-0.01, ns p>0.05, p < 0.005 by Student’s test for unpaired data.   
The CRAC domain is responsible for the MPER mediated membrane perturbation. 
FLIM-FRET experiments revealed an explicit influence of the CRAC domain on the gp41 
properties (Figure 4-14). Since the cell toxicity of gp41 fusion proteins seems to depend on a 
direct membrane interaction of the bilayer adjacent MPER (Figure 4-28B) it is conceivable to 
surmise a CRAC related membrane perturbation. To test this hypothesis, CRAC mutants were 
expressed and compared regarding plasma membrane perturbation with their respective wild 
type forms. Indeed, both variants, gp41mCRAC and Δ1mCRAC, showed a significantly 
reduced membrane perturbation (Figure 4-28A and B) pointing to an important function of the 
CRAC motif in the membrane perturbation caused by the MPER. 
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5. Discussion 
The goal of the present study was to investigate inherent properties of the HIV-1 
transmembrane protein gp41. Several biophysical and biochemical methods were utilized to 
elucidate raft partitioning, oligomerization, localization and trafficking of a YFP labeled, 
membranotropic wild type form and several truncation and mutation variants of the viral 
glycoprotein.  
We used FLIM-FRET to examine whether gp41 partitions into lateral domains of the plasma 
membrane. To our knowledge, this is the first experimental approach to determine a 
preferential lipid raft sorting of a relevant portion of the viral envelope complex in living 
cells. Constructs were produced containing all parts of the wild type protein that are able to 
interact with cellular membranes in the assembly context, namely transmembrane domain, 
external membrane proximal region, C-terminal heptad repeat and most importantly, 
cytoplasmic tail. An N-terminal labeling approach was favored over cytoplasmatic tagging to 
avoid interference of the fluorescent protein with the predominantly membrane associated C-
terminal domain. We could show that expressed gp41 variants cluster with the raft marker 
protein GPI-CFP in cellular plasma membrane microdomains and by comparing the different 
fusion protein variants we were able to identify the intrinsic cholesterol binding motif, the 
CRAC domain as the main factor of this property.  
5.1 Raft partitioning of the glycoprotein gp41 
5.1.1 Critical evaluation of FLIM-FRET data 
We found a low, but reproducible FRET efficiency for the membranotropic wild type gp41-
YFP that indicates a significant raft partitioning of the glycoprotein (Figure 4-14). Neither 
abolishing of the protein’s cytosolic domain, including one palmitoylation site and three 
amphipathic α-helices, nor an additional removal of the membrane proximal external region 
did significantly impair this behavior (Figure 4-14). On the other hand, a single amino acid 
change in the cholesterol recognition amino acid consensus decreased the FRET efficiencies 
decisively (Figure 4-14). Considering the unimpaired raft partitioning of the minimal variant 
(Δ2) our results suggest, that the CRAC is a sufficient determinant of the protein’s raft 
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association. Since other motifs like palmitoylated cysteines or amphipathic α-helices, 
suspected to cause a lateral plasma membrane sorting74,90,97,98,113,144,211 are abolished in this 
variant they do not or at least to a minor extend, contribute to this property of gp41.  
5.1.1.1 Validity of the CFP lifetime data 
To judge the reliability of our results it is important to understand the meaning and validity of 
FLIM-FRET data in general and in this approach in particular. In general, absorption, 
excitation and fluorescence spectra depend on the specific electron configuration of a 
fluorophore (Figure 5-1).  
 
Figure 5-1: Conformational states of CFP. (A) In this representation Cα traces of the CFP, GFP and 
YFP β-barrel are displayed in blue and green and yellow. The two CFP chromophore conformations are 
highlighted in blue, A’ and red, B’. Adapted from 176 (B) and (C) The two conformational states of CFP 
(labeled with black and grey arrows) are reflected in (B) excitation (in light blue) and emission (dark 
blue) spectrum and in (C) the biexponential (grey dashed line) fluorescent lifetime decay that is indicative 
of two independent components (dark and bright blue)176. It is yet unknown, what spectral peak and 
which of the lifetime decay curves is representative of what molecular conformation. 
Thus, the shape and position of the spectra is characteristic for certain fluorophores and 
represent some kind of a spectral fingerprint. The same holds true for the stability of the 
excited state of the fluorophore. Fluorescent molecules often show typical fluorescence 
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lifetime decays that are representative of distinct molecule conformation and electronic 
arrangements. CFP for instance shows a complex biexponential lifetime decay that is 
supposed to originate from different conformational states of the chromophore in the β-barrel 
of the fluorescent protein176. This has to be taken into account when CFP-lifetimes are utilized 
for the calculation of FRET efficiencies to derive meaningful and reliable conclusions form 
the data obtained. 
Although FLIM-FRET measuring equipment is highly sensitive185, the accuracy of TCSPC 
experiments is typically limited by several practical aspects. Different sample parameters such 
as photostability and molecular brightness of the fluorophore under study or a high 
background fluorescence and thus low signal-to-noise often significantly restricts the 
precision of assessed data. As a result of that, from their lifetime decays it is usually not 
possible to distinguish between both CFP conformational states and therefore amplitude-
weighted lifetimes are used to describe and quantify the CFP fluorescence. Although in our 
experiments the fluorescent lifetime values were highly deviating between single cells and 
single experiments, due to many repetition low standard errors were achieved and the overall 
fluorescent lifetimes of the donor-construct and the positive controls are supported by 
published data (Table 24).  
Table 24: Amplitude-weighted average fluorescence lifetimes of GPI-CFP in presence and absence 
of FRET-acceptor proteins. Experimental data from this study are displayed together with relevant 
published data.  
 GPI-CFP GPI-CFP & GPI-YFP GPI-CFP-YFP 
Thesis 2.53 ± 0.01 ns 2.38 ± 0.01 ns 1.94 ± 0.01 ns 
Millington
212 2.4 ns ---- 1,88 ns 
Scolari
98 2.3 - 2.6 ns 2.13 - 2.39 ns ---- 
It is important to keep in mind that fluorescence in general and fluorescent lifetimes in 
particular depend on different contextual factors. FRET experiments aim on detecting the 
aftermath of energy transfer that is a lowering of the fluorescent intensity and a shortening of 
the fluorescent lifetime. But temperature, pH, presence of other energy transfer partners and 
quencher molecules can influence both properties as well and have to be considered to 
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expected144 (Figure 5-2 B and D).  This contemplation is very important to avoid false-
positive results and judge obtained values qualitatively. Since all CRAC containing gp41 
variants elucidated in this studied showed FRET saturation at low concentrations and no 
further concentration dependent increase of the FRET efficiency, we surmise that obtained 
FRET values indeed reflect raft enrichment (Figure 4-15). It is noteworthy that both CRAC-
mutants, gp41mCRAC and ∆1mCRAC did not shown saturation in the concentration range 
investigated in this study.  
Although this analysis allows a reliable and qualitative interpretation of the FRET values, a 
quantitative analysis can be quite sophisticated. FLIM-FRET values usually represent bulk-
data of numerous fluorophores at the same time. For a stoichiometric molecular binding with 
a distinct distance of the interaction, obtained data basically depend on two factors, the 
relative fraction of the donors undergoing energy transfer and the distance between the 
participating FRET-partners. Depending on the analytic precision either information can be 
separated or if not, an efficient, average distance can be surmised. However, the situation is 
much more complex if FRET is used to study raft partitioning. A qualitative conclusion can 
often be drawn easily, but it is quite difficult to get accurate distance information. Obtained 
values depend on the individual size of the lipid rafts, the relative fraction of the FRET donors 
and acceptors that are partitioning in lipid rafts and the non-stoichiometric proportion between 
donor and acceptor. This complexity of the system and the resulting high number of variables 
impedes a quantitative interpretation of the data. Nevertheless, under the following conditions 
and assumption it is possible to assess some rough estimation and develop a plausible model.  
(1) The relationship between the FRET efficiency and the inter-fluorophore distance is 
given by the equation (from 150)  
𝑭 =
𝑹 
𝟔
𝑹 
𝟔 + 𝒓𝟔
 
(2) The FRET radius R0 of the pair CFP-YFP is roughly 5nm (from 213).  
(3) The average distance of homogeneously distributed membrane anchored fluorescent 
proteins is too high for FRET to occur (based on 139), only raft enriched proteins 
undergo energy transfer. 
(4) The overall number of FRET donor molecules (GPI-CFP) in the plasma membrane 
and in lipid rafts is constant in all experiments. 
(5) ~20 % of all GPI-anchored fluorescent proteins are clustered in plasma membrane 
lipid rafts of CHO-K1 cells (based on 139) . 
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(6) Since a further increase of the acceptor amount in the concentrational saturation region 
does not increase the FRET efficiency, lipid rafts are in that range crowded with 
fluorescent proteins. 
The fourth and fifth points are of course only simplifications of the real situation. Considering 
that saturation of the FRET efficiency is a result of a crowding of the microdomains, the 
number of competing raft proteins (gp41 variants, GPI-YFP) will directly influence the 
absolute number and ratio of raft residing donor molecules and GPI anchored proteins in 
general. Nevertheless, if this is objection is neglected, quantitative information can be 
estimated.   
In the previously described flow cytometric approach (see Figure 4-12), the fluorescence of 
surface bound anti-GFP antibodies was detected as a measure of the surface localization of the 
antigen. GPI-YFP was found to be in much higher concentrations at the plasma membrane 
than the virus protein variants (Figure 4-12). The surface exposure of GPI-YFP was indicated 
to be between 3 to 6 times higher compared to the different gp41-construct. Nevertheless, for 
all non-mutated gp41 chimeras a FRET-saturation was found already at low concentration 
level. If with the high plasma membrane concentration of GPI-YFP already around 20 % of 
those proteins are sufficient to completely crowd the lipid rafts (point 5), the fraction of raft 
localized gp41 protein variants needs to be correspondingly higher to cause saturation of the 
plasma membrane microdomains (Figure 5-3). This conclusion would be indicative of 60 % 
(for the Δ1 variant) to 100 % (for the gp41-YFP variant) of the virus derived proteins 
partitioning in GPI-enriched plasma membrane microdomains. This high affinity of gp41 for 
plasma membrane lipid rafts is also indicated by the small kd values, below 10
-3 of the FRET 
saturation plots (Figure 4-15).  
What does that mean for the CRAC-mutants? Considering, that their surface expression 
resemble the respective wild type proteins, the low FRET efficiencies obtained indicate a 
significantly lower fraction of fluorescent proteins partitioning in the lipid rafts. Interestingly, 
both CRAC mutants were never, even at very high concentrations found to reach the FRET-
saturation level of the non-mutant proteins (Figure 4-15). We surmise that no, or only a very 
low percentage of the mutant proteins partition into lipid raft whereas all CRAC-wildtype 
variants, gp41-YFP, Δ1 and Δ2 are preferentially localized in GPI-enriched plasma 
membrane microdomains.   
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by only 20 % of the GPI-anchored CFPs whereas 80 % remained unchanged (according to 
point 5), the energy transfer of the lipid raft localized GPI-CFP molecules is around 5 times 
higher than the calculated 8 % and thus reports average distances between GPI-anchored 
fluorescent proteins of 5.3 nm in the lipid rafts (according to point 1 and 2). It should be 
underlined that this consideration is apriori independent of the actual fraction of raft residing 
acceptor molecules since it is assumed that in the FRET saturation region as many acceptors 
as possible are localized in the microdomains (that means the same number for all different 
proteins causing FRET saturation). Therefore, the same calculation can be conducted for gp41 
constructs. Again, a fivefold higher FRET efficiency is assumed (based on point 5). Since all 
raft residing gp41 variants showed a FRET efficiency of around 5 percent, a final average 
distance of 8.5 nm between GPI-CFP and gp41 derived chimeras is obtained. 
5.1.2 Giant plasma membrane vesicles as a tool to study raft partitioning 
As a complementary method to study a preferential association of proteins with ordered 
membrane domains, a GPMV approach was conducted. It has been shown previously that 
proteins supposed to partition into lipid rafts colocalize with markers of the ordered but not of 
the disordered domain of phase separating GPMVs97. However, the most common preparation 
method based on PFA/DTT is supposed to produce artificial results and not to be reflective of 
native conditions since DTT is a strong depalmitoylation agent97. Therefore, a DTT-
independent preparation technique was established utilizing NEM instead of PFA/DTT to 
circumvent this effect97. Unfortunately, this preparation method is in general less efficient 
than the unphysiological PFA/DTT approach (see 4.10.1) and in our experiments viral fusion 
chimeras were always barely detectable in the NEM-GPMV membranes (see 4.5.3). Even an 
additional amplification of the fluorescence signal using fluorescent anti-GFP antibodies was 
not sufficient to increase the signals significantly (see 4.5.3). This observation of only weak 
expression of the fluorescent proteins in NEM-induced GPMVs was quite unexpected and the 
fact that clearly higher amounts of the viral chimera were found in PFA/DTT-GPMVs 
suggests an underlying sorting mechanism during the vesicle formation or in other words a 
selective exclusion of the proteins from forming NEM-induced GPMVs. Therefore, an 
investigation of the gp41 phase preference in plasma membrane-derived vesicles was 
impossible in our hands.             
  DISCUSSION  133 
5.1.3 Biological relevance of the gp41 raft partitioning 
The biological role of lipid rafts in general and their significance in the context of virus 
assembly is still under debate136. In case of the HIV-1 glycoprotein gp41 the intrinsic 
cholesterol binding motif was suspected to cause microdomain partitioning but foregoing 
studies on this topic reported partly inconsistent findings. Whereas the gp41 CRAC domain 
was clearly shown to specifically bind cholesterol76, in other publications CRAC mutations 
turned out not to cause sequestering of gp41 from detergent resistant membrane fractions81. 
The role of the gp41 lipidation in this context is even more ambiguous. DRM partitioning was 
described to be palmitoylation independent in one study101 and dependent in others90,99,100. 
The different methodical approaches used in those studies might be one explanation for the 
discrepancies, partly also with the results at hand. As mentioned before, most of the 
investigations of gp41 raft association are based on DRM assays, which are in general 
believed to be prone to artifacts and misinterpretation  and have to be scrutinized carefully119. 
Furthermore, results from other publications cannot be compared directly with the data of the 
present study since different virus isolates, typically the isolates HXB2 and NL4-3 (in this 
study: JRFL), with important deviations in the amino acid sequence were repeatedly used. In 
particular, the palmitoylated cysteine at position 837, lacking in the envelope complex used in 
this study, was described to be vital for raft association of HXB2 gp4190. Possibly, CRAC 
mutations introduced in those HXB2 derived glycoproteins81 might have been 
counterbalanced by the raft driving properties of that lipidation. Another hypothesis is implied 
by observations suggesting that different population of lipid rafts exist in plasma 
membranes90,99,214. Light and heavy rafts, possessing different densities in sucrose gradients, 
were found to be enriched in different proteins. Conceivably, CRAC domain and 
palmitoylation trigger association of the protein with different raft species. Palmitoylation 
mutants found to be excluded from one subpopulation of lipid rafts in DRM assays might still 
be sorted into another kind of microdomains due to the raft driving properties of the CRAC 
domain and, as a result of that, are still able to co-cluster with the raft marker GPI-CFP. This 
hypothesis is supported by the work of Nebl et al.214 who reported GPI anchored proteins in 
both fractions, light and heavy rafts. Of course GPI anchoring is a very abundant protein 
modification and it is not known in which of the fractions GPI-YFP and GPI-CFP would be 
enriched in. Interestingly, it was reported that the introduction of serines at both 
palmitoylation sites of gp41 completely abolished incorporation of Env in light and heavy 
rafts99 in the context of a non-truncated protein backbone. However, it could be shown that 
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bulky, hydrophobic amino acids could replace palmitoylated cysteines without eliminating the 
raft association of the protein99. This observation again points to a minor role of the lipidation 
for the microdomain partitioning. The phenomenon of light and heavy raft will be discussed 
again in the population heterogeneities section of the discussion. 
Another interesting hypothesis  is implied by recent in silico experiments215. The membrane 
organization of the Influenza transmembrane protein hemagglutinin (HA) was simulated in 
phase separating bilayers. In summary it was proposed that HA localizes at the periphery of 
microdomains as a result of an exclusion of the irregular and bulky transmembrane domain in 
combination with a preferential lipid raft incorporation of the protein’s cytoplasmic 
palmitoylation in the intracellular leaflet. In addition, palmitoylations have already been 
identified as the crucial factor of HA lateral membrane organization  by using the same 
FLIM-FRET approach as applied in this study98. In this light, our finding of a palmitoylation 
independence of the gp41 raft partitioning is even more surprising.  
What could be the background of those differences between gp41 and HA? In contrast to HA, 
gp41 comprises both, intracellular and extracellular elements assumed to have raft targeting 
properties, the internal palmitoylation and the external CRAC motif. Consequently, gp41-YFP 
should equally interact with lipid rafts on both leaflets and thus might have a higher affinity 
for microdomains in general. In our experiments, a solely mutation of the CRAC domain 
significantly reduced raft partitioning (Figure 4-14: gp41-YFP vs. gp41mCRAC), whereas a 
removal of the cytoplasmic tail and thus palmitoylation site did not (Figure 4-14: gp41-YFP 
vs. ∆1). Moreover, an annihilation of both did not result in a further decrease of the 
microdomain association (Figure 4-14: gp41mCRAC vs. ∆1mCRAC). This might indicate, 
that only the interaction with external leaflet lipid rafts results in energy transfer from the 
extracellular GPI-CFP to gp41-YFP but not a potential association of the cytoplasmic 
palmitoylation with lipid rafts at the internal leaflet. The presumption is conceivable that the 
results would be different if an internal labeling approach (as published by Engel et al. 124) 
would have been applied. However, in the aforementioned FLIM approach on HA, FRET was 
found between the same raft marker of the extracellular leaflet (GPI-CFP) and the only 
internally raft coupled HA. Therefore, this hypothesis appears not very likely.  
It is also conceivable that CRAC-mutants that comprise the palmitoylation are pushed to the 
interface of raft and disordered phase as suggested for HA from the simulations for 
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palmitoylated Influenza HA215. As a result of that the average distance to the raft residing 
GPI-anchored reporter proteins would increase resulting in a significantly reduced FRET. This 
hypothesis would also explain the low, but different from zero level of remaining FRET for 
the CRAC-mutant gp41mCRAC (Figure 4-14). But in disagreement with that speculation, this 
basal level remains also for the Δ1mCRAC variant that does not contain the palmitoylated 
cysteine and thus should be completely excluded from lipid rafts. Moreover, FRET was found 
to be proportional to the acceptor intensity for both CRAC-mutants pointing to an energy 
transfer that is induced solely by random interaction and therefore reports complete absence 
of any preferred clustering or local enrichment.       
5.2 Population heterogeneity in plasma membrane lipid rafts 
To date, lateral membrane organization is often schematized in a very simplified way. 
Bilayers are typically pictured as a homogeneous surface of a disordered “sea” with some 
floating, raft domains having a higher degree of packaging and order. Although supposed to 
be highly dynamic, the size, number and composition of the lipid rafts are assumed to be 
similar amongst different cells within a cell population and temporally stable in individual 
cells. However, careful examination of our FLIM-FRET results implies an additional 
complexity of plasma membrane organization (Figure 4-16). By obtaining data on a single 
cell level we were able to distinguish two separate populations of cells displaying 
significantly differing raft-related FRET efficiencies. Most likely, those systematic differences 
of the obtained FRET efficiencies reflect variations in the average size or composition of 
plasma membrane lipid rafts between individual cells. It is noteworthy that comparable 
results were obtained utilizing C6-NBD-PC as a reporter of overall membrane 
order (Figure 4-18). Again two populations were found with significant differences in the 
plasma membrane organization and factors like position in a cell colony or local cell density 
could be ruled out to be source of this heterogeneity. A flow cytometric cell cycle analysis 
revealed the average fractions of individual cells being in G1/G0, S or G2/M-phase (Figure 
4-19) and allowed to hypothesize that the populations of high FRET and high C6-NBD-PC 
lifetime might be identical with cells being in G2/M phase, whereas the low FRET and low 
C6-NBD-PC population represents the remaining cells in G1/G0 and S phase. We want to 
point out, that potentially the finding of systematic variations of single cell lipid rafts 
described in this work might indicate the same phenomenon as the light and heavy lipid rafts 
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described before (5.1.3). It is conceivable, that the two classes of lipid rafts observed in 
biochemical bulk experiments indeed do not reflect different kind of lipid rafts in every single 
cell, as proposed in the publication of Nebl et al.214, but rather the same two populations of 
cells that caused the significant differences in the energy transfer from raft marker to gp41-
chimeras found in our experiments.    
It has to be discussed what could be the molecular background of the two observed 
populations. What are the different average FRET efficiencies indicative of? In the approach 
applied in this study, differences in the energy transfer can originate from four causations: 
differences in  
(I) the association of the fluorescently labeled protein’s with rafts,  
(II) the orientation of the fluorescence dipoles,  
(III) the distance of the participating fluorophores and most importantly  
(IV) the overall number of fluorescent proteins residing in plasma membrane lipid rafts. 
Considering the crowding of the lipid rafts with fluorescent proteins that has been discussed 
before, (IV) should reflect overall ratio of microdomains vs. plasma membrane area. Since it 
can be assumed that the protein properties do not systematically differ between individual 
cells, (I), (II) and (III) can be neglected and variations in the plasma membrane organization 
are the only explanation left. Considering that, in addition the overall order of the plasma 
membrane could be demonstrated to vary from cell-to-cell, we surmise that the individual size 
of the lipid rafts or their absolute number is significantly higher in the small cell population 
since this hypothesis is suited to explain both, increased FRET efficiency and reduced NBD-
lifetime.    
5.3 Oligomerization of gp41 variants 
The question remains open, what exactly the biological role of the gp41 preference for plasma 
membrane microdomains is. And closely related to that question: Why is a conservation of a 
cholesterol binding motif evolutionary beneficial for human immunodeficiency viruses? It has 
often been hypothesized that an enrichment of the virus components in cholesterol enriched 
lipid rafts facilitates the virus assembly processes. However, direct experimental evidences for 
this hypothesis are missing. In this study, fluorescent polarization microscopy was used to 
address gp41 oligomer assembly in living cells. Firstly, GPI-YFP was used as a 
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multimerization negative control and the obtained values are in agreement with previously 
published data (Table 25). Then, it could be shown that gp41-YFP exist as oligomer at the 
plasma membrane and in intracellular compartments, demonstrating that gp41 alone, even in 
absence of gp120, has the propensity to form stable protein oligomers (Figure 4-26). In 
contrast to gp41-YFP, the variant Δ1 was found to be oligomerized exclusively at the surface 
of the cells (Figure 4-26). Obviously, for the multimerization of this variant, conditions are 
required that are only provided by the plasma membrane environment. The difference 
between Δ1 and gp41-YFP is the truncation of the cytoplasmic tail. Therefore, the difference 
in the oligomerization behavior of those variants can be explained by two models: 
(I) The oligomerization of both variants occurs at the plasma membrane, but whereas the 
internalization-deficient variant Δ1 remains at the plasma membrane, gp41-YFP is 
endocytosed efficiently after oligomerization at the surface. Thus, only this variant can be 
found in its oligomeric form in internal compartments.  
(II) The cytoplasmic domain causes intracellular oligomerization of gp41-YFP.  
Model (II) is supported by the work of Lee216 who reported spontaneous multimerization of 
the gp41 cytoplasmic domain. However, from our data it is impossible to distinguish between 
both models. A pulse chase oligomerization analysis or the introduction of mutations in the 
internalization motifs of gp41-YFP could shed further light on that question. In contrast to 
previous, indirect studies on gp4184,204 we could clearly show, that the transmembrane domain 
of gp41 is not sufficient to cause an efficient oligomer assembly of gp41-YFP (Figure 4-26, Δ2 
variant). This finding also indicates that MPER and the adjacent heptad region are the main 
factor of gp41 oligomerization and is therefore in line with several publications69,205–209. 
However it is contradictory to two studies reporting that the gp41 transmembrane domain 
causes di- and trimerization of reconstituted proteins in in vitro-cross linking experiments204 
and that it maintains a trimeric structure in a molecular dynamics simulation. However, both 
experimental approaches are highly artificial and might not reflect the native protein behavior. 
On the other hand, it has to be taken into account as well, that the Δ2 variant used in this 
study only comprises a short linker between transmembrane domain and the bulky, 
fluorescent protein. Therefore, it is also plausible, that the membrane spanning domain indeed 
contains motifs able to cause intermolecular interactions but the oligomerization is impeded 
by the sterical hindrance through the label. Interestingly, we also demonstrated that the 
oligomerization of the gp41-YFP fusion proteins is diminished for variants with CRAC 
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mutations (Figure 4-26). This observation may implicate a function of the CRAC domain for 
an efficient assembly or stabilization of protein oligomers and has not been reported before.  
Table 25: Anisotropies of chimeric fusion proteins. Experimental data are displayed together with 
relevant published data.  
 Protein Anisotropy 
Thesis GPI-YFP 0.28 ±0.01 
Gp41-YFP 0.21 ±0.01 
Gp41-YFP (intracellular) 0.18 ±0.01 
Gp41-YFP(plasma membrane) 0.19 ±0.01 
Gp41-mCRAC 0.30 ±0.01 
Δ1 0.22 ±0.01 
Δ1 (intracellular) 0.25 ±0.01 
Δ1 (plasma membrane) 0.11 ±0.02 
Δ1mCRAC 0.29 ±0.02 
Δ2 0.30 ±0.01 
Sharma et al.139 GPI-YFP (lipid rafts) 0.29 ±0.01 
GPI-YFP (∞ dilution) 0.31 
Bader et al.143 GFP (monomer) 0,29 
GFP (dimer) 0,25 
GFP (trimer) 0,21 
Whereas the importance of the external region of gp41 for formation of functional trimers has 
already been described extensively69,205–209, the discovered role of the CRAC motif needs to 
be further deliberated. What could be the molecular background and biological relevance of 
this CRAC dependent oligomerization observed for the gp41 constructs? We surmise that the 
lateral sorting of gp41 in plasma membrane lipid rafts is the crucial point in this context. We 
suppose that, as a result of the CRAC dependent protein accumulation in microdomains, the 
probability of oligomer assembly events was significantly enhanced and that this resulted in a 
higher fraction of oligomers in case of a raft partitioning fusion proteins gp41-YFP and Δ1.  
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However, we want to point out, that the observed trafficking and oligomerization behavior of 
our constructs does only partly reflect the native progression of the HIV-1 envelope complex. 
Trimerization was previously reported to be influenced by different parts of gp4169,203,205–
209,216 but also by the surface subunit gp120203. It is likely that gp120 or some of the external 
parts of gp41 that have been removed in this study could provoke an intracellular and raft 
independent oligomer assembly. Under physiological condition, the precursor gp160 
(gp41/gp120) already trimerizes in the ER 27,203 and subsequently, after cleavage in the Golgi 
apparatus the two individual subunits remain associated by weak, non-covalent interactions69, 
while the stability of this mature hetero-oligomer has been reported to be significantly 
impaired203 by the processing. However, stable trimers are a prerequisite for an efficient virus 
progression since virus-cell-fusion requires formation of the coiled-coil motif and, finally, the 
six-helix-bundle of the gp41 ectodomains. Hypothetically, the conformational change of the 
ectodomain that accompanies the membrane fusion may temporarily destabilize the external 
region and thus influence its role of in the preservation of functional trimers. The CRAC 
motif dependent oligomerization of gp41 in raft domains could be important to keep the 
stability during the conformational change. This is in support of a model suggesting lipid rafts 
not only as protein enrichment platforms but also as a subcompartments that stabilize protein 
complexes and facilitate protein interactions.  
Without any doubts, our data demonstrate, that gp41 transmembrane domain and external 
domain alone (Δ1 variant) have the potential to form stable oligomers at the plasma 
membrane of expressing cells and furthermore, that the oligomerization is significantly 
enhanced by the gp41 cholesterol binding domain.  
5.4 Membrane perturbation by gp41 
It seems reasonable to assume that either, raft association and oligomerization state of gp41 
influence other properties and functions of this protein. To address this question, as an 
example, the membrane destabilization potential of the different protein variants was studied 
in live cell cytometer experiments. The propidium iodide-uptake of transfected cells was used 
as an indicator of gp41 toxicity and pore-forming properties in the plasma membrane. The 
protein gp41-YFP was demonstrated to cause a significantly decrease of the membrane 
integrity compared to the negative controls (Figure 4-28). Supporting recent results of vesicle 
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leakage experiments9 primarily the MPER was found to cause gp41-mediated membrane 
disturbance (Figure 4-28) as seen by the negative control-like result for the Δ2 variant. A 
truncation of the cytosolic protein domain produced a further slight increase of PI uptake 
compared to gp41-YFP as a result of higher plasma membrane concentrations caused by the 
concomitant removal of the gp41 internalization motifs. It is of note that the cytoplasmic 
domain also comprises the three lentivirus lytic peptides (1.2.2.3.1) and could thus be 
expected to cause membrane perturbation as well. From our experiments it can be deduced 
that this function of the cytoplasmic tail is not of relevance in the assembly context. Instead it 
might be constricted to entry processes and is supposably mediated by interaction with other 
components within the virion. However, as before the CRAC mutation of wild type and 
truncated gp41 influenced the protein behavior significantly. A reduced number of PI positive 
cells was found, pointing to an important function of this motif in the MPER induced 
membrane perturbation (Figure 4-28). Most likely, the gp41 lyticity is strongly influenced by 
the CRAC dependent lateral sorting in lipid rafts. The MPER might depend on the 
microdomain environment that significantly deviates from other parts of the bilayer, to cause 
membrane perturbation. At first glance this seems to be implausible since lipid rafts are, due 
to their compositional differences, supposed to be more ordered and more rigid than other 
parts of the plasma membrane, which should impede a disturbance of the bilayer integrity. 
However, recent experimental data demonstrated an amplified membrane perturbation of 
MPER peptides in vesicles containing cholesterol38.  
In recent years, different conformations have been suggested for gp41 with the MPER 
oriented perpendicular or parallel to the plasma membrane69 allowing to suggest an expanded, 
conceivable model of the observations described before. We propose a mechanism based on a 
cholesterol dependent conformational change in the gp41 membrane adjacent, external region. 
The interaction of the CRAC domain with cholesterol might cause a recruitment of the MPER 
α-helix towards the membrane which in turn exerts pore-forming and membrane leakage 
(Figure 5-4). This mechanism might be evolutionary beneficial since protein conformation 
and function are in this way directly regulated by the lipid composition of the surrounding 
membrane. Since cholesterol is enriched in viral, plasma and endosomal membranes but less 
in Golgi apparatus and endoplasmic reticulum163,217 an unfavorable disruption of intracellular 
protein synthesis compartments might be prevented. Consequently, the mechanism could 
permit longer survival of infected cells and as a result of that, higher yields of virus particles.  
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Of course, other explanations of the phenomenons observed are conceivable as well. 
Considering obtained results from oligomerization experiments it is also reasonable to 
assume, that the gp41 membrane perturbation property depends on assembled oligomers. 
Hence, the obtained CRAC-dependence of the bilayer destabilization/pore-formation81,210 
would be an indirect result of the gp41 oligomerization, which in turn is constrained to a 
lateral sorting into lipid rafts and by that to a functional CRAC domain.  Further experiments 
are necessary to achieve a complete and conclusive understanding of the interplay between 
raft partitioning, protein complex formation and membrane perturbation of the HIV-1 
envelope protein.            
 
Figure 5-4: Hypothetical mechanism of CRAC dependent membrane perturbation. (A) Gp41 
structure in absence of membrane cholesterol. (B and C) Magnification of the relevant portion of gp41. 
(B) Possibly, in absence of cholesterol, the gp41 CRAC domain does not bind to the membrane resulting 
in a protein conformation with the MPER oriented rather perpendicular to the bilayer. (C) As a 
consequence of an interaction between the CRAC domain and cholesterol in the membrane the MPER 
might be recruited towards the plasma membrane, thereby penetrating the bilayer surface and disturbing 
the membrane integrity. 
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5.5 Integration of the results into the prevailing understanding of gp41 
In this study several properties of the HIV-1 glycoprotein gp41 were investigated in a live cell 
context. Data were obtained that report intracellular trafficking, oligomerization, plasma 
membrane lipid raft partitioning, protein-cytotoxicity, membrane perturbation, palmitoylation 
and virus particle incorporation. Although many of those properties appear completely 
independent of each other, in particular in case of gp41 they might be highly interconnected. 
Lipid raft partitioning for instance, might be of relevance for oligomerization and virus 
particle incorporation of gp41. Oligomerization is a conceivable factor of protein-induced 
membrane perturbation and pore-formation. Thus, a comprehensive view on all observation is 
of high importance. For a better understanding, all variants used in this study are displayed in 
Figure 5-5. 
 
Figure 5-5: Supposed schematic structures of gp41 constructs. Important motifs are highlighted in red 
and. From YFP tagged N-terminus to the C-terminus are CRAC domain, YXXL endocytosis motif and 
palmitoylation displayed. In the mCRAC variants, the cholesterol binding motif (blue) is labeled with a 
black arrow.       
The most prominent result from all experiments is that the mutation that has been introduced 
in the protein’s cholesterol binding motif strongly influences most of the studied properties. 
Mutants showed significantly reduced raft partitioning, membrane perturbation and even 
oligomerization (summarized in Table 26). It should be underlined again, that the introduced 
mutation only comprised one single amino acid exchange from a leucin to an isoleucine and 
thus should only have a minor influence on the domains overall properties, such as folding, 
hydrophobicity or charge. Since the very same mutation was found to hamper the cholesterol 
binding potential of the CRAC domain78,79 it is very likely that this function is the crucial 
factor causing all observed mutation-induced changes. A specific binding of proteins to lipid 
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raft components is a well-known mechanism of raft partitioning control (Reviewed in 74). We 
surmise that cholesterol binding of the gp41 CRAC domain causes the protein’s sequestering 
in plasma membrane microdomains. Moreover, we suggest that this local enrichment 
significantly stabilizes gp41 oligomers (also discussed in 6). 
Table 26: Summarized results of major experiments. FRET efficiencies, anisotropies and PI-uptake 
rates are shown for GPI-YFP and different gp41 variants. GPI-YFP should be considered as a raft 
partitioning positive control, whereas it serves as a negative control regarding oligomerization and 
membrane perturbance.  
Protein GPI-YFP Gp41-YFP Gp41mCRAC Δ1 Δ1mCRAC Δ2 
FRET efficiency [ns] 7.93 ±0.33 5.00 ±0.37 2.00 ±0.37 4.81 ±0.38 2.10 ±0.34 5.43 ±0.56 
anisotropy        [a.u] 0.28 ±0.01 0.21 ±0.01 0.30 ±0.01 0.22 ±0.01 0.29 ±0.02 0.30 ±0.01 
PI-uptakenorm   [a.u.] 0.64 ±0.06 1.01 ±0.02 0.88 ±0.03 1.09 ±0.04 0.85 ±0.07 0.67 ±0.04 
Since Env oligomerization is a non-covalent, reversible association of laterally diffusing 
proteins it is subjected to the laws of mass action. In a steady-state the overall number of 
oligomers is concentration dependent and high local concentrations in lipid rafts should 
therefore increase the probability of the formation of functional oligomers. Interestingly, the 
CRAC-mutation was found to influence gp41 membrane perturbation as well. We suggest that 
cholesterol binding again is the basis of that behavior. Two different models can be proposed. 
(1) Cholesterol binding causes an enrichment of gp41-YFP in plasma membrane lipid rafts 
and thus facilitates or stabilizes oligomerization. Since oligomerization is often assumed to be 
prerequisite of poreformation92 in this way cholesterol binding might be linked with 
membrane perturbation via raft partitioning dependent oligomerization. (2) In the presence of 
cholesterol, the MPER membrane binding affinity is significantly increased. The region is 
recruited towards the bilayer, partly penetrates it and thus disturbs the membrane integrity 
causing leakage.  
It is reasonable to guess, that other protein functions are related to lipid raft partitioning as 
well. It has been proposed that gp41 adopts different conformations with structural 
consequences for the accessibility of endocytosis motifs92,102. Conceivably, this refolding 
process is related to microdomain incorporation as well. Therefore, even counterintuitive 
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properties like trafficking might be related to lipid raft partitioning. However, this hypothesis 
is not supported by our surface exposure data (4.5.2). 
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6. Summary and conclusions 
In the framework of this study we used several methods to study different properties of the 
HIV-1 glycoprotein gp41. Aim and purpose was to shed further light on membrane-related 
phenomena and intrinsic properties of the protein in the context of expressing cells without 
the influence of other viral components. The surface subunit of the envelope complex, the 
glycoprotein gp120 and some external parts of the transmembrane subunit, gp41 were 
replaced by a yellow fluorescent protein to allow different fluorescence-based experiments. 
Fusion proteins were produced containing all membrane proximal regions and domains 
supposed to interact with cellular membranes in the synthesis and assembly phases of the 
virus lifecycle. This approach offers several advantages. The fluorescent tag allows a 
microscopical visualization of the intracellular localization but moreover also direct 
interaction studies based on FLIM-FRET and anisotropy measurements that enabled us to 
assess information in a length-scale below the detection limit of light microscopy. By 
replacing only external and membrane-distanced parts of the envelope complex with the 
fluorophore it was ensured that direct membrane-interactions and in particular the function of 
the cytoplasmic tail are unaffected by the tagging. However, conclusions about properties of 
the envelope complex that might be related to the removed parts, such as for example about 
the oligomerization43,207,209 cannot be definitely judged from our results.  
Although HIV and its components have been extensively studied and thus this virus is in 
general one of the best characterized pathogens, still many questions remain open. The 
cytoplasmic tail of the envelope complex is a typical example. Although the unusually length 
of this domain is highly conserved in lentiviruses, it does not exist in that form in other 
retroviruses91. The role of the cytoplasmic tail in the virus lifecycle and its specific function is 
not fully understood91. Moreover, other already identified domains and motifs, in particular in 
the membrane adjacent, intracellular but also external region of gp41 have not been 
concludingly elucidated yet and their relevance is often still under debate91. Known and 
supposed interactions of virus components with host cell proteins, compartments and 
structural elements need to be further investigated to achieve a complete understanding of the 
virus biology and allow an efficient control of the HIV pandemic and individual infections. 
For example, it has been proposed that many viruses and in particular HIV might use the 
lateral subcompartmentation of cellular membrane systems to facilitate their highly regulated 
assembly (reviewed in 218). Many, strong indications have been already found pointing to an 
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important function of cholesterol-enriched lipid rafts. Most importantly, it has been 
demonstrated that virus envelope strongly resembles host cell microdomains163,164, and thus 
significantly differs from the overall plasma membrane, with respect to lipid and protein 
composition. Moreover, it was shown that virus assembly shifts away from the plasma 
membrane to the Golgi apparatus in cells harboring a non-sense mutation in proteins involved 
in the cholesterol-trafficking that causes a respective dislocation of the cellular cholesterol219. 
On the other hand, in some studies lipid raft partitioning of the virus envelope complex was 
observed not to be important for different protein functions such as Env incorporation and 
virus progression in general. Furthermore, contradictory and inconsistent results were 
obtained regarding gp41 intrinsic factors of a potential microdomain preference.       
The outstanding question that we aimed to address with this study was, what is the role of 
lipid rafts in the HI virus assembly. The obtained results allow drawing the following 
conclusion in that context. 
1. The majority of overexpressed HIV-1 gp41 glycoproteins do efficiently partition into 
GPI-enriched plasma membrane microdomains in CHO-K1 cells.  
2. The proteins intrinsic cholesterol binding motif (CRAC) is the sufficient and 
necessary determinant of this property. Other parts of the protein from the virus isolate 
JR-FL such as palmitoylation or membrane interacting amphipathic α-helices do not 
contribute to the raft affinity. 
3. CRAC mutations do not influence protein expression and surface exposure.  
4. The glycoprotein’s C-terminal heptad repeat, membrane proximal external region 
(MPER) and transmembrane domain alone are sufficient to drive oligomerization of 
gp41 even in absence of other parts of the Env gene product. 
5. The external region is crucial for the oligomerization of the chimera. Upon removal, 
this property is abolished. 
6. The external region-induced oligomerization is CRAC dependent which might point to 
an oligomer stabilizing function of the protein’s lipid raft partitioning. 
7. Gp41 possesses membrane perturbing properties that are CRAC and external region 
dependent. 
8. The plasma membrane organization significantly differs between individuals of a cell 
line. At least two populations exist with systematic differences in the lipid rafts.  
Taken together those findings confirm the hypothesis that gp41 is a lipid raft residing protein. 
Moreover, the highly conserved CRAC domain was found to be an indispensible prerequisite 
of the lateral sorting. Surprisingly, we found that other properties such as oligomer stability 
and membrane perturbation also depend on a functional CRAC domain. Whether this is a 
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direct consequence of CRAC interactions in the respective contexts or results from CRAC 
induced lipid raft partitioning remains open.  
Since the removal of the gp41 external domain and gp120 significantly interferes with the 
oligomerization properties of the glycoproteins, conclusions from the results at hand about the 
native situation are highly hypothetical. Nevertheless, a model is suggested that integrates our 
observations with previous results (Figure 6-1).  
 
Figure 6-1: Model of HIV-1 Env progression from synthesis site to the plasma membrane. The Env 
glycoprotein is synthesized as a polyprotein precursor in the rough endoplasmic reticulum. Here, 
monomers of gp160 also oligomerize into predominantly trimers. Upon proteolytical cleavage by cellular 
proteases in the Golgi apparatus the surface subunit gp120 and the transmembrane subunit gp41 are 
generated. Although, gp120 and gp41 remain associated by non-covalent interaction, forming a 
heterotrimeric glycoprotein spike, this process reduces the oligomer stability significantly. In the late 
Golgi apparatus and in the plasma membrane the complex partitions into microdomains, causing a local 
enrichment and therefore effective stabilization of the oligomeric structure.  
From biochemical experiments it is known, that the precursor protein of the envelope 
complex, the protein gp160 is synthesized in the rough endoplasmic reticulum27. The 
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precursor oligomerizes and is transferred to the Golgi apparatus where proteolytic cleavage 
into gp41 and gp120 occurs27. This cleavage decreases the oligomer stability203 but the 
complex remains assembled as a trimer of heterodimers that is finally transported to the 
plasma membrane. We surmise, that indeed factors within gp120 are important for the early 
trimerization of Env in the endoplasmic reticulum. Upon enzymatic cleavage in the Golgi 
apparatus and due to the instable, non-covalent linkage connection between the two subunits, 
the oligomerization influence of gp120 might be only weakly transferred to gp41 and thus the 
complete complex is destabilized. But, the emerging local enrichment of the glycoproteins in 
lipid rafts of the Golgi apparatus and later in the plasma membrane might compensate for this 
destabilization. As a result of the high concentrations that are induced in the lipid rafts, the 
monomer to oligomer equilibrium is pushed towards the oligomerization state. This 
hypothesis would be in agreement with the previously published biochemical results and the 
findings of this work. 
However, this study also raised some completely new issues. Is there any influence of the 
CRAC domain on the investigated properties even in physiological environments (i.e. 
macrophages)? Although lipid raft partitioning can be expected to be unaffected by the 
truncations introduced in the protein gp41-YFP, oligomerization and membrane perturbation 
might be different compared to the wild type situation. The relevance of CRAC mutations 
here would be an interesting topic to elucidate. Undoubtedly, the most prominent question that 
was raised by this work is what is the biological meaning of the observed inhomogeneity of 
the membrane organization? What are the cell-to-cell differences related to? Do they follow 
cellular adaptions while the cell is progressing through the cell cycle or do they reflect 
differences in the microenvironment of individual cells? What is the molecular background of 
the deviating lipid raft size and overall membrane order? Some of the hypothesis made before, 
are based on assumptions that need further verification. The uncertainties and the open 
questions have to be studied in complementary and perpetuating approaches.  For this 
purpose, some of the produced constructs may be used in the future to study their behavior 
especially upon coexpression with Gag-constructs. Moreover, the finding that the cytoplasmic 
tail of gp41 is not involved in the proteins raft partitioning should be considered for further 
raft partitioning experiments and suggests an intracellular gp41 labeling approach as 
conducted by Engel et. al124.      
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